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ABSTRACT
An accurate autoradiographic method capable of assessing, qualitatively and
quantitatively, the spatial and kinetic microdistribution of boron compounds at the
cellular level has been developed. The B-10 distribution and cell morphology obtained
are employed in a novel 2D Monte Carlo simulation to study microdosimetry. This 2D
approach was validated to be equivalent to the actual 3D transport.
A novel approach to measuring cell and nuclear volumes has been developed.
This approach does not require any assumptions on the cell shape or geometry. A wax
phantom was built for the validation of the calculations. This is an important parameter
in micordosimetry.
An approach based on fast-fourier transform (convolution) to determining
multiple-event energy distributions from single-event result has been proposed. Using
this FFT approach the long computational time required by Monte Calro simulations is
reduced by order of magnitudes.
Radiobiological effectiveness of different B-10 compounds and potential capture
nuclides were eveluated. This evaluation technique can be used to predict the RBE
values for different capture agents.
The high resolution alpha-autoradiography technique was employed to determine
the B-10 concentrations in human tissue samples for the MIT Phase I Clinical Trial.
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Chapter 1 Introduction
1.1 Foreword
Since the first use of radiation in clinical therapy, the science and technology of
ionizing radiation has been developed and expanded to effectively treat a wide variety of
tumors. For many, radiation therapy as a primary or adjuvant treatment either leads to
cure of their disease or is a highly effective means of palliation. However, the results of
even modern radiotherapy for the management of primary brain tumors and tumor
metastases to the brain from primaries arising elsewhere in the body have been extremely
disappointing. Standard radiotherapy for the treatment of high-grade brain tumors
following a biopsy or subtotal resection is to give external beam radiation with high-
energy x-rays (4 or 6 MeV) to a dose of approximately 60 Gy in fractions of 1.8 or 2.0-
Gy daily, five days a week. 1 Recently, there have been a number of series published in
which high dose interstitial radiation has been added to conventional external beam
radiation to provide localized tumor dose up to 160 Gy.2 ,3 Unfortunately, despite these
high doses, a clear therapeutic benefit for these brain tumor diseases has not been proven.
Average results of treatment show that for anaplastic astrocytomas, the median survival is
approximately twenty-seven months, whereas for glioblastoma multiforme it ranges from
eight to fourteen months.4 It has been demonstrated that untreated glioblastoma
multiforme results in a median survival of approximately three months. Hence, the effect
of the external high energy x-rays beam radiation delivered at classical dose is to add
only approximately six months to the survival of the patient.3 One of the main problems
in any form of treatment for these brain tumors is the difficulty in defining the tumor
border because there may be a tendency for disease to infiltrate diffusely into surrounding
normal brain tissue. In the United States, there are about 10,000 new primary brain
tumor cases annually. 4 A new promising type of radiation modality for curing primary
brain tumors and brain metastases is expecting. Neutron capture therapy is one of the
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most potential candidates. Clinical trials of NCT with boron as capture element have
been undergoing recently with encouraging progress .5,6
1.2 Principles of Neutron Capture Therapy
The concept of neutron capture therapy (NCT) was proposed soon after the
discovery of the neutron by Chadwick in 1932. Gordon Locher, proposed the principle
of boron neutron capture therapy (BNCT). 7 The naturally existed boron-10 atoms (B-10)
have a high absorption cross section for slow neutrons, about 4000 barns for thermal
neutron. Immediately after capturing a thermal neutron, B-10 becomes B-11 and then
disintegrates into an energetic alpha particle and a recoiled Li-7 ion, which have a
combined range of about 11 to 12 microns (4.81 gim for Li-7 and 7.7 plm for alpha).
Figure 1.1 is a schematic diagram of the B-10 nuclear capture process. If B-10 enriched
compounds could be selectively concentrated in a patient's tumor, a high radiation dose
to the tumor cells would result while sparing the adjacent normal tissues..
In 1940, Kruger 8 reported on the reduced viability of transplanted mouse tumors
following their exposure to boric acid paste and subsequent irradiation with thermal
neutrons. Zahl et a19 also reported the regression of murine sarcomas in similar BNCT
experiments. However, due to the poor penetration of thermal neutrons in tissue, BNCT
would be difficult to apply to the deep seated tumors but only to those located
superficially. In 1941, Zahl and Cooper 10 suggested that to overcome this problem
epithermal neutrons would need to be used because they would not be captured by B-10
atoms until they had slowed down to thermal energies at a depth of several centimeters in
tissue. Since then, neutron beam development has been the major task in the BNCT
research. The medical therapy neutron beam at the MITR-II reactor has been developed
with neutron energy at the epithermal regions. Characteristics of the MITR-II beam are
summaried in Appendix A.
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AI.
Ia
Thermal neutron
Boron-10
Boron-11*
-i-7 (0.84 MeV)
Y-ray (0.478 MeV 93%)
Figure 1.1 A schematic description of thermal neutron capture by a B- 10 atom and
the resulting charged particles release.
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Apart from neutron beam development, successful NCT requires an intensive
effort in boron compound pharmacology and techniques that localize and quantitate
boron in tissues at both macroscopic and cellular levels. The therapeutic ratio achievable
with BNCT depends upon the boron concentrations in tumor and in normal tissue or
blood. The ideal boron delivery agent must exhibit high concentrations in tumor with
infinitesimally low concentrations in surrounding normal tissue and blood. 11 Given the
short ranges of the alpha and Li-7 ions emitted from the boron neutron capture reaction,
an intracellular or, preferably, an intranuclear boron localization is desired. Although
boron-10 has been the major candidate for NCT, there are other potential elements which
may be useful for the purpose, e.g., Gd-157, U-235, He-3, etc. A summary of the
physical properties of potential capture elements is listed in Table 1.1.
1.3 Thesis Objectives
The objectives of this thesis were:
[I] To develop a technique for analyzing the actual B-10 distributions in human
tissue samples. (Ch.3)
[II] To develop a 2D microdosimetry model. (Ch.4)
[Im] To validate the 2D microdosimetry model. (Ch.5)
[IV] To develop a technique for determining cell and nuclear volumes. (Ch.6)
[V] To perform B-10 analysis for the Phase-I trials conducted at MIT/NEMC. (Ch.7)
[VI] To develop a technique for the evaluations of compound efficacy for NCT. (Ch.8)
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Thermal Neutron Capture Cross-Sections of Potential Nuclides for
[a] Radioactive
[b] Data obtained from Ref.[12]
[c] Calculated by conservation of energy and linear momentum
[d] Calculated by TRIM-91 [13]
Abbreviations: CP=charged particle, FP=fission product, f=fission reaction, y=gamma
capture reaction.
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Neutron Cap ture Therapy
Nuclide Abundance 2200 m/s Neutron K.E. Range
(a/o) or Cross- reaction of C.P. of C.P.
half-lifeb section (MeV)c (rnm)d
(barns) b
Helium 1.38E-4 5.33E3 3He(n,p) 3H p = 0.5725 p = 10.0
(3He 2) 3H =0.1913 3H = 3.03
Lithium 7.5 941 6Li(n, a) 3H a = 2.056 a = 10.5
(6Li 3) 3H = 2.729 3H = 61.0
Boron 19.9 3838 10B(n,a) 7Li a = 1.473 a = 7.3
( 10B 5 ) 7 Li =0.840 7 Li = 4.0
Cadmium 12.22 2.06E4 113Cd(n,y)114Cd NA NA
( 11 3Cd4 8 )
Xenon 9.1 hr. 2.6E6 135Xe(n,y) 136Xe NA NA
(13 5 Xe54)a
Samarium 13.8 4.0E4 149Sm(n,y)150Eu NA NA
( 14 9 Sm62)
Europium 47.8 5.9E3 151Eu(n,y)1 52mEu NA NA
(15 1Eu 6 3 )
Gadolinium 14.8 6.1E4 155Gd(n,y) 156Gd NA NA
(155Gd64)
Gadolinium 15.65 2.55E5 157Gd(n,y) 158Gd NA NA
(157Gd64)
Uranium 0.72 585(f) 235U *(n,f) FP1=112.5 FP1=27.2
(235U92)a 99(Y) FP2=61.5 FP2= 11.6
Table 1.1
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Chapter 2 Rationale of Microdosimetry
2.1 Introduction
Due to the nature of ionizing radiation, the interactions with the atoms of the
medium through which it passes is discrete. However, absorbed dose is defined as
statistical average of the energy imparted per unit mass that disregards the resulting
random fluctuations of energy distribution at the cellular levels. 1 For most
radiobiological considerations this quantity therefore loses all direct meaning. The
knowledge of absorbed dose may permit no statement on energy actually imparted to
individual cells or to subcellular structures. The deviations are most substantial for small
targets, for small doses, or for high LET ionizing radiations; in many cases the energy
imparted at a given absorbed dose can be zero or it can exceed the expectation value by
orders of magnitude due to the inhomogeneity of energy distribution.
There are many biological applications with specific limited objectives where the
techniques of conventional (macroscopic) dosimetry provide an adequate physical
description of the interaction between the radiation field and biological material. For
example, conventional photon radiotherapy treatment can be based on physical
dosimetric descriptions of isodose contours in the patient. 2 Resolution of the order of
millimeters is required and inhomogeneity of energy deposition within cellular or
subcellular dimensions of micrometers is unimportant (Fig. 2.1). However, even in some
radiotherapy situations fluctuations at the cellular level may be of practical important,
especially when the localized energy deposition is considerate by densely ionizing
particles (such as in neutron, pi-meson, heavy ion, and radionuclide radiotherapy).
Additional concepts and quantities are therefore required to specify the energy
concentrations in microscopic regions. This is the subject matter of microdosimetry .3
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Radiation target
Type
of
radiation Whole Individual Chromatin DNA Mean No.
Tissue cells fibre of lethallesions
(total -5 cm /cell) (total ~- 2 m /cell) per cell
- 20 gm 25 2 nm
External I /
rays , / 2nm
Dose Uniform -Uniform Very large Very large ~ 0.001
fluctuations fluctuationsuniformity Dose=1 cGy Dose=1 cGy 0 to 103 Gy 0 to 106 Gy
Mean No. -50 per cell -10-6 per segment -10-8per segment
of tracks 109 gm -1  No cells -20 segments ~10 segmentsunirradiated hit per cell hit per cell
~ 20 gm 25 nm 2nmInternal A 2
220Rn A^ 6A, 20
(3 a's)
Variable Large Very large Very large ~ 0.01
Dose doses fluctuations fluctuations fluctuations
uniformity 0 to -2 cGy 0 to - 30 cGy 0 to 104 Gy 0 to 2xl06Gy
Mean No. -0.1 per cell -6x10-7/segment -10-8per segment
of tracks 7 gm-1 - 90 % of cells ~ segments -10 segmentsof tracks 10 g unirradiated hit per cell hit per cell
S20 ýmn 25 nm 2nm
E xternal h cl
10 MeV A
neutrons 2nm
Large Very large Very large - 0.005
Dose Uniform fluctuations fluctuations fluctuations
uniformity Dose=1 cGy 0 to- 5 cGy 0 to 5x10 3 Gy 0 to 106Gy
Mean No. ~ 1 per cell -4x10-6/segment ~10-8 per segment
107 -1 -37 % of cells -8 segments -10 segments
of tracks 10 gm unirradiated hit per cell hit per cell
Fig. 2.1 Diagrammatic representation of microscopic patterns of radiation tracks
corresponding to 1 cGy macroscopic absorbed dose. (Adapted from Ref. [2])
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The term microdosimetry originated when Rossi and coworkers 4-9 developed a
conceptual framework and the corresponding experimental methods for the systematic
analysis of the microscopic distribution of energy deposition in irradiated matter.
Stochastic quantities, such as the specific energy, z, and the lineal energy, were defined
and measured. These quantities describe the energy-deposition events in microscopic
structures, such as small spherical volumes - simulated radiation target. Such quantities
and their probability distributions are central concepts in microdosimetry. 10 A summary
of the standard microdosimetric parameters or quantities suggested by the ICRU Report
36 is outlined in Appendix B. Some of these parameters will be used in this thesis.
2.2 Review of Microdosimetry for Neutron Capture Therapy
Microdosimetry has been an important tool to investigate the biological
effectiveness of the BNCT reaction. Figure 2.2 is a chronological chart of the published
microdosimetry works since 1970. The work of Davis et all represents the earliest
attempt at employing Monte Carlo simulation to calculate the absorbed dose fraction and
the RBE of the 10B(n, o)7Li reaction in a spherical model representing a HeLa cell.
Inspired by the earlier experimental work of Munro et a112 who showed that cell
cytoplasm is virtually insensitive to alpha particle damage, Deutsch et a113 used Monte
Carlo simulation to examine the hit probability to the cell nucleus employing cylindrical
representations of various sized blood vessels with associated spherical nuclei. Kitao 14
modeled the location of boron within annuli of various radii centered on the nucleus of a
spherical cell model. This was the first attempt at modeling a more general
heterogeneous distribution of boron in cells to examine the dependence of dose or hit
probability on boron location, which enabled chemists working on boron compound
synthesis to appreciate the increased potency of intranuclear boron compounds vs, for
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Figure 2.2 Historical review of BNCT microdosimetry
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example, antibody mediated (cell surface localizing) boron compounds. Rydin et al 5
employed Monte Carlo simulation to calculate the absorbed dose fractions to spherical
tumor cell models of various diameters and to endothelial cell models with various wall
thicknesses. In their capillary models Deutsch et a13 and Rydin et a115 assumed boron to
be localized in the blood, and both concluded that under such conditions the endothelial
nuclear hit probability or absorbed dose fraction, respectively, would be approximately
1/3-1/5 of the values with homogeneous boron distribution. Therein lay the first
characterization of the "geometric factor," which defined the protection that endothelial
cells from boron in blood. In a later paper Gabel et a116 described this parameter more
objectively as the "compound factor". Kobayashi et a117 used deterministic calculations
for a matrix of tumor cells and nuclei to calculate effects on the nuclei using various
microdosimetric parameters such as nuclear absorbed dose fraction and hit probability,
including cell-to-cell "crossfire" effects. They defined the "boron selective dose ratio"
which, similar to the geometric or compound factors, quantified the relative efficiency of
the 10B(n,a)7Li reaction against the cell nuclei but for homogeneous boron distribution.
Using a concept originally proposed by Bond, Gabel et a116 calculated the RBE for the
loB(n,a)7Li reaction using a "hit size effectiveness function" which proposed an effect
threshold for particles striking the nucleus, and then either a step function or a
progressively increasing effect with increase in track energy deposited. Wheeler et al 18
combined Monte Carlo simulations of a cylindrical capillary model with a "stochastic
survival function," which included an exponential dependence on the mean number of
nuclear hits, incorporation of the concept of Gabel's HSEF, and a "microscopic biological
response function" which could be defined from radiobiological experiments. Charlton et
al 19-21 used Monte Carlo simulation to examine in detail the probability distributions of
energy deposited in the nuclei of spherical, ellipsoidal, and disc-shaped tumor cell and
cylindrical capillary models from both the lOB(n,a) 7Li and the 14N(n,p) 13C reactions.
These were then related to the probability of survival based on the distribution of specific
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dose to the cell nuclei. Charlton's papers provide a different and useful perspective in
attempting to understand the radiobiology of BNCT through microdosimetric modeling.
Wuu22 examined lineal energy experimentally using a tissue-equivalent proportional
chamber with a spherical gas cavity representing target diameters of 1-10 pm. These
measurements were made in the BNL epithermal beam and explicitly included thermal
and fast neutron components and the effects of boron present in the chamber gas. Such
measurements combined with radiobiological data obtained in that beam might lead to
the development of a model for estimating RBE in other biological systems exposed to
the BNL epithermal beam. Solares et a123,24 described a different approach to the
microdosimetry of BNCT, where neither subcellular boron distribution nor cell geometry
needed to be assumed but were derived from high-resolution autoradiographic and
histological analysis. Monte Carlo simulation was used to calculate various
microdosimetric parameters for boron as BPA or BSH present in GL261 murine brain
tumors. In lieu of using high-resolution autoradiography or any other direct subcellular
boron distribution assay technique, Nguyen et a125 measured the subcellular distributions
of various boron compounds (BSH, BSSB, BPA, BOPP, and VCDP) by cellular
fractionation techniques and then calculated the nuclear absorbed dose fractions by
Monte Carlo simulation. Verrijk et a126 used biologically derived response functions and
Monte Carlo simulation to model tumor control ("cure") probabilities and normal cell
"damage" probabilities for cells irradiated at different depths in the BNL epithermal beam
at various dose levels.
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2.3 MIT/NEMC Approach to BNCT Microdosimetry
The technique used in our group for microdosimetry is a combination of high-
resolution quantitative alpha-autoradiography (HRQAR) and Monte Carlo
simulations. 24,27 First, HRQAR is employed to define the microdistribution of B-10
atoms within a 1 micron frozen tissue section. Next, this microdistribution is used as
input to a novel 2D Monte Carlo particle transport calculation which computed various
microdosimetric parameters within the environment of actual tissue morphology, i.e., cell
nuclei, cytoplasm and intercellular space. Figure 2.3a shows a typical image obtained
after the HRQAR process in 400X under a light microscope. The picture shown is
murine brain sarcoma tissue with BPA loaded. Figure 2.3b shows the results of B-10
locations extracted by applying a lowpass filter figure to 2.3a. The morphology (mainly
interested in the locations of the nuclei) of the tissue is then obtained after subtracting
figure 2.3b by 2.3a and with suitable gray-level adjustment. Figure 2.3c is the result of
the HRQAR process, a combination of the B-10 atoms and the segmented nuclei. Then,
2D Monte Carlo transports of the high-LET alpha and Li-7 ions of l0B(n,a) 7Li reaction
are employed at each B-10 atom location and energy depositions in the nuclei are
recorded. Figure 2.3d is a close-up of the square region marked in 2.3c which shows the
combined range of these two ions is about 11 to 12 microns. Using this approach, single-
event microdosimetric parameters can be obtained from real tissue cells and B-10
distributions.
With the knowledge of the microscopic energy distribution at the cellular levels,
microdosimetric parameters can be defined to explain the biological effect of BNCT. On
the other hand, this technique can be used to evaluate the efficacy of various boron
compounds or capture elements. Figure 2.4 is a schematic diagram of the MIT/NEMC
approach in microdosimetry.
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Figure 2.3 Results of the HRQAR process of murine brain sarcoma tissue. [a]
original image of the tissue sample after neutron irradiation, staining, and etching. [b] The
B-10 atoms are extracted by applying a low-pass filter to the original image. [c] The final
image of the segmented nuclei and B-10 atom locations. [d] Monte Carlo simulations of
the high-LET alpha and Li-7 ions of 10B(n,a) 7Li reaction at each B-10 location. (Figure
adapted from Ref. [24] )
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Figure 2.4 A schematic diagram of the MIT/NEMC approach to microdosimetry.
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Chapter 3 High-Resolution Quantitative
Autoradiography
3.1 Introduction of High-resolution Quantitative Autoradiography
As discussed in chapter 2, microdosimetry has been an active research field in
BNCT during the past several decades, different approaches have been proposed. Most
of these approaches are based on hypothetical and mathematically simple cell models and
relatively simple assumed B-10 distributions, except high-resolution Quantitative
Autoradiography (HRQAR) process proposed by Solares and Zamenhof1-3 which uses
real B-10 distributions and actual cell morphology for microdosimetry. In this thesis,
HRQAR has been used to determine B-10 distribution and cell morphology.
Basic theory and development of the HRQAR process are provided detailed in
Solare's thesis.4 This section provides a brief description of the HRQAR technique.
More detailed explanations of each step are provided in the following subsections. The
main objective of high resolution autoradiography as applied in the context of BNCT is to
analyze with a resolution of approximately 1-2 im the spatial concentration distribution
of B-10 in tissue. Furthermore, this should be accomplished to allow the simultaneous
visualization of the etched alpha and Li-7 tracks in the detector (representing the
locations of the original boron atoms) and the histologically stained tissue morphology so
that subsequent microdosimetric calculations can be implemented. The HRQAR
technique uses a very thin (=0.8 gm) film of Lexan as the track detection medium. This
allows physical contact to be maintained between the track detector and the tissue during
the entire process of detector etching and tissue staining, and combined with the use of
very thin tissue sections permits the desired spatial resolution of approximately 1-2 gtm to
be achieved and the result to be visualized.
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A quartz glass microscope slide is coated with a solution of 8% Lexan dissolved
in dichloromethane. This forms an =0.8 micron-thick Lexan film over the slide which
constitutes an alpha and 7Li particle detector with essentially zero sensitivity to lower
LET background radiation components such as photons, electrons, or protons. Next, a
drop of Ixan solution (vinylidine chloride/vinyl chloride; basic component Ixan-SGA
resin obtained from Solvay and Cie, Brussels, Belgium), is placed on the surface of a
water bath creating an =0.3 micron-thick film of Ixan on the water surface. The Ixan film
is transferred to the slide to coat the surface of the Lexan film. The Lexan and Ixan films
are laminated together by exposing them to dichloromethane vapor. The Ixan film
provides a physical barrier between the tissue section that will be placed on top of the
Ixan film and the highly caustic etching solution which will be used to etch the particle
tracks from the opposite side of the Lexan film.
The tissue to be examined is frozen in dry ice within a minute. This rapid
freezing is necessary in order to prevent the migration of the boron from its in vivo
distribution. The frozen tissue is embedded in Optimal Cutting Temperature compound
(OCT) (Miles Inc., Diagnostic Division, Elkhart, IN), and 1-2 ltm sections are cut using a
cryostatic microtome. The tissue sections are immediately transferred onto the surface of
the Ixan film and the assembly packed in dry ice.
The assembly is irradiated with thermal neutrons in one of the reactor in-core
rabbit facilities at the Massachusetts Institute of Technology Research Reactor (MITR-
II). Alpha and Li-7 particles generated as the result of thermal neutron captures by B-10
in the tissue impinge on the Lexan film and create stress points. After the sample is
irradiated the tissue is stained using a modified Hematoxylin and Eosin (H&E) method.
These steps are illustrated in figure 3.1; A,B, & C.
A second glass slide is mounted on top of the stained tissue section using
glycerol/gelatin mountant, and the arrangement is refrigerated for two days at a
temperature of = 40C (Fig. 3.1; D, E). The original quartz glass slide is then carefully
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Figure 3.1 Schematic diagram of the HRQAR process.
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removed leaving the Lexan film, Ixan film, and tissue section adhering to the second
glass slide in reverse order; i.e., with the Lexan film now exposed to the outside (Fig.
3.1; F).
The Lexan film is etched using PEW, a solution of 15% KOH in ethanol and
water at a temperature of 55 OC. The Ixan provides a physical barrier to prevent the
caustic etchant from damaging the stained tissue (Fig. 3.1; G). The slide is finally rinsed
in distilled water and dried in air. The slide can now be viewed under a light microscope
with the stained tissue and tracks being visible simultaneously (Fig. 3.1; H), or it can be
recorded by a CCD camera and digitized for computer analysis as described in more
detail later.
The complete HRQAR process as described above can be accomplish in
approximately 8 days. This permits the simultaneous processing of up to 15-20 tissue
sections. This length of time is of the same order of magnitude as is necessary for other
"high-resolution" conventional autoradiography methods which do not approach the
present HRQAR method in spatial resolution or other attributes. However, the HRQAR
process as described does not include the time investment needed for image in order to
derive quantitative results.
For B-10 analysis standard tissue samples are used to setup a calibration curve.
Fresh mouse brains are soaked in known B-10 concentration solution for 1 day to allow
diffusion equilibrium established. After that, B-10 concentrations of these mouse brains
are measured using prompt gamma neutron activation analysis (PGNAA). A calibration
curve of track density versus B-10 concentration is established.
Detailed procedures of the HRQAR process will be presented in the following
subsections : 1) frozen tissue preparation,. 2) detector-slide formation, 3) tissue
sectioning, 4) neutron irradiation, 5) post-irradiation treatment, 6) tissue staining, 7) track
etching, and 8) image analysis.
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3.2 Experimental Procedures of HRQAR
3.2.1 Frozen Tissue Preparation
This is the first step of the whole process. In order to maintain the prevent in-vivo
B-10 compound migration, "rapid" freezing of the tissue sample using liquid carbon
dioxide (dry ice) is used. It was found that the best approach to freeze these tissues is by
using the technique schematically shown in Figure 3.2. The procedure is as follows: (1)
Four blocks of soft dry ice are prepared using a "dry ice maker". The dry ice cubes are
then stored in a well insulated container, e.g., a plastic cooler. (2) Shake the container for
2 minutes so that a smooth flat surface of the dry ice will form. Then dig a number of
square pits on the surface of the dry ice using a rigid spoon or a flat headed screw driver.
The size and the depth of each pit should be just big enough for one plastic vial to fit in.
The dimension of each vial is about 1.75 cm x 1.75 cm x 2 cm. (3) About 3 cc of O.C.T.
compound (Miles Inc., Elkhart, IN) are placed inside a small plastic vial. The compound
must be pouring very slowly so that no air bubbles are formed. (4) A small piece of
unfixed tissue (= 1 cc) from a recently (= 5 mins) killed animal or a small block of tissue
from a human biopsy is dropped into the O.C.T. filled plastic vial. The tissue must be
immersed in the O.C.T. completely. Suitable labels should be marked outside the vial to
locate the sample. (5) Put a vial into each hole and fill any gaps around it. Do not put
any dry ice into the O.C.T. compound when it is still in liquid form. (6) After putting all
the vials into the dry ice, close the container and seal it properly. The dry ice will
sublimate to gas gradually, therefore, check the dry ice content frequently during
transportation. The normal temperature of dry ice should be at -760C.
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Figure 3.2 Tissue freezing procedure.
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3.2.2 Production of Lexan layer
The detector used for registrations of the alpha tracks is Lexan polycarbonate
polymer. Lexan is not sensitive to proton ions therefore no proton tracks are registered
which eliminates the background noise contributed by the 14 N(n,p) 14C and 1H(n,n')p
reactions. Figure 3.3 is a plot of primary ionization rate (unit of track formation) as a
function of ion velecity or energy for different detectors. As shown in this plot, for Lexan
polymer, proton (H) is below the threshold sensitivity and alpha (a) is just above that
threshold. For the loB(n, a) 7Li, alpha particle will have kinetic energy 5 0.35 MeV per
nucleon during the slowing down process, therefore tracks are registered in Lexan.
There are four main factors affecting the resolution of HRQAR, and they are:
[1] Tissue thickness;
[2] Ixan film thickness;
[3] Lexan film thickness and;
[4] Bulk etching removal thickness.
Extensive works have been studied trying to optimize the resolution from these
factors. 4,6,7 The HRQAR process developed in our group 4 can be used to detect tracks
with a resolution of 1 RLm.
This section presents a summary of the experimental procedure involved in
production of the Lexan layer as track detector. Theoretical calculations of the resolution
and detailed experimental development of the process are available in ref. [4,6]. Table
3.1 is a summary of the general specifications of the HRQAR process in the present
work..
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Figure 3.3 Damage vs. velocity for different charged particles. Each detector has a
level below which no tracks are etched and one above which all particles create tracks.
The experimental points for accelerator ions in Lexan polycarbonate are given as open
circles for zero registration and as filled circles for 100% registration. Thresholds for
other detectors are also indicated. (Adapted from ref. [5])
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Table 3.1 The general specifications of the HRQAR that were employed in the
present research follow:
Detector: Lexan Polycarbonate.
Initial Film Thickness: 0.8 - 1.0 microns.
Bulk Etched Lexan Removed: 0.7 - 0.8 microns
Final Lexan thickness: 0.1 - 0.2 microns.
Typical track dimension: 0.5 - 1.0 microns.
Impermeable membrane: Ixan-SGA Vynil Copolymer
Ixan Membrane: 0.2 - 0.4 microns
Tissue Sample Thickness: Various, typical 1 micron.
Etchant: P.E.W.(15% KOH, 40% EtOH, 45% H 20)
Etchant Temperature: 55 oC.
Etching Time: 8 - 12 Minutes.
Est. Spatial Resolution: Various, typical = 1.0 micron.
(Adapted from ref. [4])
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First, a Lexan solution is prepared by dissolving Lexan resin (General Electric Co,
Pittfield, MA) in Methylene Chloride. The solution recipe described below will give an
8%(w.) solution, Kirsch 6 recommended a 5%(w.) solution but it has been found that the
8% gives more appropriate thickness as it will be shown later,
LEXAN SOLUTION
INGREDIENTS: Lexan Resin: 8 grams
Methylene Chloride: 92 grams.
PROCEDURE:
Mix the Lexan resin and the Methylene Chloride and dissolve by constantly
stirring with a magnetic bar. Total dissolution takes approximately 6 - 8 hours. Since
Methylene Chloride evaporates rapidly at room temperature, the container should be
covered at all time.
After use, a Lexan solution can be stored for re-use; however, long-time storage
(> 2 months) is not recommended . To store a stock solution the Lexan should be kept
away from light and stored in a well stoppered glass container. A suitable glass container
is a glass bottle with a glass top roughed at the join and wrapped with several layers of
parafilm (American Can Co, Greenwich, CT) around the joint externally. Then, the
entire glass container covered completely with Al foil and store in a dark place. One last
point has to be mentioned is that the container must be air-tight, otherwise the solution
will dry up quickly resulting in a thick solution which has higher concentration.
Therefore, the volume of the original prepared solution is a good reference marker to
determine if the concentration of the Lexan is changed.
Chapter Three 46
Since fresh Lexan is transparent, a Lexan solution that has been exposed to light,
can be easily recognized because it will present a "yellowish" color, in such a case the
Lexan should be dispose of and a new fresh solution made.
Lexan is the first layer to cover the autoradiographic microslide, this is achieved
by coating using the "Dipping Technique." Figure 3.4 shows a schematic of the setup
used. A bottle of the Lexan stock solution prepared as mentioned above is placed in the
center of a floating dish on a water bath. With the Lexan solution bottle in the center, the
position of the ring is adjusted such that it is slightly above the water level. The floating
dish is then stabilized in the water bath by giving it a slight downward push and letting
the water grab the ring by surface tension. By siphoning the water out from the water bath
at a constant rate, the floating dish and the Lexan solution will also drop down at a
constant rate. The rate at which the water is siphoned out can be adjusted by a screw
clamp as shown in the diagram. By slowly lowering and submerging the microslides in to
the Lexan solution before the siphoning starts, a thin layer of Lexan will form on the
slides as the Lexan solution drops. Let the Lexan-coated microslides stay stationary on
the clamp for one minute or so after they are out of the Lexan solution. Note that more
than one slide can be coated at a time, if they are arranged with spacers as shown in the
diagram; however, coating more than three or four usually will cause the Lexan solution
to adhere to the bottom of the microslides preventing the Lexan from forming a uniform
coating.
Two parameters are critically important to make a uniform Lexan film from this
setup: The concentration of the Lexan and the rate at which the Lexan solution drops.
The concentration of Lexan is achieved by following the above mentioned recipe and the
rate at which the Lexan coats the microslides can be shown6 that is given by:
2
Rd= Re Ar [1 1 - 9g 3 (3.1)Ps PL 1-CJ 2 gf
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Figure 3.4 Setup apparatus for the production of Lexan Film.
(adapted from ref.[4,6])
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where:
Rd = drawing rate
Re = Solvent evaporation ratio
Ps = Solvent density
PL = Lexan density
pf = Lexan solution density
C = Lexan solution weight concentration
g = gravity acceleration
gf = Lexan solution viscosity
Ar = Non-uniform region due to the edge effects
The thickness of the film, AX, is related to the drawing rate by:
AX2 Rd gf PL1 + 1 (3.2)
Pfg ps C
To estimated the drawing rate, the following values are substituted into equations
(3.1) and (3.2)
Re = Solvent evaporation ratio = 3.3 x 104 g cm -2 sec-1
Ps = Solvent density = 1.325 g cm-3
PL = Lexan density = 1.2 g cm-3
pf = Lexan solution density = ps
C = Lexan solution weight concentration = 0.08
g = gravity acceleration = 980 cm sec-2
gLf = Lexan solution viscosity = 0.69 g cml1 sec-1
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This gives for the drawing rate, Rd = 3.93 cm min-1 and the film thickness, AX =
0.73 pm. These values calculated with equations (3.1) and (3.2) are in excellent
agreement with values measured experimentally. It was established experimentally that
using a drawing rate of 4 cm per min will give a film thickness of 0.8 pm.
The thickness measurement is based on the "reflected interference color method"
which has been used extensively in thin film measurements. 4 For the purpose of this
work, suffice to say that it based on the phenomenon that when incident white light goes
through a film, the phase change will manifest itself as a reflected interference colors.
These interference colors are only observable in thin films and disappear in thick films.
The empirical upper bound for a thin film is normally found by the condition that:
n d < 2.5 (4.10)
where, d = thickness of the thin film, plm.
n = refractive index of thin film
Typically for a polymer, such as Lexan, n = 1.6. Therefore, d is of order of 1 Apm.
Since both the Lexan and Ixan films are below this thickness, the interference color
method is applicable. 4
When a white light incident shines on a film, the transmissivity and reflectivity of
a particular incident wavelength through the film depend on the optical thickness of the
film and the surroundings. For optical thicknesses very small compared to the wavelength
of the light, the spectral reflectivity varies very little from one wavelength to another so
that no interference colors are seen. For optical thicknesses comparable to the
wavelengths of the light, a number of extremes in reflectivity intensity occurs in the
visible part of the spectrum, giving rise to visible constructive colors.
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The interference colors observed at 450 incident at various film thicknesses, are
summarized for Lexan and Ixan in table 3.2. The reference thicknesses were established
by weighting 4'6 and ellipsometry measurements. 7
3.2.3 Production of Ixan layer
In order to preserve the tissue and its stain, it has been discussed that a very thin
impermeable membrane must be placed between the tissue and detector that would
prevent any passage of the caustic etching solution to the tissue when etching the
detector.
The need for such a protective layer was evident in the past. The first attempt to
cast an impermeable membrane on film for preventing chemography in autoradiography
was done by Sawicki and Darzynkiewicz. 8 Unfortunately, the polymer of their choice,
Polyvynil Chloride was discontinue. This led to further investigations by Kaiser and
Wijffels, who found a suitable alternative to vynilidene chlorides. The specific material
they used is now known as Ixan-SGA copolymer (Solvay and Cie, Brussels, Belgium), a
vinylidene chloride/vynil chloride.
The original recipe used by Keyser and Wijffels for making the polymer solution
is used in the present work and is as follows:
IXAN SOLUTION
INGREDIENTS: Ixan-SGA Resin: 9.7 grams (Solvent).
Butylacetate: 30.0 grams (Solvent).
Trichloroethylene: 57.9 gams (Solvent).
Trichloroethylene: 57.9 grams (Solvent).
Cyclohexanone: 0.8 grams (Plasticizers)
Dibutylphthalate: 1.6 grams.(Plasticizers)
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Table 3.2 Correlation of film thickness with observed interference colors for Lexan
and Ixan Films. (adapted from ref.[4,6])
Film Ellipsometry Observed Color Observed Color
Thickness (Glass at 450) (Water at 450)
(A)
Lexan 6686 Blue
Lexan 7365 Blue/Purple
Lexan 7923 Purple/Red
Lexan 8100 Purple/Red
Lexan 8702 Green
Ixan 1594 - Gold
Ixan 2082 - Violet
Ixan 2251 - Blue
Ixan 2315 - Blue
Ixan 2438 - Blue/Green
Ixan 2628 _ Green
Ixan 2745 _ Yellow
Ixan 3057 - Yellow/Red
Ixan 3177 Red
Ixan 3368 _ Red/Violet
Ixan 3487 Purple/Red
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PROCEDURE:
Carefully crush with a mortar the 9.7 grams of Ixan-SGA resin and pestle to yield
a fine powder. Then gradually add the Ixan powder to the 30 grams butylacetate with a
constant stirring to prevent clusters. Complete dissolution is reached only after
approximately 48 hours. After which the 57.9 grams of trichloroethylene are added to
yield a clear yellow solution after constant stirring during another 24 hours.. The last two
solvents are used as plasticizers. After filtering the Ixan solution through millipore
filtering apparatus with a filter 1.2 gm pore size and 47 mm. diameter, the plasticizers are
added and then the solution stirred for another 12 hours.
It is worth noting that the Ixan solution is also light sensitive as the Lexan and
tend to darken significantly if exposed for any length of time to tungsten light or daylight.
However, this seems to be a transient effect and does not alter the performance of the
solution but in case is better to take the same precautions for protecting it from light, such
as storing it in a light protected container and wrapping it all around with Al foil. As
mentioned above, the concentration of the solution is another critical factor for a
successful HRQAR process, therefore, the volume of the solution should be monitored
after it is prepared.
Fortunately, Ixan is not as sensitive to aging as Lexan. For instance, if Ixan is
store under the conditions mentioned before it could last for at least three or four months.
Lastly, since Ixan is a very dense and sticky substance, containers that are used for
its preparation are difficult to clean. However, this task is easily accomplished if these
containers are first submerged in methylene chloride.
Once the Ixan solution is prepared and ready to use, the procedure to cast the film
and apply it to the slide is performed and is shown schematically in figure 3.5. A water
bath is prepared by filling a glass dish about 125 mm in diameter and 60 mm deep with
de-gassed, de-ionized and distilled water. The dust particles floating in the water surface
can be easily removed by applying a piece of glassine sheet on to the water surface and
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gently lifting it off. Since any impurity in the water might result in Ixan films that are
unacceptable, Millipore filtration (0.4 plm) of the water is also recommended prior to
filling the glass dish. Then the water is added at room temperature (=25 0C) nearly to the
edge of the dish. A pre-cleaned 3" dropper pipet (American Scientific Products, McGraw
Park, IL) is then used to apply one drop of solution onto the surface of the water bath.
The best results are obtained when the pipet is place close to the surface of the water but
without touching it. If the drop of solution is dropped from too high, the drop most likely
will go to the bottom of the container rather than spreading and extending itself into the
surface of the water. If applied correctly, the film will spread out evenly and uniformly in
a radial fashion due to its highly hydrophobic nature. The interference colors discussed
in the previous section should manifest themselves brilliantly if a bright light is held
incident to the surface of the water and viewing it from a 450 angle to the surface. There
are usually three major regions formed after the film stop spreading. The most uniform
region is in the center. Its interference colors are generally violet or blue and has a
diameter of 5 or 7 cm. The outermost ring will have be the thinnest and presents a silver-
gray color which represents a thickness of less than 500 A. An important step here is to
look for minute holes that sometimes are formed in the Ixan film. If a film with holes is
used, then the etching solution that will be applied later will penetrate this barrier and
ultimately destroy the tissue. Kirsch 6 recommended to do a leakage test to familiarize
oneself with the detection of these holes. The test consists on putting drops of the etchant
to the surface of the Ixan film. If there are holes in the film, then a wavy stream of the
etching solution is formed underneath the film. Note that the film cannot be used even if
no holes where detected.
Once the quality of the film has been established, the next step is to pick up the
Ixan film with the method illustrated in figure 3.5. By gently touching the outermost ring
with a disposable Pasteur pipet (VWR Scientific, San Francisco, CA), one can pull the
film to one side of the water bath, so as to create enough space on the other side of the
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Setup apparatus for the production of Ixan Film..
(adapted from ref.[4,6])
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water bath to allow the entrance of the microslide without contacting the film. Now a
pair of angled forceps with flat grips to grasp the microslide are used. Submerging
vertically the microslide into the water bath the Ixan film is pick up horizontally trying to
get the uniform part of the film on the center of the microslide. Since the Ixan is very
sticky, touching the film with any part of the microslide will adhere the film to the slide
and therefore the film will be lost. If the film has been successfully picked up, there will
be an excess wrapping around the microslide, this wrapping shouldn't be eliminated
because it helps secure the Lexan and Ixan films. Now the microslide should be turned
vertically upside down (i.e., with the forceps in the bottom) to drain the excess water and
then placed in a dust-free environment to allow them to dry. The drying time is usually
about 5 hours. A desiccator can be used to let the slide to dry, making sure that they do
not touch, because otherwise they will adhere to each other.
To coat another microslide, one has to make sure that no debris exist on the
surface of the water bath. Debris can be pick up by using a glassine sheet (Eli Lilly and
Co, Indianapolis, IN). Also making sure that distilled is used but not tap water which
might contain boron compounds.
3.2.4 Lamination of Lexan and Ixan
This section describe a method of fusing the Lexan an Ixan together. After the
slides are dry from the previous step, both films Lexan and Ixan have to be laminated.
Methlylene Chloride is used in a vapor chamber set up as shown in figure 3.6. A glass
petri dish of dimensions 35 mm by 10 mm is placed in the center of another petri dish of
dimensions 90 by 30 mm. Inside the larger petri dish two regular Pasteur pipets are
placed, they serve as support for the microslides. Methlylene Chloride in then added
inside the larger petri dish, enough to reach the height of the smaller petri but not to cover
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amber
Methylene Chloride Autoradiographic Microslide
Figure 3.6 The apparatus used for the lamination of the Lexan and Ixan Films.
(adapted from ref.[4,9])
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the two pipets. The Lexan/Ixan covered microslide is then place on top of the pipets and
the larger petri dish covered for approximately 50 seconds. The entire arrangement will
be saturated with the solvent vapor which will penetrate the Ixan film and laminate it to
the Lexan film. Note that if the microslide is left in this arrangement for too long, the
solvent will also penetrate the Lexan film. This manifests itself by the Lexan film
becoming fogged and no longer useful.
3.2.5 Tissue Sectioning
The next step is sectioning the tissue and then transferring it to the Lexan/Ixan
covered microslide. The sectioning of the tissue has to be done on a cryostatic
microtome. It is very important that the tissue sample must be kept frozen before the
neutron irradiation. Because any change in temperature may have changed the tissue
matrix and as well as the B-10 distributions. Therefore during the sectioning process,
samples must be kept inside the microtome at low temperature.
Successful sectioning of tissue has four requirements: (1) a proper microtome: (2)
properly prepared material; (3) a sharp microtome knife and (4) a skilled microtomist. In
most of the cases requirement number 4 is the main reason why good sections cannot be
obtained. The only way to get good sections consistently is to spend a considerable
amount of time doing trial and error runs until the "art of microtoming" is perfected
Even though the optimum temperature at which the sections should be cut varies
considerably for different tissues. In general 1 - 5 gpm sections can be cut from most
tissues in the region of -20 0 C to -350C. It is also a good practice to set the microtome's
knife at a lower temperature than the tissue. If that is not possible to set in a given
microtome this can be accomplished by fitting a trough filled with dry ice to the
microtome handle.
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In this work the "box" temperature (i.e., the knife temperature) was always set at
-24'C and the "object" temperature (i.e., the tissue temperature) was set at -200 C.
After a successful section has been cut, the section hangs from the edge of the
microtome knife. Picking up is done by gently touching a cold (= -50C) Lexan/Ixan
microslide against the section. The sections adhere to the films due to temperature
differential (sections at -200 C and films at -50C). The exact forces involved are yet
unknown, though it is probable that static charges between the section and the films play
some part in the initial adhesion.
After the section has been picked up the microslide is kept inside the microtome
to prevent the section from melting. When the last section has been picked up the whole
batch of microslides is placed inside a container with dry ice. Sections picked up in this
way do not melt and remain in perfect contact during irradiation, staining and subsequent
etching.
3.2.6 Neutron irradiation
After the tissues have been cut and mounted on the microslides the slide-tissue
assemblies are kept in polyethelene bags and inserted into a special plastic reactor-used
container called a "rabbit". Figure 3.7 shows the packing procedures. After packing dry
ice is also inserted inside the rabbit to maintain low temperature before irradiation.
During all the handling, the microslides are always kept in contact with dry ice to prevent
melting of the tissue sections.
The rabbit is placed in the thermal irradiation facility called 2PH2 in the 5 MW
MITR-II Research Reactor. To prevent overheating of the Lexan, the irradiations are
always carried out at low power during the weekly's power level start-ups. The
irradiations are done at 100 kW and last for 15 mins. In addition, gold foils are always
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Figure 3.7 Packing of microslides in the MITR-II rabbit irradiation tube
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packed with the microslides to monitor the thermal neutron flux. The measured thermal
flux in the 2PH2 port is: 1.86 x 1010 n cm-2 sec -1 + 0.39 x 1010 n cm-2 sec -1 at 100kW.
During irradiation the temperature in 2PH2 port has been shown9 to rise from 24°C to
26 0 C which doesn't cause any problems.
The main radioactivation product that results from the irradiation of the
microslides is 2Na [ 23Na(n,y)24Na, (a = 0.53 barns, T1/2 = 15 hrs]. 23Na is present in
the tissue itself and in fingerprints marks if rubber gloves were not carefully used during
the total handling of the microslides. A normal waiting period for retrieval of the slides is
typically 2 days. There is also production of 31Si (T1/ 2 = 2.6 hrs) in the microslides,
which comes from neutron activation in the quartz slides.
3.2.7 Tissue Staining
After the irradiation tissue samples are stained by Hematoxylin and Eosin staining
method, commonly known as "H & E" stain. Hematoxylin, a natural dye which was first
used about 1863, is simply the most valuable staining reagent used in histological work.
It has little affinity for tissue when used alone but in combination with aluminium, iron,
chromium, copper or tungsten it is a powerful nuclear stain. The most common formulas
for staining with hematoxylin are the combinations with aluminium in the form of alum.
Sections stained with alum hematoxylins may be counterstained with Eosin, a contrast
stain.
Successful staining depends on many factor: 1) freshness of the stains, 2) timing
of each staining step, and 3) skills of staining. Unlike the sectioning process which
strongly requires experience and endurance, staining mainly depends on the freshness of
the staining agents. It is worth to prepare fresh solutions for each staining process, do not
take chance to use old stains, which might ruin the entire HRQAR process. The
ingredients and procedures of making these stains are listed below.
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HEMATOXYLIN
INGREDIENTS: Hematoxylin Crystals 5.0 grams
Alcohol, 100% 50.0 ml
Ammonium alum 100.0 grams
Distilled water 1000.0 ml
Mercury oxide 2.5 grams
PROCEDURE:
Dissolve the hematoxylin in the alcohol, the alum in the water by aid of heat.
Remove from heat and mix the two solution. Bring to a boil as rapidly as possible (limit
heat for a minute and stir often). Remove from heat and add the mercury oxide slowly.
Reheat to a simmer until it becomes dark purple, remove form heat immediately and
plunge the vessel into a basin of cold water until cool. The stain is ready for use as soon
as it cools. Addition of 2-4 ml of glacial acetic per 100 ml of solution increases the
precision of the nuclear stain. Filter before use.
1% STOCK ALCOHOLIC EOSIN
INGREDIENTS: Eosin Y, water soluble 1.0 grams
Distilled water 20.0 ml
Alcohol, 95% 80.0 ml
PROCEDURE:
Dissolve completely the Eosin and the distilled water and then add the alcohol and
stir.
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WORKING EOSIN SOLUTION
INGREDIENTS: 1% eosin stock solution 1 part
Alcohol, 80% 3 parts
Glacial acetic acid 0.5 ml/per 100 ml
PROCEDURE:
Just before use, dissolve completely the stock eosin solution and the alcohol then
add the 0.5 ml of glacial acetic acid to each 100 ml of stain and stir.
ACID ALCOHOL(ETOH)
INGREDIENTS: Alcohol, 70% 100 ml
hydrochloric acid 10 ml
PROCEDURE: Mixed both and stir.
AMMONIA WATER
INGREDIENTS: DI water 50 ml
ammonium 3 ml
PROCEDURE: Mixed both and stir.
The staining steps should be done with pipets rather than immersing the slides
into the solutions as is customary in H & E staining. The reason for this is that since the
tissues that are being analyzed were cut at very small thicknesses and no mountant was
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used to mount the tissue in the Lexan/Ixan coated microslides, many times it happens that
if the whole slide is immersed, in any one of the staining steps, the tissue will detach from
the microslide and therefore the autoradiograph will become useless. The procedure that
is described below, should be done using a different Pasteur pipet for each solution and
special care should be given in each step to apply the solutions very gently.
HEMATOXYLIN - EOSIN STAINING METHOD
Step 1. Harris Hematoxylin:
Position the microslide on a flat surface and then put several drops of hematoxylin
on top of the tissue enough to cover it completely. Leave it for 18 minutes.
Step 2. DI Water:
Rinse with the water until the hematoxylin has been completely removed.
Step 3. Acid-EtoH:
Differentiate in the acid alcohol. Pour from 3 to 8 drops very quickly on the
tissue. Check the differentiation on a microscope. Nuclei should be distinct and
the background very light or colorless.
Step 4. DI Water:
Pour 10 drops on the tissue very briefly.
Step 5. Ammonia Water:
Pour either one on the tissue until it turns bright blue (= 5 drops).
Step 6. DI Water:
Wash the tissue several times (= 30 drops). If inadequate cleaning occurs eosin
will not stain evenly.
Chapter Three 65
Step 7. Eosin:
Position the microslide on a flat surface and then put several drops of eosin on top
of the tissue enough to cover it completely. Leave for 2-3 minutes.
Step 8. 95% EtoH:
Several drops until eosin is completely removed.
Step 9. 100% EtoH:
Pour 20 drops.
Step 10. DI Water:
Pour a few drops on the tissue until the slide is mounted in the reversal step.
3.2.8 Reversal and Separation of the Quartz Slide
The objective of this step is to reverse the order in which the microslides are
mounted. This is done so that the Lexan detector can be etched. The Lexan which has
recorded the alpha particles, would be then the first layer in the autoradiographic
arrangement, directly under the Lexan would be the Ixan and under this layer, the tissue.
The purpose of the Ixan should be obvious now. The Ixan, as has been mentioned
several times before, serves the purpose of protecting the tissue from the caustic action of
the etchant. Note that the reversal also has the feature of allowing the Lexan tracks to be
viewed, while at the same time permitting observation of the microanatomy of the tissue
that lies under it. Since the Lexan and the tissue have been in close contact throughout the
experimental procedure, and the resolution of this technique is on the order of 1 jim, the
correlation of the boron tracks and the tissue microstructure is excellent.
Immediately after staining the tissue, the microslides have to be mounted against a
second glass microslide. The coupling of both slides is achieved by using glycerol/gelatin
mountant (Sigma Co, Saint Louis, MO). The mountant has to be warmed in a water bath
or oven to about 38 0 C before it is apply since it is in solid state at room temperature.
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After the glycerol/gelatin liquefies, gently squeeze three drops of it into a previously
warmed glass slide (also warmed to about 380 C). Then remove the excess water from the
recently stained microslide that is to be mounted and place it on top of the warm glass
slide as figure 3.8 schematically shows . Press firmly both slides until the glycerol/gelatin
mountant covers the whole area between both slides. Note that only the area opposed to
the Lexan coating should be mounted (also shown in Figure 3.8). Repeat this procedure
for all the stained microslides. Next, the assembly is kept at 40C in a cold room for 48 to
60 hours to allow the mountant to firm up. The temperature of the cold room must be
kept in low temperature so that the physical properties of the tissue matrix and the
detector are maintained. High temperature or sudden rise of temperature may result in
"cracking" of the Lexan detector and tissues. Figure 3.9 is an image showing the cracks
in the Lexan due to sudden rise of temperature from 30C to > 150C. Once the cracks are
formed, the HRQAR process is devastated; because the tissue samples will be destroyed
definitely in the next step, etching. The reason of that is because the etchant will leak
into the tissues along the cracks created. Therefore, it is important to be having a safe
place to keep the slides.
After removing the assembly from the cold room and allowing-it to warm-up for
about 5 minutes, the two microslides are separated by applying a quick small "mutually-
opposed" torque on the extended end of each slide (i.e., apply the quick torque clockwise
on one slide and counter-clockwise on the other). The separation procedure is shown in
figure 3.10.
Note that the two slides will separate at the interface between the Lexan detector
and the quartz microslide, making the Lexan the first layer, Ixan the second, and the
tissue the third. The resultant assembly is ready now for etching.
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Figure 3.8 Autoradiographic microslide mounting.
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Figure 3.10 Autoradiographic microslide reversal and separation.
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3.2.9 Track Etching
The objective of this step is to enlarge the original alpha tracks from about 5 to 20
A to larger than 0.5 glm, the limit of the light microscope, so that the tracks can be
observed. The etching of the high resolution autoradiographs is a delicate procedure. The
thickness of the Lexan employed is very small and becomes even smaller after etching.
Also, etching is most effective if the etchant used is heated at high temperatures (=70'C);
however, the Lexan turns very soft and fragile when heated
Even though, many etchants have been used in solid state autoradiography, two of
them are by far the most commonly used.4 These are Sodium Hydroxide (NaOH) and
Potassium Hydroxide (KOH). KOH was chosen as etchant in this work due to its higher
bulk etching rate in Lexan at lower temperatures compared to that of NaOH. 5 In
addition, KOH can be mixed with ethanol (EtOH) to improve its bulk etching rate in
Lexan. 4
PEW SOLUTION
INGREDIENTS: KOH pellets: 9 grams
Distilled Water: 27 grams.
100% Ethanol (EtOH) 24 grams
PROCEDURE:
In a glass container, dissolve completely the KOH and the distilled water (note
that this is an exothermic reaction). Then add the EtOH and stir for several minutes.
The etching procedure is illustrated in figure 3.11. A glass vial, 2.5 cm. base
diameter, 6.0 cm. height and 2.0 cm. mouth diameter, just wide enough to cover the inner
part of the slide, is filled with PEW solution and placed on a water bath pre-heated to
550 C. Use thermal couple to monitor the temperature. An empty glass vial of similar
dimensions is placed next to the PEW-filled vial in the water bath with weights inside so
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that the vial will not float. The empty vial is used only for supporting the microslide.
Also the glass container with the PEW stock solution should be placed in the water bath,
making sure it is tightly closed because the PEW solution is very volatile. Allow several
minutes for the whole arrangement to reach thermal equilibrium. Just before placing the
microslide in the etching solution, a disposable Pasteur pipet is used to refill the PEW in
the glass vial, the level of the PEW in the vial should be right at the border just before it
spills. Due to the surface pressure of the PEW, the surface of the solution has a convex
shape as shown in figure 3.11. Note that sometimes small air bubbles are formed in the
PEW; these should be removed.
Next, the microslide is placed on top of the two glass vials, with the Lexan surface
in contact with the PEW solution as illustrated in figure 3.11. The region of the
microslide that should be placed on the mouth of the vial, should be the region of the
Lexan immediately above the tissue section. Sometimes, a small air bubble is formed
inside the etching vial during this procedure; therefore, the area above the air bubble will
not be etched. Usually, the air bubble will be formed toward the edge of the vial's
mouth. If the tissue of interest lies above the air bubble, then the microslide should be
repositioned carefully without lifting the microslide. If this is not possible then lift the
slide, refill the vial with PEW and then situate the slide back in place.
The autoradiograph microslide is etched for about 8 to 10 mins. Following
removal, the microslide is tilted approximately 45 0degrees, with the Lexan film facing
up, and is rinsed with distilled water using a Pasteur pipet. The etchant should be rinsed
thoroughly taking great care of not touching the surface of the Lexan film. The
microslide is then left to dry in a standing position for about 2 to 5 mins; after which the
autoradiograph is ready to be examined in a light microscope or computer-aided analyzed
as described in the next section.
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Figure 3.11 Schematic of the etching procedure.
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3.3 Image Processing of HRQAR
3.3.1 Digitizing of the Autoradiograph
Images of autoradiographs are acquired using bright field transmitted illumination
which was discussed in ref. [4]. Autoradiographs under this kind of illumination can be
viewed in two ways. First, by focusing the microscope on the tracks themselves. In this
way the ax particles and Li-7 nuclei tracks appear as black circular dots when viewed
under 400X magnification, and the track sizes vary from approximately 1 to 3 gm in
diameter. The tissue appear slightly out of focus but are clearly seen in the background.
Focusing in this manner is specially useful when the nuclei and cytoplasm of the cells
have not absorbed much staining agents(Hematoxylin and Eosin), and therefore the
contrast of tracks against the background is considerable. The second approach, involves
focusing the plane between the tracks and the tissue. The scattered light going through
the a/Li-7 tracks will reveal these as white "holes" in the image. The tissue is seen better
in focus than in the previous approach. This method is particular useful when the tissue
absorbs a dark stain or when there are features in the tissue that appear dark (e.g., melanin
in melanoma cells). Both of these methods have been used in this study to obtain the
track/tissue pictures.
After the HRQAR process, the autoradiograph slide is examined using a light
microscope, e.g. ZEISS microscope. The alpha/Li-7 tracks are focused using the track-
focusing technique described above, black circular dots are seen. Adjust the
magnification of the microscope to 400X, i.e., "objective" magnification = 40X and "eye-
piece" magnification = 10X. Attach a good quality camera to the image capturing
extension on the microscope, e.g., NIKON camera. Turn off the cross sign "+" on the
screen and set the light intensity at 11. Adjust the focus again and take color pictures
from the image. The color film used in this work is KODAK 100 Gold II color prints.
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The developed picture is scanned as a gray scaled image with 256 gray levels using
Adobe Photo Shop, an image processing software running on a Macintosh Quadra 950
33MHz machine. Figure 3.12a is an autoradiograph of normal mouse brain loaded with
BPA obtained using the first method - track focusing. As seen from figure 3.12a black
dots represent the locations of B-10 atoms and gray regions represent the cell nuclei.
3.3.2 Extraction of the Alpha Tracks from Background Image
The autoradiograph shown in figure 3.12a is a combination of B-10 distributions
"tracks" and cell morphology ,i.e., cell nuclei, cytoplasm, and extra-cellular space. Track
distributions and morphology are inputs for microdosimetry. Therefore, the tracks and
the cellular morphology must be separate.
The extraction of features in a digital image depends heavily on the contrast of the
features one wants to extract from the background. The closer their gray levels the more
difficult it is to separate them. Fortunately, in the case of autoradiography most of the
tracks present a sharp transition in their gray level with respect to the background, as can
be seen in figure 3.12a. Tracks are presented in almost dark color with a gray-scaled
level of 255, and the rest are ranged from 0 to 254. Therefore, if the background can be
eliminated, the tracks will be exposed. This can be done by the following steps:
[1] Smear (convolve) the original image with a 5x5 Gaussian linear filter.
[2] Subtract the smeared image by the original image.
[3] Threshold the gray level to enhance the tracks.
The extraction of tracks also can be accomplished using frequency-domain
methods (i.e., based on the Fourier transform of an image). Edges and other sharp
transitions in the gray levels of an image contribute heavily to the high frequency content
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Figure 3.12 Autoradiogram of mouse brain loaded with BPA compounds. (a) Original
image. (b) Lowpass filtered of image [a]. (c) Subtraction of images [a] and [b]. (d) Gray-
level threshold of image [c] - final track image.
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of its Fourier transform. It therefore follows that blurring can be achieved via the
frequency domain by attenuating a specified range of high frequency components in the
Fourier transform of a given image.
Figure 3.12b shows the autoradiograph with 20% high frequency cutoff. The
algorithm used in this work is a FFT-IFFT routine developed in our group which was
incorporated in the NIH Image 1.57 version, an image process software on Macintosh, by
Mr. Joe Palano.10
Figure 3.12c shows the result of subtraction between figure 3.12a and 3.12b. As
seen in figure 3.12c, the 20% high frequency portion, dark pixels, are revealed and they
are tracks. By applying threshold to figure 3.12c with suitable gray scaled level, the final
track image is obtained, as shown in figure 3.12d.
The threshold image can be used as input for particle counting in NIH Image. The
calculated track density is then used to determine the B-10 concentration. B-10
concentration is determined by comparing a standard calibration cross calibrated with
prompt gamma neutron activation analysis (PGNAA). The technique of HRQAR B-10
calibration will be discussed later in this chapter.
3.3.3 Enhancement of the Nuclear regions
This section describes the method to obtain cell nuclei locations from the
autoradiograph. This is the second input parameter for microdosimetry.
Edge detection is a common method to outline the boundary of objects in gray
scaled image. However, in the case of autoradiograph, the image contains both tracks
and nuclei, it is difficult to locate nuclei by edge detection. Another straight forward
manner is to outline the nuclei manually, this method requires a longer time than the edge
detection method but is more reliable. Figure 3.13 is an image of the nuclear regions
manually outlined from figure 3.12a.
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Figure 3.13 Outlined nuclear regions of the mouse brain autoradiograph:
(a) Original autoradiograph; (b) manually outlined nuclei.
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3.4 Absolute Calibration of HRQAR for B-10 Analysis
The absolute calibration of the autoradiographs is an essential step toward the
determination of B-10 concentrations in tissue samples. However, in order to produce a
standardization curve, known concentrations of boron in a standard medium must be
produced. Ideally, a medium that is identical to the tissues being analyzed should be
used. The reason for this is as follows. Consider the detection of alpha particles. There
exists a maximum depth within the tissue form which an alpha will traverse the tissue to
reach the detector and still have enough energy to create the damage necessary to reveal
an etched track. Beyond that depth, no alpha particles will contribute to the etched track
density. This limiting thickness depends on the range of the alpha particle and the
composition and density of the medium it traverses. If, for example, a metal such as iron,
p = 8 g/cm3, and a tissue equivalent medium, p = 1 g/cm 3, are loaded homogeneously
with equal concentrations of boron, under the same irradiation and etching conditions,
they will result in two very different track densities in the Lexan because of the
significant difference in range. Therefore, the ideal standard medium should be a tissue,
equivalent in these respects to the tissue being examined, cut to the same thickness as the
tissue to be examined, and homogeneously loaded with boron at precisely known
concentrations.
The standards used in this work are dissected normal mouse brains, which are
sectioned in a frozen state at the same thickness as the tissues to be analyzed (i.e., 2 Jpm).
In order to produce the best possible frozen sections, the water in the brains should first
be removed because otherwise freezing artifacts might appear at the time of sectioning.
This can be accomplish if the brains are soaked in a glucose solution and left overnight in
a refrigerator at a temperature of about 4 *C. When the water has been completely
displaced by the glucose, the brains that originally floated in the glucose solution will
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sink to the bottom of the container. In addition, to ensure a homogeneous boron
concentration, BPA compound was used to yield 0, 5, 15, 20, and 50 ppm B-10.
The actual B-10 concentrations in mouse brain samples were measured by
PGNAA. Track densities of these samples were obtained by HRQAR process as
described in previous sections. Table 3.3 is the B-10 analysis calibration data. The
calibration curve for B-10 analysis is shown in figure 3.14.
Table 3.3 Calibration data for the HRQAR B-10 analysis
Calculated PGNAA Number of Area Track density
B-10 conc. B-10 conc. alpha tracksc (urm2) (tracks/glm 2)
in solutiona in tissueb
0 0.8 103 64329 1.59000e-03
5 4.7 406 50748 8.00000e-03
15 13 1430 64958 2.20000e-02
20 18.4 1340 41209 3.25000e-02
40 38.5 4166 61722 6.75000e-02
a: mouse brains were soaked in BPA solution.
b: B-10 concentrations were determined by PGNAA at MIT.
c: tracks were countered following the HRQAR process.
Chapter Three 80
C-,
'4sH
0.08
0.07
0.06
0.05
0.04
0.03
0.02
0.01
0.00
Figure 3.14
0 5 10 15 20 25 30 35 40
B-10 concentration (ppm)
Calibration curve for the HRQAR absolute B-10 analysis.
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Chapter 4 Two-Dimensional Approach to BNCT
Microdosimetry
The principle of neutron capture therapy depends upon two factors: (a) a selective
concentration of a suitable neutron capture element within or near the tumor cells; and
(b) the delivery of an adequate thermal neutron fluence to the tumor region. The capture
of thermal neutrons by the nucleus of choice then results in the emission of localized
particulate ionizing radiation which, in turn, produces a higher dose to tumor cells than to
normal tissue. Boron-10 is the isotope generally selected for neutron capture therapy due
to its favorable nuclear and chemical properties, and consequently boron neutron capture
therapy (BNCT) has been the most common form of neutron capture therapy studied.
Neutron capture by the B-10 atom results in a nuclear fission process as summarized
below:
4 He + 7Li + 2.79 Mev (6.3%)
oB +nth-
4He + 7Li*+ 2.31 MeV - 3Li + 'Y + 0.48 Mev (93.7%)
(4.1)
Most of the released energy is carried by the two charged particles, Li-7 and He-4
(or alpha particle), with ranges in tissue of approximately 5 and 7 microns, respectively;
i.e., comparable to typical cell dimensions. Therefore, the pattern of energy deposition in
the sensitive sites depends very strongly on the spatial microdistribution of the 10B atoms
within the tissue at a subcellular level. If the microdosimetry of BNCT can be
understood and quantified it should be possible to gain a clearer understanding of the
radiobiological properties of the 10B capture reaction, the relative radiobiological merits
of different capture nuclei, and to perhaps predict the relative efficacy of different
targeting compounds.
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This chapter describes a 2D particle transport model for BNCT microdosimetry
with actual B-10 distributions, real cell morphology, and LET functions as inputs. B-10
distributions and cell morphology are obtained from the HRQAR process as discussed in
chapter 3. LET functions are calculated using TRIM 91,2 a PC based Monte Carlo ion
transport code. The validation of this 2D model will be discussed in chapter 5. Outputs
are single-event microdosimetric parameters, e.g., absorbed energy fraction, absorbed
energy distribution, number of hits to the nucleus, hit size distributions, etc. Detailed
descriptions of some of these parameters are provided in Appendix B
4.1 Monte Carlo Particle Transport Model
The two charged particles, He-4 and Li-7, emitted from the 10B(n,ca) 7Li reaction
are high-LET and short ranged. They emit isotropically from the origin of the
10B(n,a)7Li reaction and travel back to back to each other. The path of each particle is
almost a straight line when traveling in human tissue or water equivalent material. So, it
is assumed that these two particles travel on the same linear path but in opposite
directions during the transport. For high-LET radiation (i.e., BNCT) we are interested at
the energy depositions of these particles to the cell nucleus. A computer code was
developed to calculate energy depositions in nuclei. Figure 4.1 shows a schematic
diagram of this transport model. Steps (1) to (5) were discussed in chapter 3 of how to
obtain the information of cell shapes and boron distributions. These two parameters are
used as inputs to a 2D Monte Carlo simulation program to perform microdosimetry. Step
(6) is to calculate LET functions for the charged particles, He-4 and Li-7, using TRIM-
91. The 2D simulation code was written in Pascal like Macro language incorporated in
NIH Image 1.57. The code can simulate both actual and random B-10 distributions.
Single-event microdosimetric parameters are determined. An algorithm based on fast
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(2) (3)
Fig.4.1 Microdosimetry using a 2D model. Information of cell structures and
boron distributions are obtained from steps (1) to (5) using the technique of
autoradiography. These information will be used as inputs to a 2D Monte Carlo
simulation code, step (7), to obtain microdosimetric parameters, step (8).
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shapes (locations)
input #3
Fourier transform (FFT) convolution was developed which determines the multiple-event
distributions from the single-event results. This will be discussed later in this chapter.
4.1.1 Input Parameters for the 2D Simulation
Three input parameters are required for the Monte Carlo simulations: 1) B-10
distributions, 2) cell morphology (nuclei), and 3) LET functions of He-4 and Li-7 ions.
B-10 locations and cell morphology are obtained from HRQAR process as described in
chapter 3. Figure 4.2 is a typical example of B-10(BPA) distributions obtained process
an autoradiograph of mouse brain frozen tissue sample. Figure 4.3 is the cell morphology
from the same autoradiograph. These two images are inputs for the 2D Monte Carlo
simulations which will be described in next section. The third input parameter is the LET
functions of He-4 and Li-7. The LET or stopping power values of these two ions were
calculated using TRIM-91. The physical quantities and nuclear branching ratios of these
two ions are listed in table 4.1. As seen from this table, after a B-10 nucleus captures a
thermal neutron, it decays to two daughters, He-4 and Li-7. During the decay process, in
93.7% of probability, the two daughters are resulted in an excited state which then emits a
gamma ray of 0.478 MeV subsequently. The other 6.3% of the decay goes to the ground
state and without any delay gammas. These two different types of decay were considered
in the LET calculations.
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Table 4.1 Physical quantities of the charged particles at boron neutron capture
reaction.
Atomic state Branching ratio 4He energy 7Li energy
Exited* 93.7 % 1.47 MeV 0.84 MeV
Ground 6.3 % 1.78 MeV 1.01 MeV
* the excited nucleus will emit a prompt y ray of 480 keV.
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Figure 4.2 B-10 distributions of mouse brain used as input for Monte Carlo
simulations in the 2D model. Black dots represent B-10 locations.
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Figure 4.3 Cell morphology of mouse brain used as input for Monte Carlo
simulations in the 2D model. Gray regions represent the cell nuclei.
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The stopping power and range of the charged particles were calculated using
TRIM-91 program with tissue/muscle equivalent material as target. The physical
properties and elemental composition of tissue equivalent material used are summarized
in table 4.2.
The number of simulation events employed in each case was 10,000. TRIM-91
was ran on an IBM486DXII 66-MHz PC computer. For each simulation run, with 10,000
events, computation time was about 58 minutes. Figures 4.4 to 4.6 are plots of stopping
power, average range, and ion distributions of the He-4 and Li-7 ions. Both excited and
ground states were calculated. As seen in figure 4.6 the range straggling problem is not
significant but still is questionable for the assumption that He-4 and Li-7 are traveling in
a perfect straight line. The straggling problem was investigated in this thesis and will be
presented in chapter 5. Table 4.3 summaries the mean ranges for these two ion in water
equivalent material. the calculated ranges and LET values for He-4 and Li-7 ions are
used as inputs for the 2D Monte Carlo Simulations.
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Table 4.2 Physical properties and elemental composition of the tissue equivalent
material.
Material p H C N O Na P S Cl K
(g/cm 3) (W/o) (W/o) (W/o) (W/o) (W/o) (W/o) (W/o) (W/o) (w/o)
(ICRU)* 1.0 10.6 9.0 3.2 74.2 0 2.6 0.4 0 0
Cell
nucleus
(ICRU)* 1.05 10.2 14.3 3.4 71.0 0.1 0.2 0.3 0.1 0.4
Muscle
(TRIM-91) 1.0 10.3 12.2 3.5 74.0 0 0 0 0 0
Muscle
*Data from ICRU Report 18.
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Figure 4.4 Stopping powers of He-4 and Li-7 ions.
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Figure 4.5 Ranges of He-4 and Li-7 ions. I is the intensity of the particle through the
medium (tissue equivalent material) and Io is the intial intensity. In TRIM-91
calculations, the term "average range" is used to describe the particle range, instead of
using "mean range". The mean range is defined as the distance traveled by the particle
and by which the intensity is reduced to one half of the original value. 4
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Figure 4.6
Average range of the 10B(n, x) 7Li charged particles in tissue/muscle.
Ion Energy (MeV) Mean range (pm)
He-4 1.47[a]  7.268
He-4 1.7 8 [b] 8.930
Li-7 0.84[a] 3.993
Li-7 1.01 [b] 4.475
[a] ions are created at excited state with probability of 93.7 %
[b] ions are created at ground state with probability of 6.3 %
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Table 4.3
4.1.2 Algorithms of Monte Carlo Simulation
This section describes the algorithm of the 2D Monte Carlo simulation code
which simulates the particle transportation of the He-4 and Li-7 ions. Figure 4.7 is an
illustration of the transport model. Black dots represent the origins of the 10B(n,X) 7Li
reactions. Ions are emitted isotropically with a random angle drawn from a random
number generator. The average ranges of He-4 and Li-7 are about 8 and 4 R m,
respectively. As shown in figure 4.7, the effective target zone for each 1 0B(n,a) 7Li
reaction is circular with a radius equals to the range of the He-4. Energy depositions in
nuclei are recorded when the ions hit inside the nuclei (gray regions), see figure 4.7 for
physical explanation.
A 2D Monte Carlo simulation code was developed to calculate energy depositions
as well as other microdosimetric parameters. The code was written in Pascal like Macro
language incorporated in NIH Image 1.57 running on an 120 MHz Power Macintosh
computer. Figure 4.8 is a flow chart of the transport algorithm for the simulation code. 3
Six input files - stopping power tables, boron locations, and cell morphology are used in
the program. A random number, 1 (from 0 to 1), is used to determine the final state of
the compound nucleus at the end of the capture reaction. If ý 1 is less than 0.937, then the
final state will be at excited and the energy of the charged particles will be 1.47 and 0.84
MeV for He-4 and Li-7, respectively. Otherwise, if ý 1 is bigger than 0.937, it will be at
ground state and the energy will 1.78 and 1.01 MeV. The number of increments for each
particle track is determined by it's range with 0.1 jim for each step. Two charged
particles will be simulated at each boron-10 location emitting back-to-back isotropically.
The program will follow the particle track at each step and energy will be recorded if the
track is falling into the nucleus regions. Initial and final positions of the charged particles
will also be recorded to determined other microdosimetric parameters, starter, crosser,
outsider, stopper, and insider.
Chapter Four 97
_f cell cytoplasmScell nucleus
boron site
Figure 4.7 Charged particle transport in a 2D model. A hypothetical autoradiography
image which contains cell cytoplasm (light region), cell nucleus (gray region), and B-10
locations (black dots). Two charged particles, He-4 and Li-7, emit isotropically in 2D
from each B-10 origin and transport back to back on the same straight line. Energy
dissipation along their paths is according to the LET function as shown in figure 4.5.
Energy depositions, hit size, hit frequency, etc. are recorded for the microdosimetry.
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Figure 4.8 Transport algorithm of the 2D Monte Carlo simulation code.
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As discussed above the two charged particles emitted from the 10B(n,co) 7Li
reaction travel along the same straight line and release their energies according to their
stopping powers. The coordinate frame used in this code was Cartesian coordinate.
There are advantages to describing particle flight paths by Cartesian coordinates when the
target objects are in complicated geometry. Since, a particle's direction of flight in
Cartesian coordinates is uniquely specified by the direction cosines (Ox, fly, 2z) with
respect to the x, y and z axes, respectively. The new position of the particle after
traveling an increment X from the nth position is simply
Xn+1 = Xn + QxX
Yn+1 = Yn + fyk
Zn+1 = Zn + KzI
where ( Xn, Yn , Zn) is the coordinates of the old position. See figure 4.9 for physical
descriptions.
Example:
In this 2D model, the transport of the particle is in 2D, so there are only two
coordinates involved. As shown in the flow chart of the transport algorithm (figure 4.8)
the new position of the particle after traveling an increment of 0.1 gIm should be
Xn+1=Xn + 0.1*dx
Yn+l=Yn + 0.1*dy
where dx= Ox, and dy= Oy.
Chapter Four 100
Figure 4.9 Direction of flight of the charged particle
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4.1.3 Error analysis
In applying the Monte Carlo method to obtain solutions to practical problem, one
must have confidence in the numerical values obtained. This usually involves an
estimate of the statistical errors in these values. One way to evaluate this error is by
applying the law of large number. 1,5 This law states that the accuracy of an estimate of a
quantity tends to improve as one averages larger and larger samples of observations of the
value of the quantity. To apply this to our Monte Carlo calculations, suppose that xl, x2,
... , XN are sample values of the N random variables (x). If the sample mean
N
x= xi (4.2)
Ni=
is formed, the law of large numbers states that the sample mean, with a probability that
approaches 1 as N tends to infinity, approximates the population mean (or true mean), m.
In a practical calculation, one should keep in mind that the true mean is unknown. To
estimate how far the sample mean i to the true mean m, we can use the sample variance
i=1
as our approximation to the true variance a 2 . If N is sufficient large that a 2 is
approximated by
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The sample mean x is our Monte Carlo estimate of m with a standard error Y. Therefore,
the predicted value of random variable x with N trials can be expressed by
x = x±+ (4.5)
Of course, the accuracy of this value x will increase with larger sampling number N. The
statistical errors of all the microdosimetric data obtained by Monte Carlo calculations in
this work were evaluated by this method.
4.2 Calculations of Single-event Microdosimetric Parameters
A Monte Carlo based simulation code was developed to perform microdosimetric
calculations using actual B-10 distribution (e.g., figure 4.2) and cell morphology (e.g.,
figure 4.3) as inputs. The source program and instructions for this code are described in
Appendix C. The algorithm of this code is shown in figure 4.8. Table 4.4 is a list of the
output parameters. These results are referred to the single-event, i.e., effect per B-10
reaction, and can be generalized for multiple-events using convolution. The calculations
for multiple-event parameters will be discussed in Section 4.3.
Figures 4.10 to 4.12 show the screen displays of Monte Carlo simulations after
different number of trial runs completed (500,1000 and 2000). Results of these
calculations are presented in table 4.5 and figures 4.13.
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Summary of output microdosimetric parameters
Parameters* Symbol Unit Nature
Absorbed Energy Distribution f(E) dimensionless Stochastic
Mean Absorbed Energy E keV Non-stochastic
Hit-Length Distribution f(0) dimensionless Stochastic
Mean fHit-Length g m Non-stochastic
LET Distribution f(L) dimensionless Stochastic
Mean LET E keV/.m Non-stochastic
Non-Hit Probability H dimensionless Non-stochastic
Hit-Size Distribution f(z) dimensionless Stochastic
Mean Hit-Size f keV/gm3  Non-stochastic
*Definitions of microdosimetric parameters are discussed in Appendix B or in ICRU
Report 36 "Microdosimetry".
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Table 4.4
Figure 4.10 Screen display of the Monte Carlo simulations with 500 trial runs
completed.
Chapter Four 105
Figure 4.11 Screen display of the Monte Carlo simulations with 1000 trial runs
completed.
Chapter Four 106
Figure 4.12 Screen display of the Monte Carlo simulations with 2000 trial runs
completed.
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Table 4.5 Calculated microdosimetric parameters with actual B-10 distributions
Nuclear fraction 15.8 %
Absorbed energy fraction 16.1 %
Mean absorbed energy 0.237 MeV
Mean hit-length 2.21 pm
Mean LET 182.2 keV/tm
Non-hit probability 0.53
*Results were obtained after
(single-event).
10,000 random-angle trial runs
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Figure 4.13 Absorbed energy distribution calculated by 2D Monte Carlo simulations
with actual B-10 distribution (figure 4.2) and cell morphology (figure 4.3).
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The microdosimetric results presented in above are obtained with actual B-10
distributions employed which reflects the effectiveness of the B-10 compound involved.
The effectiveness of B-10 compound can be evaluated by comparing the associated
microdosimetric parameters (or any effect) to the homogeneous situation. A term called
"compound factor" has been proposed' to account for the B-10 distribution effect.
Compound factor is defined as:
Microdosimetric effect produced by compound X B- 10 distributionCompound factor = Microdosimetric effect produced by homogeneous B- 10 distribution
(4.6)
Simulation runs were performed with homogeneous B-10 distributions for the
same inputs. Results of the homogeneous runs are presented in table 4.6. Compound
factors were calculated for different effect (microdosimetric parameters). Results show
that compound factors for the BPA compound in mouse brain are close to unity. This
implies that the B-10 distribution of BPA is very homogeneous.
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Parameter Actual B-10 Homogeneous Compound
Distribution B-10 Distribution Factor
Nuclear fraction 15.8 % 15.8 % NA
Absorbed energy fraction 16.1 % 15.6 % 1.03
Mean absorbed energy 0.237 MeV 0.229 MeV 1.03
Mean hit-length 2.21 gm 2.07 pm 1.07
Mean LET 182.2 keV/ptm 179.5 keV/pm 1.02
Non-hit probability 0.53 0.55 0.96
*Results were obtained after 10,000 random-angle trial runs (single-event).
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Table 4.6 Calculated microdosimetric Parameters
4.3 Determination of Multi-event distributions using FFT
The physical limitation of Monte Carlo simulation is that the number of
'lB(n,a)7Li reactions incurred per cell is limited to integer values. Therefore,
microdosimetry cannot be studied for all dose levels. For example, a physical dose of
0.325 Gy is equivalent to one IOB(n,a) 7Li reaction occurred in a V79 cell model, a
13X13X13 pm cubical cell. Using Monte Carlo simulations one can simulate 1, 2, 3, ..... ,
N reactions per simulation run to obtain the absorbed energy distributions. The number
of reactions per cell for the simulations must be an integer. Therefore, in terms of dose,
one can only obtain results for physical dose levels of 0.325, 0.65, 0.975, 1.3, ..... ,
Nx0.325 Gy. Therefore, absorbed energy distributions for other dose levels (or N is a
non-integer) are not available. This is the basic disadvantage of Monte Carlo simulation.
On the other hand, the running time of Monte Carlo simulations is proportional to N.
A method using fast Fourier transform (FFT-convolution based) has been
developed to determine results for multiple-events which does not limit N to be an
integer. This is done by manipulating the single-event distribution in the frequency
domain, using the Bayesian operations, to calculate the results for multiple-events. This
section describes the FFT approach and the validation. The validation was performed by
comparing the results from: 1) Monte Carlo simulation, 2) time domain convolution, and
3) frequency domain FFT calculations. Results show that absorbed energy distributions
determined by these three different approaches are identical. There are two advantages of
using this FFT approach:
[1] Microdosimetric parameters (distributions) can be determined at any dose level
that Monte Carlo simulation or convolution cannot.
[2] The computer running time is reduced which is otherwise inevitably long due to
the complicated Monte Carlo algorithms.
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4.3.1 Absorbed Energy Distributions from Monte Carlo Simulation
Absorbed energy distributions were calculated using Monte Carlo simulations in a
3D cell-matrix model. The cell model assumed was based on the dimensions of the
frequently studied V79 cell line.9 A single cell consists of a cubical cell body, 13x13x13
gm, and a central spherical nucleus of radius 3.8 gim. A matrix of 27 such single cells
was used to include the "cross-fire" effect. 9 Figure 4.14 is the geometry of this cell
mode. Energy depositions in the nucleus were scored by integrating the LET values of
the a and Li-7 ions along their paths, the LET values were calculated using TRIM91. 13,14
For simplicity, the two daughter nuclides, He-4 and Li-7, were assumed to decay to the
excited state with 100% branching ratio. Figure 4.15 shows the LET functions for these
two ions. The B-10 distribution was assumed to be homogeneous . The transportations
of these ions were assumed to be straight line as discussed in section 4.1 of this chapter
The absorbed energy distributions for 1, 4, and 8 B-10 reactions occurred per cell
were calculated with 10,000 trial runs in each case. These distributions are symbolized as
f(e,DI), f(e,D4 ), and f(E,D 8), where DN represents the given dose level D with N
o0 B(n,a) 7Li reactions occurred per cell. The calculated results are shown in figure 4.16.
The results are represented in hit-size, z, which is defined as the absorbed energy divided
by the volume of the nucleus. For the cell model employed in simulations, the volume of
the nucleus is 230 gm,3 therefore, an absorbed dose of 0.3256 Gy is equivalent to N=1.
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Figure 4.14 Cell model for V79 Chinese hamster cells.
diameter with a central nucleus of radius 3.8 gtm.
Cubical cell body 13 pm
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Figure 4.15 LET functions for He-4 and Li-7 ions. 100% branching ratio for the
excited state was assumed.
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Figure 4.16 Hit-size distributions calculated by Monte Carlo simulations. N is the
number of B-10 reactions occurred per cell.
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4.3.2 Absorbed Energy Distributions from Convolution
It has been discussed in ICRU Report 36 "Microdosimetry" that multiple-event
microdosimetric spectra can be derived from single-event spectrum using successive
convolution [ ]. Because the convolution operation is fundamentally in probability
theory, and because it has all the characteristics of multiplication, it is convenient to
simplify the complicated integral. Convolution between functions with operator "*" can
be expressed as
fn+m() = f n(x) fm(X - ý)dx = fn(()*fm(4), (4.7)
in which fn( ) is the probability distribution function of ý with n events. In a further step
the repeated convolution of a distribution with itself can calculate the solution for N
events, i.e.,
fA) = fN-1 () * fl()
fN-1 () = fN-2(A) * fl()
(4.8)
f3() = f2(A) * fl()
fA) = f(A) * fl()
Starting from the single-event distribution we can obtain all the distributions for
any values of n, providing n is an integer. As an example, hit-size distributions f(z,D 4)
and f(z,Ds) were calculated using Eq. (4.7) starting with f(z,D 1). The calculated hit-size
distributions are shown in figure 4.17.
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Figure 4.17 Hit-size distributions calculated by successive convolutions. N is the
number of B- 10 reactions occurred per cell.
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4.3.3 Absorbed Energy Distributions from FFT Approach
The convolution method discussed above seems useful in calculating hit-size
distributions. However, if N is a large number the computational time of the convolution
process will be complicated. In addition, if N is not an integer the convolution method
does not work. A method based on the fast Fourier transform (FFT) was developed, the
basic idea of the approach is to manipulate the convolution in the frequency domain.
One of the most important properties of the Fourier transform with regard to its
use in dealing with linear time-invariant systems is its effect on the convolution
operation. Consider that hit-size distribution f(z,Dn+m) is the result from convolution of
two distributions f(z,Dn) and f(z,Dm). This can be expressed mathematically as
f(z, Dn+m) = f(z, D)* f(z,,Dm) = ~.f(x, D). f(x -z, Dm)d (4.9)
Recall the operation of Fourier transform,
F(w) = FFT{f(t)} = f+f(t)- e-dt (4.10)
and its inverse transform
f(t) = IFFT{F(co)} = F( ) eiweds (4.11)
then, taking FFT of equation (4.9) in both sides, it becomes
F(o, Dn+m) = FFT{f(Z,Dn+m)) = J+cL[f(x,Dn) f(z-x,Dm) dx]- e-wdz (4.12)
Interchanging the order of integration, we have
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F(w, Dn+m) = I f(x,D)[ f(z - x, Dm) -e- w dz] dx
By the shifting property of Fourier transform, the bracketed term is simply e-it x F( Co,D ).
Substituting this into equation (4.12) yields
F((O,Dn+m) = f +f(x,D,) e-wx F(o,D,) dx = F(O,Dm)jf +f(x,D,)' e-'wxdx, (4.14)
and hence
F(w,D,+m) = F((O,Dm)-F(w,D,). (4.15)
That is,
f(z,D,+m)= f(z,D,)*f(z,Dm) to F(o,D,.m)= F(o,Dm)- F(o,D,) (4.16)
Equation (4.16) is also applicable for periodic functions. If { anj ), { am,j }, and { an+m,j I
are the Fourier series coefficients of periodic functions f(z,Dn), f(z,Dm), and f(z,Dn+m),
respectively, then
an+m,j = To an,j am.j
If n=m=1, then equation (4.17) becomes
where, j = 0, 1 .... , To /2.
a2, j = To . a2 j (4.18)
where, {al,j is the Fourier coefficient of FFT f(z,D 1)), the Fourier transform of the
single-event hit-size distribution, which is obtained from Monte Carlo simulation.
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(4.17)
(4.13)
Equation (4.18) is the basis for frequency domain multiplication for N=2 and that can be
generalized to
aN, = T 1o aTaN  (4.19)
for any values of N, any real numbers.
Finally, the time domain f(z,DN) can be obtained by the inverse fast Fourier
transformation. That is
f(z,DN) = IFFT{aNj} (4.20)
For mathematical calculation and digital computer programming, the period To
should be equal to the number of increments of the hit-size distribution, this number
should be an integer with value of 2n. For example, if the maximum hit-size is 64
keV/g.m3, To can be selected to be 32, 64, or 128. The precision of the function depends
on the number of harmonics (To) selected. If To is selected to be 32 then the width of
each channel is 2 keV/glm3; if To is 128, then width will be 0.5 keV/glm3, and so on. Of
course, the smallest channel size will result more precise estimations.
Hit-size distributions were calculated for N = 4 and 8 from the single-event
distribution (N= 1). The period To of the hit-size distribution was selected to be 256 with
channel width of 0.5 keV/gm 3. Figure 4.18 shows the probability densities of single-
event hit-size distributions for both space and frequency domains. The frequency
distributions for N=4 and 8 were calculated from f(o,D 1) using Eq. (4.19). The
frequency distributions of f(o,D4) and f(o,D 8) are shown in figures 4.19a and 4.19b.
The inverse transforms of these two frequency distributions were presented in figures
4.20a and 4.20b. The hit-size distributions, zef(z), for N=1, 4 and 8 are shown in figure
4.21.
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(a) Hit-size for N= 1 in space domain, f(z,D 1)
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(b) Hit-size for N= in frequency domain, f(o,D 1)=FFT { f(z,D 1) }
Figure 4.18 Probability densities (P) of hit-size distribution for the single-event case.
(a) Hit-size distribution of f(z,D 1) in space domain(z). (b) Hit-size distribution of f(z,D 1)
in frequency domain(o), FFT{f(z,D 1)). The magnitudes of the frequency domain
distribution is expressed in it's norm value, i.e., P0 = Re(P,) + Im(P, ) . The
operations were performed in MathCad software running on a Macintosh computer.
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(a) Hit-size for N=4 in frequency domain, f(oD4)
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Figure 4.19 Probability densities (P) of hit-size distributions calculated from f(0o,D 1)
using FFT approach. (a) f(o,D4) for N=4. (b) f(0o,D 8) for N=8. The magnitudes of the
frequency domain distribution is expressed in it's norm value, i.e.,
PW = Re(P,) + Im(P,) .
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(a) Hit-size for N=4 in space domain, f(z,D 4)=IFFT { f(co,D 4)}
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Figure 4.20 Inverse FFT of f(o,D4) and f(co,D 8). (a) Hit-size distribution for N=4,
f(z,D 4). (a) Hit-size distribution for N=8, f(z,D8).
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Figure 4.21 Hit-size distributions calculated by FFT approach. N is the number of B-
10 reactions occurred per cell.
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4.3.4 Validation of the FFT Approach
To validate the FFT approach, hit-size distributions calculated by Monte Carlo
simulations, convolution, and FFT were compared. First, hit-size distributions obtained
from these methods were expressed in z-f(z), as shown in figures 4.16, 4.17 and 4.21.
Then these results were fitted by a Gaussian distribution with form
f (z) = m, * exp-[m2 (-m3)2],  (4.21)
and mean hit-size values were calculated. The comparisons are summarized in table 4.7
Results of table 4.7 show that the hit-size distributions obtained by Monte Carlo
simulations or calculated by convolutions or fast Fourier transforms are identical. There
is no surprise of this positive validation because the fundamental principles among these
three approaches are the same, i.e., based on compound Poisson process. However, the
FFT has its unique advantages than the other two approaches. First of all, FFT approach
can calculate the hit-size distributions at any dose levels (any N). Secondly, the
manipulation in the frequency domain is much more convenient than multiplication or
integration in the time domain. Also, Monte Carlo simulation is very time consuming
when N is a large number.
As an example, considering the calculations involved in this validation, the
running time for Monte Carlo simulation of single-event (N = 1) with 10,000 trial runs on
a PC 486DX-II 66 MHz computer is about 13 seconds. The running time for two-event
process will be 26 seconds and so on. If we want to obtain all the hit-size distributions
for N = 1, 2, 3, ..., 128 (Dose = 0.325 to 41.67 Gy) by Monte Carlo simulations, the total
computer time required will be equal to 0.5x(1+128) 2x13 = 108167 seconds. However,
with this proposed FFT approach using MathCad 4.0, an engineering mathematics
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Table 4.7 Comparisons of hit-size distribution functions
simulation, convolution, and FFT approaches.
obtained by Monte Carlo
N Parameter Monte Carlo Convolution FFT
1 mi 0.113 0.113 0.113
1 m2 0.158 0.158 0.158
1 m3  4.803 4.803 4.803
1 max[z of(z)] 0.1135 0.1135 0.1135
4 mi 0.217 0.222 0.222
4 m2 0.037 0.039 0.039
4 m3 6.924 6.819 6.815
4 max(z°f(z) 0.2509 0.2492 0.2493
8 mi 0.302 0.299 0.299
8 m2 0.018 0.017 0.017
8 m3 10.915 10.802 10.798
8 max(z *f(z) 0.3399 0.3024 0.3024
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software, running on a Macintosh II-vx 33 MHz computer, the running time is only 180
seconds. Plus the 13 seconds for the single-event Monte Carlo simulations, the total
computer time required for all the 128 hit size distributions is 193 seconds.
4.3.4 Applications of the FFT Approach in the 2D HRQAR Model
The stochastic microdosimetric parameters, e.g., absorbed energy distribution, hit-
size distribution and LET distribution, obtained from the HRQAR process are referred to
the single-event situation, i.e., dose = one 10B(n,aX) 7Li reaction per cell. Using the
proposed FFT approach, multiple-event distributions can be calculated. As an example,
the multiple-event absorbed energy distributions were calculated with figure 4.13 (single-
event distribution obtained by HRQAR & Monte Carlo simulation) as input. Figure 4.22
show the results of absorbed energy distributions calculated by FFT approach with N=2,
4, 6 and 8.
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Figure 4.22 Multiple-event absorbed energy distributions for the mouse brain-BPA.
Figure 4.13 was used as single-event distribution and FFT approach was employed.
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Chapter 5 Validation of the 2D Approach
5.1 Introduction
In chapter 4 a novel method is presented for calculating various microdosimetric
parameters for boron neutron capture therapy. High-resolution quantitative alpha-
autoradiography (HRQAR) and image processing techniques have been developedl-4 to
measure with subcellular resolution and high sensitivity boron distributions in frozen tissue
sections. These data are then used as input to a novel microdosimetric model with which
various microdosimetric parameters are computed by Monte Carlo simulation. In the
proposed scheme a large number of randomly oriented cell cross-sections are derived from
a single 2D tissue autoradiographic section. According to stereological theory5 the cross-
sectional images of cells obtained from such 2D random sections contain all the 3D cell
morphological information. Thus, microdosimetric parameters derived from charged
particle transport performed in this 2D domain also may represent the true 3D situation.
However, no mathematical proof exists to confirm this hypothesis.
The objective of this chapter is to validate the 2D microdosimetry model. Monte
Carlo simulation of the 10OB(n,a) 7Li reactions was employed to calculate standard
microdosimetric parameters 6 in both 3D and 2D domains and thus to test their equivalence
in that context. To facilitate Monte Carlo simulations a simple cell geometry and two
simple boron distributions were modeled. Limitations of this approach also are evaluated,
including effects on the spatial resolution of the thicknesses of the histological sections and
the track detector, and the influences of He-4 and Li-7 range-straggling.
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5.2 Materials and Methods
Microdosimetric parameters were calculated using Monte Carlo simulations in both
full 3D and 2D surrogate domains with certain common input parameters (i.e., cell
models, LET functions, and boron-10 (B-10) distributions). The 2D results were then
compared with the 3D results for various simple cell models and 10B distributions.
Cell Models
Two cell models were assumed for the calculations based on the dimensions of the
frequently studied V79 cell line. 1) a single cell consisting of a cubical cell body,
13x13x13 gm, and a central spherical nucleus of radius 3.8 Rm, as shown in Figure 5. la.
2) a matrix of 27 such single cells, as shown in Figure 5.1b. These cell models were
selected because of their simple geometry, which was more easily adapted to Monte Carlo
simulation; however, for the purposes of validation virtually any cell model would have
been adequate.
Energy Ionization Functions(LET)
Two different sets of energy ionization functions for a and 7Li were used to
determine the spatial energy dissipation along the paths of the charged particles from the
10B(n,a) 7Li reactions. The first set of functions are experimental linear energy transfer
(LET) data from Northcliffe and Schilling7 as fitted by Gabel 8 with water as the transport
medium:
dEHe 
-4.05( X - 1.36)2 + 234.0
dX (5.1)
dELi = 92.232 (4.81-X)-7.1009 (4.81-X)2  (5.2)dX
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Figure 5.1. Physical input parameters for Monte Carlo simulations. (a) Cell model #1 - Single
cell with a spherical nucleus of radius 3.8 gtm. (b) Cell model #2 - cell matrix with nucleus of
central cell as dose "target". (c) LET functions #1 - water-equivalent medium, Northcliffe and
Schilling data (14). (d) LET functions #2 - tissue-equivalent medium, Ziegler TRIM91 data (15).
(e) Homogeneous o1 B microdistribution. (f) Inhomogeneous o1 B microdistribution - preferential
boron-10 uptake in nucleus.
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In these equations, X is the distance of the particle from its origin and dE/dX is the
LET (in keV/gm). The maximum values for X are 4.81 and 8.96 gm for the 7Li and the
4He (or alpha particle), respectively. Using these ranges the above LET functions integrate
to give total energies of 803.5 and 1500.6 keV for 7Li and 4He, respectively. Figure 5. 1c
shows these LET functions graphically. The second set of ionization functions are
stopping power functions which were calculated using TRIM91, 9 a Monte Carlo based
simulation code for calculating ionization functions with tissue equivalent material as the
transport medium. The two branching pathways for the energy kinetics of the He-4 are
individually represented. Figure 5. id shows the calculated stopping power functions.
B-10 Microdistributions
Both homogeneous and inhomogeneous B-10 microdistributions were employed
in the simulations. In the case of a homogeneous distribution B-10 was randomly
distributed within the cells with equal average concentrations in the cytoplasm and the
nucleus, as shown in Figure 5.1e. In the inhomogeneous distribution all the B-10 was
assumed to be contained in the nucleus, as shown in Figure 5. If.
Monte Carlo Simulation of the 1°B(n,a) 7Li Reaction Products
Capture reaction origins were simulated according to the assumed B-10
microdistributions, as described above. The a and 7Li particles, with specified LET
functions, were emitted isotropically and anti-parallel to each other from each assigned B-
10 location, with randomly determined directional vectors.10 The particles released their
energy along their paths at increments of 1 gm, according to the specified ionization
functions. Energy depositions for each increment were recorded until the particles' kinetic
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energies were reduced to zero. Figure 5.2 illustrates the 3D transport geometry with a
single cell model. The same cell model was used for the 2D simulation. In this case the
cell model with the assumed 10B distribution was randomly "cut" by 2D planes to simulate
the physical tissue sampling process employed in the high-resolution autoradiography
technique. 1 Figure 5.3 illustrates this cutting process. Each cut plane contains B-10
reaction origins and corresponding morphologies of the sectioned cell nuclei. These
become, respectively, sources and targets for the 2D Monte Carlo simulations performed
for each plane. These calculations and tally schemes are identical to that described above
for the 3D model except that one degree of freedom is removed from the choice of particle
direction vectors.
Simulation of Random Cut Planes for the Simulated 2-D Calculation
In order to sample a 3D object with randomly oriented 2D cut planes the object is
first "seeded" with a large number of randomly oriented points. For an arbitrary point all
possible 2D planes cutting through this point can be obtained by rotating a reference plane
around two of the three axes using all possible angles. Consider an arbitrary 2D plane
sampled by this process, as shown in figure 5.4, the equation of this new plane can be
computed (11); that is:
(xi + yj + zk) * ((yl*z2-y2*zl)i + (x2*zl-xl*z2)j + (xl*y2-x2*yl)k) = 0. (5.3)
The 2D directional vector of each particle's transport can then be obtained from this
equation using random number sampling methods. Although it is difficult to apply
random numbers with a probability distribution function in such a quadratic form one can
circumvent the problem by exploiting the properties of vector operation. Since F and G
are
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10(n,a) ?Li
Y
X
a 3-D Isotropic Transport
Figure 5.2. 3D Monte Carlo simulation transport model for o1 B(n,aX) 7Li reactions. In a boron
capture reaction, two charged particles (a and 7Li) emitted from the original locations of the o0B
travel back-to-back along the same straight lines in 3-D space.
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Figure 5.3 2D Monte Carlo simulation transport model for 10B(n,a) 7Li reactions. The 3D cell
model is sampled by 2D sections through the nucleus and cytoplasm and 'oB distribution in each
cut. This 2D sampling process simulates the 2D physical HRQAR process.
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Figure 5.4 A random 2D sampling plane created by rotation of two axes. 2D random
directional vectors for particle transport are determined by the linear combinations of two arbitrary
vectors.
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known vectors one can generate other random vectors V lying also on the same plane by
calculating the linear combination (20) of these two vectors:
V = l1*(xli + ylj + zlk) + ý2*(x2i + y2j + z2k)
= (ýl*xl+ ý2*x2)i + (l1*yl+ ý2*y2)j + (l1*zl+ ý2*z2)k. (5.4)
In this equation, lI and ý2 are two random numbers with value from -1 to 1. So, a
new random directional vector for the particles can now be assigned with direction cosines
nx, Dy, and Oz. These direction cosines can be expressed as:
(~l*xl+ý2*x2)
(ýl*yl+ý2*y2)
S r , and
(1 *zl+ý2*z2)
= r (5.5)
where,
r = V/(l*xl+ ý2*x2) 2 + (ýl*yl+ ý2*y2) 2 + (1l*zl+ ý2*z2) 2
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5.3 Results
Surrogate 2D and 3D Monte Carlo particle transport simulations were performed
with various input parameters as summarized in table 5.1. The standard microdosimetric
parameters 6 computed were: (i) absorbed energy fraction; (ii) absorbed energy
distribution; (iii) dose-weighed LET distribution; and (iv) hit theory parameterization
(crossers, starters, stoppers, insiders, and outsiders). The results are described below.
(i) Absorbed Energy
The absorbed energy fractions were obtained for eight different runs: four for the
homogeneous model and four for the inhomogeneous. 10,000 events were simulated for
each run. Table 5.2 shows that energy deposition in the nucleus from the surrogate 2D
approach agrees very well with the 3D calculations in all cases, if a sufficient number of
simulation histories is used. For simplicity, only the results for the homogeneous model
are shown in Figures 5.5a and 5.5b. The 2D and 3D results are seen to converge as the
number of events increases. With 10,000 events simulated in each run, the maximum 2D
vs. 3D discrepancy in all four cases is less than 1 %.
(ii) Absorbed Energy Distribution
The total amount of energy deposited in the nucleus, as characterized in (i) above,
may not be the only factor that determines biological response; the quality of the absorbed
energy, i.e., the instantaneous energies of the charged particles as they interact in the cell
nucleus, may also be important. Radiation interaction with matter is a stochastic process
and the energy deposition is, therefore, a probabilistic phenomenon depending on the target
geometry and source distribution. Probability distributions of the energy absorbed in the
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Summary of the input parameters for the Monte Carlo simulation calculations.
Run # Domain Cell model LET function B-10 distribution
1 3D Single cell Northcliffe & Schilling-LET Homogeneous
2 2D Single cell Northcliffe & Schilling-LET Homogeneous
3 3D Single cell TRIM91-Stopping power Homogeneous
4 2D Single cell TRIM91-Stopping power Homogeneous
5 3D Cell matrix Northcliffe & Schilling-LET Homogeneous
6 2D Cell matrix Northcliffe & Schilling-LET Homogeneous
7 3D Single cell Northcliffe & Schilling-LET Inhomogeneous
8 2D Single cell Northcliffe & Schilling-LET Inhomogeneous
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Table 5.1
Table 5.2
parameters.
Summary of calculated absorbed energy fractions for each set of simulation
Runs # % of energy % of energy Error
absorbed* - 3D absorbed - 2D (%)**
I and 2 9.839 9.898 +0.59
3 and 4 10.089 10.150 +0.60
5 and 6 10.685 10.474 -1.97
7 and 8 50.282 50.270 -0.02
* % of energy from Li-7 and He-4 particles deposited in the nucleus
** Error % = (2D - 3D)/3D x 100%
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Figure 5.5 Comparisons of the 3D and 2D results. (a, b) 3D and 2D absorbed energy
fraction vs number of simulated events. (c, d) 3D and 2D absorbed energy spectra.
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Figure 5.5 (continued) Comparisons of the 3D and 2D results. (e, f) 3D and 2D DWLET
values - see text for explanation. (g, h) 3D and 2D hit parameter probability distributions; outsider
- *, crosser - x, starter - , stopper - A and insider - o.
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nucleus were calculated for each run. Once again, with a simulation of 10,000 events for
each run it can be seen from table 5.2 that the surrogate 2D and 3D energy distributions
are completely equivalent in all cases. Figures 5.5c and 5.5d show the energy absorbed
probability distributions for the homogeneous model.
(iii) Dose-Weighted LET Distribution
Since in most mammalian biological systems there is generally an increase in
biological effect per unit dose with increase in LET, a microdosimetric parameter which
would be expected to correlate with biological response is the dose-weighted LET
(DWLET) distribution. Thus, the average DWLET value for each hit should be a measure
of the effectiveness of this hit on the nucleus by an alpha or recoiled Li-7 particle. The
integrals of the LETs along each segment of the paths of the particles through the cell
nucleus are the dose weighting values applied to the LET values in that segment.
Therefore, for multiple histories there will exist a DWLET value probability distribution.
The equation for the DWLET value for a single alpha/Li-7 history is given below.
Na MLi
I (Pi(x,y,z, a). L Er(a)) + 1 (pj(x,y,z, Li). LEr(Li)f
DWLET- i (5.6)
Na Mu
X (Pi(x,y,z, a)- L Eri(a)) + (Pj(x,y,z, Li). L ET(Li))
i j
where,
I1 if the nucleus is hit by the particle at this LET increment
ior j = 0 if the nucleus is not hit by the particle at this LET increment)
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Figure 6 is a graphical explanation of the DWLET value. For example: there are 10
hits to the nucleus in example 1 and only 1 hit in example 2. However, in both examples
the total amount of energy absorbed in the nucleus is the same since the track segments
interacting with the nucleus in example 1 do so at much lower LET than those in example
2 (refer to the corresponding LET data in Figures 5.1c and 5.1d). DWLET value
distributions were calculated for the 3D and simulated 2D models using 10,000 histories
for each. Figures 5.5e and 5.5f show the results of these calculations for the homogeneous
model. Figure 5.5e shows that most of the dose delivered to the nucleus is at very high
LET. Comparison of Figures 5e and 5f shows that the DWLET value distribution
obtained by the surrogate 2-D approach is completely equivalent to that obtained by the 3D
approach.
(iv) Hit Theory Parameterization
According to conventional radiobiological theory cell inactivation by heavy charged
particles can be described by hit theory models. 12-14 Conventional hit theory is often
characterized by five kinds of events involving the passage of charged particles in the
vicinity of the target. These are often referred to as: insiders, outsiders, crossers,
starters, and stoppers.15 The relative frequency of these events was calculated for various
numbers of histories. Table 5.3 compares the results of these calculations for the surrogate
2D and 3D models. Figures 5.5g and 5.5h show the convergence of the surrogate 2D and
3D homogeneous models as the number of events approaches 10,000.
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Figure 5.6 Graphical representation of the DWLET value - the weighted LET concept. Case I
requires 10 hits to the nucleus in order to deposit the same amount of energy as in case II in which
only a single hit occurs. Thus, the DWLET value of the single hit in case II is higher than that of
all 10 hits combined in case I.
Chapter Five 147
Case II
nucleus
deposition is the same
Case I
Ly
g
Table 5.3 Summary of calculated hit parameters and non-hit probabilities for each set of
simulation parameters.
Run # Outsider Crosser Starter Stopper Insider Hit %
3D:2D 3D:2D 3D:2D 3D:2D 3D:2D 3D:2D 3D:2D
1 : 2 15971:15989 888:878 1870:1981 1059:981 212:171 20.1:20.1
3 :4 16039:16045 632:631 1806:1906 1247:1171 276:246 19.8:19.8
5 : 6 487466:487343 48501:48623 1951:1959 1873:1882 209:193 9.7:9.8
7 : 8 0:0 0:0 18160:18215 0:0 1840:1785 100:100
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5.4 Discussion
A major goal of this paper was to demonstrate that the novel 2D approach to
microdosimetry for BNCT that has been proposed in chapter 4 is functionally equivalent to
the "benchmark" 3D approach. To this end Monte Carlo calculations have been performed
for two simple biological models. The first represents a single cell, consisting of cubical
cytoplasm containing a spherical nucleus; the second represents a three-dimensional
matrix of 27 such cells. Two different B-10 distributions are assumed: a homogeneous
distribution throughout cytoplasm and nucleus; and an inhomogeneous distribution, with
all the B-10 contained in the nucleus. Four different microdosimetric parameters have been
examined as "tests" for the surrogate 2D vs. 3D equivalency hypothesis; these are: (i)
absorbed energy fraction; (ii) absorbed energy distribution; (iii) dose-weighted LET
distribution; and (iv) hit theory parameterization (crossers, starters, stoppers, insiders, and
outsiders). For each cell model and B-10 distribution and for each microdosimetric
parameter Monte Carlo calculations were performed using the "conventional" full 3D
approach as well as the surrogate 2D approach. Various numbers of histories were run for
each case to examine the sensitivity of each approach to constrained statistics and to
determine the required number of events to result in equivalency of the surrogate 2D and
3D models.
The results show that in all test cases examined the surrogate 2D and 3D results
completely converge as the number of histories increases. With 10,000 or more histories
the convergence for each microdosimetric parameter is to within better than 2%. In
addition to fulfilling the stated goal of validating the surrogate 2D approach as a surrogate
technique for the 3D approach, the numerical microdosimetric results obtained are worth
reviewing. For the absorbed energy fraction, the nucleus absorbs about 10% of the total
energy for the homogeneous model and about 50% for the inhomogeneous model. For the
hit theory characterizations, the nucleus receives hits from 20% of the particles for the
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homogeneous model and 100% of the particles from the inhomogeneous model. This is
quite consistent with the calculations performed by Kitao20 for similar cell models and B-
10 distributions.
5.5 Limitations of the 2D Approach
(i) Sample Thickness
The microdistribution of B-10 at the cellular level is determined from the
distribution of alpha and Li-7 charged particle tracks recorded in a thin (jlgm thick) Lexan
track detector in contact with a thin (1-2 gtm thick) tissue sample.I The actual locations of
the B-10 reactions are described by a gaussian probability function analogous to a point-
spread function. 16 Before discussing the spatial uncertainty (or resolution) of the HRQAR
method it was decided to investigate the sensitivity of at least one of the microdosimetric
parameters to this uncertainty in B-10 location. Figure 5.7 shows the cross-section of a
spherical nucleus of radius 3.8 jm. B-10 capture reactions were simulated along a line at
different distances from the nuclear center. The simulations were performed at seven B-10
locations: 0, 2, 4, 6, 8, 10 and 12 jim. At x = 0 jgm B-10 reactions occur at the nuclear
center, while at x = 12 jgm the alpha particle is just beyond its "firing range" to the nearest
nuclear surface (7.7 jgm alpha range + 3.8 jgm nuclear radius = 11.5 jgm) . At each of
these B-10 locations the apparent reaction origin is distributed in 3D as a gaussian function
of the form:
P(x) = ---exp- (5.7)
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Figure 5.7 Cross-section of a single cell with B-10 locations at various radii from the nuclear
center. Absorbed energy fractions were calculated with different FWHMs of the 2D point-spread-
function of the B-10 locations.
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where, x, is the B- 10 location (0, 2, 4, 6, 8, 10 or 12 glm) and a is a measure of the spread
of the gaussian function. The spread of this function is characterized by its full-width-at-
half-maximum (FWHM), where FWHM = 2.35 X a. To investigate the effect of B-10
location uncertainties at different values of FWHM, a is chosen to be 0, 0.5, 1 or 2 gim.
With seven B-10 locations (xo) and four gaussian distributions (a) a total of 28 cases was
calculated by Monte Carlo simulation to determine the absorbed energy fractions by the
nucleus (refer to section (i) under RESULTS). It was felt that the conclusions that would
be drawn using this test parameter would be at least qualitatively applicable to the
remaining microdosimetric parameters. The results are shown in figure 5.8. These show
that with a < 1 jIm the effect of the uncertainty in the B-10 location on the absorbed energy
fraction by the nucleus is insignificant. For a 5 2 jm for intranuclear locations of the B-
10 there is an underestimate of the nuclear absorbed fraction of 11-13% due to uncertainty
in the location of the B-10; for extranuclear B-10 locations there is no significant effect of
the uncertainty in B-10 location. Consequently, except in the case of fully intranuclear B-
10 locations the impact of a 1-2 jlm FWHM uncertainty in B-10 location would appear to
be rather small.
The resolving power of the HRQAR technique is about 1-2 jm (1), principally due
to the finite tissue sample thickness and the critical angle (the greatest departure from
perpendicular incidence where charged particles are still capable of causing tracks in the
detector material). 16 The geometrical configuration of a sample with an etched surface is
shown in figure 5.9. A track is formed due to the different etching velocities (VG and VT)
in detector material that has been crossed by heavy charged particles vs. that which has not,
and the difference in average etching directions relative to the sample surface. The
maximum width of the track aperture, D, is determined by the critical angle and the sample
thickness. In the HR.QAR method the detector thickness is approximately 1.1 i.m (Lexan)
and the critical angle, 0, is approximately 450. 16 Therefore, D = 2 X tan(450 ) X 1.1 = 2.2
mm. Conservatively assuming no bulk etching of the sample (which, as shown in
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Figure 5.8 Calculated absorbed energy fractions as a function of B-10 location from the
nuclear center for different a values relating to the assumed FWHMs.
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Figure 5.9 Geometrical configuration of the sample assembly for the etching process
calculation in 2D HRQAR. VT and VG are etching velocities in two different directions along the
track. TL and TI are the thickness of the track detector (Lexan) and the tissue protective layer
(Ixan), respectively. D is the width of the track aperture after etching and 0 is the critical angle for
track registration in the detector.
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figure 5.9, reduces the visible track aperture) and setting D equal to the FWHM of the
gaussian function:
0 2.35 D = 2.2= 0.94 4m. (5.8)2.35 2.35 2.35
The inherent uncertainty in B-10 location (a) is, therefore, slightly less than 1 gm,
which from the previous analysis suggests that its impact on the test microdosimetric
parameter, the absorbed energy fraction, is insignificant for both intra- and extranuclear B-
10 locations.
Another possible source of error related to sample thickness is connected with the
stereological transformations made between the 2D and 3D sampling. The thickness of the
tissue sections obtained is typically 1 gm whereas the characteristic size of typical cell
nuclei are in the 4-8 gm range. There will, therefore, be some degree of inaccuracy related
to the coarse sampling of nuclei by the 2D sectioning process. This particular problem is
currently under investigation.
(ii) Effects of lateral and range straggling of the a and 7Li particles
It has been a common assumption in BNCT microdosimetry that the a and 7Li
particles travel back-to-back, along a common straight line, and each with a fixed range
without straggling. 18-27 In fact their tracks are not exactly collinear due to the lateral
straggling effect and their ranges are not fixed due to the range straggling effect .9 Figure
5.10 shows a particle entering a medium. The "ideal" trajectory, with no influence from
either lateral or range straggling, is R. The actual trajectory is described by a probability
distribution represented by SL (to represent lateral straggling) and a corresponding
uncertainty along the ideal trajectory represented by SR (to represent range straggling).
Lateral and range straggling distributions were calculated with the TRIM91 code9 with the
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Figure 5.10 Interpretation of range straggling for a charged particle entering the medium with an
angle of 00 to the surface. RR and RL are the mean ranges in X and Y directions and SR and SL are
the FWHMs of the statistical particle density distributions. In the ideal situation RL, SR, and SL
should be equal to zero, i.e., no straggling, then the range of the particle equals RR. In the case of
BNCT these parameters may be non-zero - see Table IV for the relevant numerical values for RR,
SR , and SL.
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results shown in table 5.4. Lateral straggling is clearly very small (or not insignificant).
Figure 5.11 shows the range straggling of the two particles. To examine the impact of
range straggling on the absorbed energy fraction for the cell nucleus of the single cell
model, absorbed energy fractions were calculated with and without the effects of range
straggling for nuclear radii of 0.8-5.8 jtm; the results are shown in Figure 5.12. It is
evident that range straggling is of inconsequential significance in BNCT microdosimetry
for nuclei of practical sizes, such as the nuclei in most mammalian cells which are
generally less than 5 glm in diameter.
5.5 Conclusions
In previous chapters a novel approach to measuring subcellular distributions of B-
10 using high resolution alpha-autoradiography and imaging processing has been
described. Further, it has been shown that combining this approach with Monte Carlo
simulation of the B-10 capture reactions enables more accurate microdosimetry to be
performed for boron neutron capture therapy and the consequent derivation of more
realistic "compound factors." In the proposed scheme a large number of 2D cell cross-
sections is obtained from a 2D tissue section with a distribution of B-10 previously
determined by high-resolution autoradiography. The hypothesis tested was that a full 3D
Monte Carlo calculation of charged particle transport is equivalent to a surrogate 2D
sampling technique, as suggested by stereological theory. The purpose of this chapter was
to validate this hypothesis using Monte Carlo simulation.
The results indicate that the hypothesis that was proposed is indeed correct. The
surrogate 2D approach was found to produce essentially identical results to full 3D
calculations for all microdosimetric parameters examined, as long as the number of Monte
Carlo histories sampled exceeded a defined minimum of approximately 10,000. As part of
the validation procedures, some actual microdosimetric results were obtained which are
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Table 5.4 Average range of the 10B(n,a)7Li charged particles in tissue-equivalent medium
calculated using the TRIM91 code.
Ion Energy Average range Straggling Lateral range Straggling
(MeV) RR (jtm) SR (9tm) RL (gim) SL (Itm)
He-4 1.47[ a]  7.268 0.177 0.216 0.257
He-4 1.7 8[b]  8.929 0.175 0.228 0.277
Li-7 0.84[a] 3.993 0.197 0.243 0.285
Li-7 1.0 1[b] 4.475 0.193 0.247 0.289
[a] ions created in an excited state with probability of 93.7 %
[b] ions created in ground state with probability of 6.3 %
[c] No significant straggling appears lateraly (SL > RL)
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Figure 5.11 Particle density distributions vs distance for o and 7Li particles showing the
uncertainties in particle ranges due to range straggling. Data were calculated using the TRIM91
code.
Chapter Five 159
3Nucleus radius ( gi m)
Figure 5.12 Calculated absorbed energy fractions as a function of nuclear size with and without
the inclusion of range straggling.
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independently interesting to report, even though such results per se are not original and
were not the purpose of this chapter. These indicate that for the simple cell models
considered a B-10 distribution confined to the cell nucleus produces 5 times the absorbed
energy fraction in the nucleus than if the same density of B-10 is homogeneously
distributed throughout the whole cell. In addition, if a measure of effectiveness is assumed
to be the number of "hits" incurred by a cell nucleus, the effectiveness ratio for nuclear vs.
homogeneous B- 10 distribution is also 5:1.
In practice there is an uncertainty in the determination of B-10 location using the
high-resolution autoradiographic method. This has been evaluated analytically and
estimated to be represented by a point-spread-function having a full-width-at-half-
maximum of 1.1-2.2 glm (depending on the assumptions used). This uncertainty (even
considering the upper value) has been shown to have negligible impact on absorbed energy
fraction estimates, for both intra- and extranuclear B-10 locations.
Charged particle transport models employed by most researchers in this field have
assumed no range straggling. Whether or not is a reasonable assumption it was tested
analytically by comparing calculations of absorbed energy fractions with and without range
straggling. The results confirm the validity of the no range straggling assumption for the
range of sizes of mammalian cell nuclei.
The advantage of the proposed surrogate 2D approach compared to earlier methods
for the microdosimetry of boron neutron capture therapy is that microdosimetric
parameters can be calculated without making any assumptions regarding either cell
architecture or a priori B-10 distribution. It is believed that this unique feature will permit
more realistic and accurate microdosimetry of boron neutron capture therapy to be
performed than has hitherto been possible using simple cell models and assumed B-10
distributions. This could potentially contribute to the understanding of boron neutron
capture therapy microdosimetry in various ways, including insight into RBEs and
compound factors which have been indirectly measured for certain physical model
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systems; and insight into the basic reasons why certain boron compounds appear to be
more effective at tumor cell killing than others. Finally the proposed approach could
provide a method for predicting the efficacy of new boron compounds as soon as
biodistribution data for them within specific tissues became available.
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Chapter 6 Determination of Nuclear Fraction and
Cell Volume for Microdosimetry
6.1 Introduction
In high-LET radiotherapy such as boron neutron capture therapy (BNCT) or other
heavy ion radiation, microdosimetry can provide guidance for radiobiological experiments
designed to investigate RBE values. Stochastic quantities, such as the specific energy, z,
and the lineal energy, y, describe the energy-deposition events in the sensitive site. Such
quantities and their probability distributions are central concepts in microdosimetry and a
wide variety of microdosimetric parameters have been developed in the past few decades. 1
Since the sensitive site for high-LET radiation was suggested to be at or near the nuclear
region,2 methods have been proposed to measure the area of the nucleus from monolayers
of cell lines.3 The measured nuclear areas were then used in the microdosimetric
evaluations of the underlying in vitro cell survival experiments. Since radiobiological data
obtained from the in vitro cell experiments can be used only as a relative index for the
clinical applications, the underlying "in vitro" microdosimetry does not represent the
realistic radiobiology . However, radiobiological data obtained from the in vivo
experiments provide more realistic information of radiobiological effectiveness for
radiotherapy. Therefore, the in vivo microdosimetry based on the in vivo data may provide
more accurate information for the evaluation of RBE values. However, to perform in vivo
microdosimetry nuclear fraction and cell volume should be known and which are difficult
to be measured directly from a tissue sample because: (i) individual cells can not be seen or
counted and (ii) cell boundary are not defined. Therefore, a special technique is required to
determine nuclear and cell volumes. The new technique (present chapter) of applying
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stereological calculations on 2D tissue sections should solve this problem. Cell volumes of
some mice and human tissue were calculated.
6.2 Approach
The mean cell volume and nuclear fraction are calculated from the 2D histological
tissue sections. Calculation is based on the principle of stereology which was originally
applied in material science to determine 3D microscopic structure from 2D sections of the
examining object.4
Consider a large number no of cells to be enclosed in a very large sample space, as
shown in figure 6.1, such that the mean cell volume can be estimated as
Vc = VT (6.1)
no
where VT is total volume of the sample space. The elliptical objects shown in this figure
represent the nuclei embedded in a sea of cytoplasm with random cell boundary. The
sample space, as shown in figure 6.1, is defined as a cube of volume
VT = 13 (6.2)
placed into an x,y,z coordinate system. If no is determined, then the mean cell volume can
be calculated. However, it is quite a challenging mission for the available imaging
techniques today to analyze the 3D structure at the submicron level. Therefore, it was the
objective of this paper to derive a methodology to determine no.
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CFigure 6.1. Sectioning randomly distributed convex objects with a plane of area AT in a
sample volume VT. (Adapted from Weibel, 1980 [ref. 4])
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Consider if this sample space as shown in figure 6.1 is randomly sectioned by a
plane parallel to the x-z plane of the x,y,z coordinate system, so that the area of a cross-
section is
AT = 12. (6.3)
In a particular random section as shown in figure 6.1 some of the nuclei with
number nN are being cut. Due to the random sectioning process, the number of nucleus
being cut in this sections nN is not equal to the number of cells being sectioned. This
sectioning probability of the nucleus is basically a function of the nuclear fraction with the
definition
nS(f) = , (6.4)
nc
where S(f) is the sectioning probability, nN and nc are the number of nuclei and cells
sectioned in AT. The sectioning probability is a function of nuclear fraction (f) and the
shape of the nucleus.
Combining Eq. (6.1) to Eq. (6.4), the mean cell volume can be calculated as
3 3
Vc = (AT = ( (f ) 2  (6.5)
nc nN
and nuclear volume
vN = f Vc. (6.6)
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In Eq. (6.5), 1 is the side of the random square section, nN is the number of
sectioned nuclei on the same section, and S(f) is the sectioning probability.
The nuclear fraction is defined as
f = VN (6.7)
vc
This equation can be written as
VN
vc
novN = VN
noVc VT
(6.8)
where VN is the total nuclear volume in the total sample volume VT. Using the first
fundamental principle of stereology (principle of Delesse)
VN AN
VT AT
then nuclear fraction f can be obtained from 2D histological sections with
Total area of sectioned nuclei in AT (AN)f=Total area of AT (Total area of AT (12)
(6.9)
(10)
The sectioning probabilities were calculated using Monte Carlo simulations for
nuclear fractions (f) ranging from 0.01 to 0.3 (1 to 30 %).
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6.3 Monte Carlo Simulations
A Monte Carlo simulation code (in Appendix G) was developed to calculate the
sectioning probabilities S(f). During the simulation a 3D cubical space (as shown in
figure 6.1) with size 400x400x400 pixels (1 = 400 pixel) was generated in Cartesian
coordinate with randomly distributed cells which are packed closely. The boundaries
between neighboring cells are also random. During each simulation run 2000 cell nuclei
were randomly seeded in this cube and without any overlaps. The positions of each cell
nucleus were generated by a random number generator. After this seeding process, a 2D
square plane was generated so that the cube was cut along one of the axes. The purpose of
having this 2D plane is to mimic the physical sectioning process to a tissue sample. The
area of this 2D plane is 400x400 pixels (AT). In this 2D section, some of the simulated
nuclei were cut and their total sectioned area (AN) was recorded. Nuclear fraction was
calculated using Eq. (6.10); i.e., f = AN/AT. The number of sectioned nuclei (nN) was
counted. Sectioning probability was calculated by dividing the number of sectioned nuclei
(nN) to the number of sectioned cells (nc). The number of sectioned cells for each plane
was determined analytically by the numerical density of cells in the sampling space (Ref.
3). For the case of 2000 cells in a 3D cubical volume the number of sectioned cells
appeared in the 2D section is 159 (used as a reference number).
Nuclear fractions for spherical and elliptical nuclei are presented in table 6.1. The range
of nuclear fraction in this simulation is from 0.01 to 0.3. The aspect ratio (q) used for the
elliptical nuclei are ranging from 0.6 to 0.9. Aspect ratio of an ellipse is defined as
Minor radius
q Major (6.11)
Major radius
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Results of table 6.1 show that nuclear fractions determined from 2D sections are equal to
the actual 3D values calculated by the physical volumes; which means these results agree
with the principle of Delesse: Eq. (6.9) and the algorithm for determining nuclear fraction is
valid. The results shown in table 6.1 are averaged values of 10 simulation runs in each
case with 2000 cells in each run. Figure 6.2 is a plot of the simulated nuclear fractions
against the actual values. Results shown in this figure also indicate that this algorithm is
applicable to any nuclei geometry.
Sectioning probabilities were also calculated for these runs with results shown in
table 6.2 and figure 6.3. The results shown in figure 6.3 show that: i) sectioning
probability increases with the nuclear fraction and ii) is a function of the nuclear geometry.
Curve fittings of these results show that sectioning probability can be expressed in a power
function with form
S = k.f 3 . (6.12)
In this equation k is a geometry dependent constant with values shown in figure
6.3. The k values for elliptical objects are ranging from 1.294 to 1.366 for q ranging from
0.6 to 0.9; these values are close to the k value for spherical object which is 1.291.
6.4 Experimental Validation
A phantom experiment was designed and performed to validate the proposed method of
calculating nuclear fraction and cell volume. First, a 450 cm 3 cylindrical wax phantom was
molded with 500 small 0.635 cm nylon spheres randomly distributed inside. The positions
of these nylon spheres were calculated using a computer random number generator. The
density of the wax body and nylon sphere are 0.875 and 1.130 g/cm 3, respectively.
Second, the constructed phantom was CT scanned in random positions along the
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Table 6.1 Nuclear fractions calculated from simulations for spherical and elliptical
nuclei. Results are averaged values of 10 simulation runs for each case.
Actual Sphere, f Ellipse, f Ellipse, f Ellipse, f Ellipse, f
f q=1.0 q=0.9 q=0.8 q=0.7 q=0.6
0.016 0.015 0.017 0.016 0.014 0.014
0.028 0.028 0.027 0.026 0.029 0.031
0.045 0.044 0.046 0.042 0.045 0.046
0.055 0.056 0.053 0.056 0.052 0.058
0.067 0.068 0.066 0.066 0.065 0.063
0.095 0.097 0.095 0.094 0.092 0.097
0.131 0.136 0.132 0.135 0.131 0. 135
0.174 0.177 0.173 0.172 0.172 0.175
0.199 0.200 0.201 0.198 0.195 0.199
0.226 0.226 0.225 0.222 0.225 0.228
0.256 0.261 0.257 0.257 0.256 0.252
0.288 0.298 0.285 0.286 0.291 0.289
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Nuclear fractions calculated by simulations.
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Figure 6.2.
Sectioning probabilities calculated from simulations for spherical and
elliptical nuclei. Results are averaged values of 10 simulation runs for each case.
Nuclear Sphere, S Ellipse, S Ellipse, S Ellipse, S Ellipse, S
Fraction, f q= 1.0 q=0.9 q=0.8 q=0.7 q=0.6
0.016 0.316 0.316 0.318 0.322 0.331
0.028 0.385 0.385 0.388 0.393 0.404
0.045 0.450 0.451 0.454 0.460 0.473
0.055 0.494 0.495 0.499 0.505 0.519
0.067 0.519 0.520 0.523 0.530 0.545
0.095 0.587 0.588 0.592 0.600 0.616
0.131 0.666 0.667 0.672 0.680 0.699
0.174 0.716 0.717 0.725 0.732 0.752
0.199 0.741 0.743 0.747 0.760 0.787
0.226 0.766 0.767 0.772 0.785 0.814
0.256 0.802 0.805 0.809 0.830 0.852
0.288 0.850 0.852 0.857 0.869 0.885
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Figure 6.3 Sectioning probability (S) as function of nuclear fraction (f) calculated for
spherical and elliptical nuclei with aspect ratio (q) ranging from 0.6 to 1.0.
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axial and transaxial directions. Due to the difference of densities between the wax and
nylon, the cross sections of the nylon spheres are registered on the CT images with wax as
background. Each CT image mimics the physical appearance of a 2D histological section
of tissue sample, so that, wax regions represent cell cytoplasm and nylon cross sections
represent the nuclei. Third, nuclear fraction and mean cell volume were calculated on these
CT images using the proposed methods. A digitized CT image of the wax phantom with
nuclei appeared in white pixels as shown in figure 6.4a. The nuclei were then outlined
manually. Then, a square region of interest was marked to the image for calculations
(Figure 6.4b). The number of white pixels in this square was counted and nuclear fraction
was calculated by dividing the number of white pixels to the total area. The number of
nuclei was also counted for determining the cell volume using equations (6.4) and (6.5).
Table 6.3 presents the calculated nuclear fraction and cell volume for the wax cell phantom.
Figures 6.5 and 6.6 present the measurements of nuclear fraction and cell volume as a
function of number of sampled spheres. The results presented in figure 6.5 and 6.6 show
that the measurements of nuclear fraction and cell volume are in good agreement to the
actual values. The determined nuclear fraction is 0.158 (actual value is 0.154) and cell
volume is 0.867 cm 3 (actual value is 0.9 cm 3). As notice from figures 6.5 and 6.6, the
calculated results converge with the number of nuclei sampled. With the number of
samplings larger than 600, the answers converge and with fluctuation less than 5 % from
the average value.
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Figure 6.4 CT scanned image of the cylindrical wax phantom with 0.635 cm diameter
spherical nylon spheres randomly distributed inside (4a). The gray-scaled image is
inverted for particle analysis (4b). Area of the square region of interest is 49 cm 2.
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Table 6.3
phantom.
Nuclear fraction and cell volume calculated from CT images of the wax
CT images No. of Nuclei Nuclear Fraction Sectioning Probability Cell volume
No. nN f S vc
1 38 0.148 0.687 0.834
2 37 0.155 0.698 0.889
3 40 0.161 0.707 0.806
4 41 0.162 0.709 0.780
5 36 0.150 0.691 0.912
6 38 0.158 0.703 0.863
7 39 0.162 0.709 0.841
8 38 0.158 0.703 0.863
9 37 0.163 0.710 0.912
10 37 0.166 0.714 0.919
11 37 0.151 0.692 0.877
12 38 0.157 0.701 0.859
13 38 0.161 0.707 0.870
14 38 0.158 0.703 0.863
15 37 0.165 0.713 0.918
16 38 0.165 0.702 0.861
Average 38 0.158 0.703 0.867
Actual NA 0.154 NA 0.90
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Figure 6.5 Calculated nuclear fraction of the wax phantom from CT images as a
function of number of sampled nuclei. Dashed line shows the actual nuclear fraction.
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Figure 6.6 Calculated cell volume of the wax phantom from CT images as a function of
number of sampled spheres. The actual cell volume is 0.9 cm 3.
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.6.5 Applications
Nuclear fractions and cell volumes were calculated from 2 tissue samples: human
muscle and mice brain. Figure 6.7 show four images of histological section of 2 plm thick
mouse brain frozen tissue. The tissue was stained by the H&E (Hematoxylin and Eosin)
staining method (ref.). As seen from this figure, the cross sections of the nuclei are stained
in purple by Hematoxylin while the cytoplasm is in yellowish brown by Eosin. A color
picture of this stained section was first captured using a camera in a high resolution light
transmission microscope with magnification of 400X. The processed picture was then
scanned to a 300 dpi gray-scaled image as shown in figure 6.7. The digitized image was
then analyzed using the NIH 1.57, an image processing software running on a Macintosh
computer - Power PC 6100/66. The nuclear fraction and cell/nuclear volumes were
calculated in the following procedures. First, the nuclei were outlined manually in a digital
computer with results shown in figure 6.8. Second, a square region of interest with area
AT was marked in this image and the number nuclear pixels (AN) was counted. Figure 6.9
show the results of the counting process. Third, nuclear fraction (f) is calculated using
equation (6.10). Forth, the number of sectioned nuclei is counted (nN). Fifth, sectioning
probability is calculated using equation (6.12) with k value of 1.293 for spherical nuclei.
As the results of sectioning probabilities shown in figure 3, the choose of the nuclear shape
does not reflect to a big change to the result in calculating S, therefore, it is up to the user's
decision to determine the nuclear shape. In most of the cases for cells with small nuclei or
small f, picking the nuclear shape as sphere or ellipse will not cause significant difference.
However, the number of nuclei counted in that region of interest is important and
fortunately the counting process is shape independent. Finally, the cell and nuclear
volumes are calculated using equations (6.5) and (6.6). Results of the nuclear fractions
and cell volume are presented in table 6.4. Similar procedures were applied to human
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Figure 6.7 Mouse brain image. Pictures were digitized as gray-scaled images with a
magnification of 400X.
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Figure 6.8 Outlined nuclear regions of the digitized mouse brain images.
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Figure 6.9 Counting of the nuclear fraction and number density of nuclei for mouse
brain image (from figure 6.8a).
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Table 6.4 Results of cell volume calculations for mouse brain samples
Sample # Nuclear area Nuclear fraction No. of nuclei Cell vol. Nuclear vol.
AN f nN VC VN
1 66461 0.2580 168 3406 pmn3  879 p.m3
pixels
2 63986 0.2489 179 3060 pWm3  769 gpm 3
pixels
3 64097 0.2494 183 2946 pmn3  735 gm3
pixels
4 61568 0.2395 169 3253 pmn3  779 gpm 3
pixels
Average NA 0.25 175 3166 ltm 3  791 tm3
*Total area = nuclei + cytoplasm; total area = 257049 pixels = 45957 pm2
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muscle tissue with images shown in figure 6.10. The thickness of this muscle sample is 4
gtm. Figure 6.11 show the same image with nuclei outlined manually. Results of the
measurements are presented in table 6.5.
6.6 Conclusions
A method based on stereology and probability has been developed to calculate
nuclear fraction, nuclear volume and cell volume. The probabilistic function used to
convert the measured nuclear density (number of nuclei counted in a square image) to actual
density was determined using Monte Carlo simulations. Cell and nuclear volumes for
human muscle cells and mouse brain cells were employed in demonstrations of the
proposed method. The results show that the mean cell volumes for mouse brain and
human muscle are 3332 and 3166 jim 3, respectively, and nuclear volumes are 791 and 207
jtm3, respectively. Also, the extra-cellular space in human muscle is significant, about 22
%.
The cell and nuclear volumes are believed to be important parameters in determining
cell kill mechanism. The direction application of this is to calculate the number of
'
0B(n,a)7Li reactions occurred per cell for a given dose, i.e.,
Number of reactions = Physical dos Cell volume * p
K.E. of 1 'OB(n,a)7 Li
where, p is the density of tissue being examined.
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Figure 6.10 Human muscle image. Picture was digitized as gray-scaled images with a
magnification of 400X.
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Figure 6.11 Outlined nuclear regions of the digitized human muscle images.
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Table 6.5 Results of cell volume calculations for human muscle samples
Sample Extra-cellular Nuclear Nuclear No. of Cell vol. Nuclear vol.
# space area, AN fraction, f nuclei, nN vC vN
1 56104 11755 0.0461 76 3511 gm3  216 tm3
pixels pixels
2 58013 12178 0.0477 83 3194 km 3  197 km 3
pixels pixels
3 55672 11827 0.0464 78 3364 km 3  208 km 3
pixels pixels
4 56523 12011 0.0471 80 3260 km 3  205 km3
pixels pixels
Average 56578 NA 0.0468 79 3332 m33 207 -m3
*Total area = nuclei + cytoplasm + extra-cellular space; total area = 255021 pixels =
45594gm2
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Chapter 7 B-10 Analysis and Dosimetry for the Phase I
Clinical Trials at MIT
7.1 Introduction
Phase-I clinical trials of Boron Neutron Capture Therapy (BNCT) using
epithermal neutrons at the MITR-II research reactor have been conducted on three human
subjects. All three subjects have noticeable metastasis melanoma nodules on the
extremeties. The irradiations were done with a single 15 cm diameter field of epithermal
neutrons from the MIT Research Reactor employing four daily fractions. The prescribed
dose level at this stage, the first escalation dose level, was 1,000 RBE-cGy to normal
tissue (RBEs used were: 4 for neutrons and the boron-10 (B-10) reaction products, and
0.5 for gamma rays).l Enriched borono-phenylalanine (L-BPA) was used as B-10 carrier.
The B-10 concentrations in blood, normal tissue, and tumor tissue were determined either
by prompt gamma analysis or high resolution autoradiography. This chapter describes
the B-10 concentration analysis and the related dosimetry calculations.
7.2 Sample Collections
After admission to NEMC's Clinical Study Unit (CSU) all three subjects were
given a test dose of 400 mg/kg of BPA orally as a suspension in fruit juice in two divided
doses one half-hour apart. Blood samples were collected for 15-18 hours and 4-7 hours
after BPA administration punch biosies of the melanoma nodules and surrounding normal
skin and subcutaneous tissue were taken. Tissue samples were fixed with O.C.T.
compound in dry ice immediately to preserve the intact B-10 micro distribution. Blood
samples were then transferred to MIT for B-10 concentration analysis using PGNAA and
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tissue samples were stored in a freezer with temperature at -240C. Tissue samples were
analyzed using HRQAR process.
7.3 Blood Sample Analysis by Prompt y (PGNAA)
7.3.1 PGNAA Calibration
B-10 concentrations of blood samples were measured by a prompt gamma
activation analysis facility (PGNAA) at MITR-II. 2 A diffracted beam with mean energy
of 0.015 eV and intensity 6x10 6 n/cm2-sec. is available at the sample position. The beam
is relatively free of fast neutrons and gamma rays and is further purified with a sapphire
single-crystal filter. The n type Germanium semi-conductor detector is shielded with a
Li-6 cylinder and lead bricks.
The facility is designed to analyze samples with sizes ranging from a few
milliliters to ten microliters, thus allowing the determination of relevant boron
concentrations from typical blood samples (0.5 ml) as well as from punch and needle
biosies (0.01 to 0.1 ml). The sensitivity for detecting B-10 is 7.5 cps per jig of boron.
Figure 7.1 shows the ratio of B-10 to hydrogen (H) capture gamma rays as a function of
the B-10 concentration in standard blood samples.
7.3.2 Blood Sample Measurements
Blood samples were measured by PGNAA to study the kinetic B-10 uptake. First,
a blood sample was transferred to a clean 0.5 ml teflon vial which does not contain any
hydrogen atoms. Then the vial was positioned in the thermal neutron beam line within
the PGNAA facility for irradiation. B-10 and H capture gamma rays were collected by
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Figure 7.1 PGNAA calibration curves for blood samples.
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the Germanium detector with count rate CPS (counts per second) displayed in a multi-
channel analyzer (MCA, Canberra Series 80). The B-10 concentrations were determined
by the B/H ratios. Figures 7.2, 7.3, 7.4, and 7.5 show the test-dose B-10 blood
concentration vs. time curves for the three human subjects. During the fractions, blood
samples were drawn before and after the irradiation for dose prescription calculations.
Table 7.1 shows the blood concentrations for these samples.
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1 oB (BPA) Kinetic Uptake - Adam, Test Dose
Time (min)
Time (min) Conc (ppm) Error (ppm)
0.0000 0.0000 0.0000
60.000 NA NA
120.00 1.5700 0.17
150.00 2.7040 0.11
180.00 2.3000 0.19
210.00 2.1100 0.13
240.00 2.7100 0.19
300.00 3.3900 0.18
360.00 3.2600 0.18
420.00 4.4200 0.22
480.00 4.6500 0.23
540.00 4.5400 0.21
600.00 4.4850 0.22
660.00 4.3400 0.21
720.00 4.2400 0.17
780.00 3.5600 0.17
840.00 2.9500 0.16
900.00 3.7400 0.18
Y = 98.17*(exp[-0.0015X] - exp[-0.0018X])
Figure 7.2 B-10 uptake curve for subject #1 - Mr. Adam (Test dose)
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10B (BPA) Kinetic Uptake for Mr. Adam
0 2 4 6 8 10
Uptake curve:
Time (hours)
Exp. # 94-1, Frac. #2 (9/9/94)
Time (hr) 1oB (ppm) Error (ppm)
0 0.4 0.1
1.0 1.4 0.08
2.0 2.4 0.1
3.0 1.9 0.1
4.0 2.5 0.1
5.0 2.5 0.1
6.0 2.5 0.1
8.0 2.2 0.1
8.5 2.5 0.1
11.25 2.1 0.1
Y = 0.42+1.32X-0.31X 2+0.031X3 -0.0011X 4
Figure 7.3 B-10 uptake curve for subject #1 - Mr. Adam (Fraction #2)
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S2.5
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0 1.0U
S0.5
0.0
200 400 600 800 1000
Time (min.)
Time (min.) loB (ppm) Error (ppm)
0 0.0* -0.1
30 0.4 0. 1
60 0.9 0.1
90 1.1 0.1
120 1.5 0.1
150 2.0 0.1
180 2.3 0.2
210 2.4 0.2
240 2.9 0.2
300 3.2* 0.2
360 2.9* 0.1
420 2.7* 0.1
480 2.6* 0.2
540 2.3* 0.1
Exp. # 94-2,Test Dose (10/18/94) 600 2.0* 0.1660 2.1* 0.1
720 1.6* 0.1
* Data are used for curve fitting 780 1.8* 0.1
840 1.8* 0.1
Curve Fitting:
Y = 4.29*(exp[-0.0011X] - exp[7.95e+05X])
Figure 7.4 B-10 uptake curve for subject #2 - Mr. Hinz (Test dose)
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"1B (BPA) Kinetic Uptake for Mrs. Young
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Time (min.) loB (ppm) Error (ppm)
0 0.0 0.0
OU U.8 U. 1
90 1.6 0.1
150 2.5 0.2
180 3.0 0.2
240 3.4 0.2
300 4.2 0.2
420 4.1 0.2
660 4.9 0.3
Exp. # 94-3, Young, Test Dose (11/22/94)
Curve Fitting:
Y = 8.94*(exp[-0.00059X] - exp[-0.0030X])
Figure 7.5 B-10 uptake curve for subject #3 - Mrs. Young (Test dose)
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Summary of 10B concentrations of blood samples by PGNAA
Human subject Blood Sample, time of blood drawn, (hour:min) 10B conc. (ppm)
Mr. Adam 1st Fraction, pre-irradiation, (7:20) 3.2 + 0.32
Mr. Adam Ist Fraction, post-irradiation, (?.) 2.0 ± 0.15
Mr. Adam 2nd Fraction, pre-irradiation, (8:36) 2.5 ± 0.17
Mr. Adam 2nd Fraction, post-irradiation, (11:00) 2.1 ± 0.15
Mr. Adam 3rd Fraction, pre-irradiation, (5:30) 2.2 + 0.18
Mr. Adam 3rd Fraction, post-irradiation, (7:28) 2.0 ± 0.14
Mr. Adam 4th Fraction, pre-irradiation, (5:55) 2.2 ± 0.18
Mr. Adam 4th Fraction, post-irradiation, (7:45) 2.1 ± 0.15
Mr. Hinz 1st Fraction, pre-irradiation, (4:50) 3.0 ± 0.21
Mr. Hinz 1st Fraction, post-irradiation, (7:08) 3.0 + -.21
Mr. Hinz 2nd Fraction, pre-irradiation, (4:40) 3.2 ± 0.22
Mr. Hinz 2nd Fraction, post-irradiation, (6:33) 3.5 ± 0.21
Mr. Hinz 3rd Fraction, pre-irradiation, (4:50) 3.8 ± 0.22
Mr. Hinz 3rd Fraction, post-irradiation, (6:30) 3.8 ± 0.19
Mr. Hinz 4th Fraction, pre-irradiation, (4:40) 4.0 + 0.22
Mr. Hinz 4th Fraction, post-irradiation, (6:35) 3.7 ± 0.21
Mrs. Young 1st Fraction, pre-irradiation, (4:55) 3.9 ± 0.22
Mrs. Young 1st Fraction, post-irradiation, (13:30) 5.8 ± 0.24
Mrs. Young 2nd Fraction, pre-irradiation, (4:45) 5.9 ± 0.26
Mrs. Young 2nd Fraction, post-irradiation, (12:00) 5.0 ± 0.25
Mrs. Young 3rd Fraction, pre-irradiation, (5:40) 6.4 ± 0.30
Mrs. Young 3rd Fraction, post-irradiation, (10:20) 7.2 ± 0.33
Mrs. Young 4th Fraction, pre-irradiation, (5:45) 8.1 ± 0.35
Mrs. Young 4th Fraction, post-irradiation, (10:30) 9.5 ± 0.39
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Table 7.1
7.4 Tissue Sample Analysis by Autoradiography (HRQAR)
7.4.1 Calibration Curve for HRQAR
A calibration curve was constructed followed the procedures described in chapter
3. Six standard tissue samples (mouse brains) were prepared for a track density
calibration. These mouse brains were loaded with L-BPA. A 90 ppm B-10 solution was
prepared by mixing the BPA powder in water with tiny amount of nitric acid. This
master solution was then diluted by DI water to form several standard solutions. The B-
10 concentrations of these standard solutions were measured by PGNAA. The
concentrations of these standard solutions were estimated to be 90, 30, 15, 5, 1, and 0
ppm. Six mice were sacrificed and the fresh brains were immersed into the standard
solutions for at least 24 hours. After that, the mice brains were divided into two parts.
The first part was measured by PGNAA to obtain the absolute B-10 concentration levels
and the second part was kept frozen for HRQAR analysis. B-10 concentrations of 85, 27,
13, 4.7, 0.8, and 0 ppm were determined by PGNAA. These standard tissue samples
were used for the cross calibration for HRQAR. Figure 7.6 shows the B-10 calibration
curve obtained from these mouse brain samples.
7.4.2 Tissue Sample Analysis by HRQAR
A total of 30 tissue samples were prepared for the HRQAR B-10 concentration
analysis, 3 standard samples and 12 human tissues (2 slides for each). The experimental
procedures of HRQAR process are described in chapter 3. Table 7.2 shows the results of
track density counting for each sample. Then, B-10 concentrations were determined from
the calibration curve (figure 7.6). Table 7.3 shows the results of B-10 concentrations for
all the tissue samples. Results show that the kinetic uptake of BPA for these patient are
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HRQAR calibration curve: a track-density vs. B-10 concentration.
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Track-density of the tissue samples followed the HRQAR process
Sample Tracks/tm2  Sample Tracks/tm2
[1] Standard 13 ppm 0.00726 [33] Hinz FN #2 0.00294
[2] Standard 13 ppm 0.00721 [34] Hinz FT #1 0.00753
[3] Standard 13 ppm 0.00729 [35] Hinz FT #1 0.00675
[4] Standard 4.7 ppm 0.00338 [36] Hinz FT #1 0.00678
[5] Standard 4.7 ppm 0.00343 [37] Hinz FT #2 0.00687
[6] Standard 4.7 ppm 0.00333 [38] Hinz FT #2 0.00666
[7] Standard 0.8 ppm 0.00160 [39] Hinz FT #2 0.00639
[8] Standard 0.8 ppm 0.00150 [40] Young FN #1 0.00316
[9] Standard 0.8 ppm 0.00145 [41] Young FN #1 0.00297
[10] Adam FN #1 0.00307 [42] Young FN #1 0.00306
[11] Adam FN #1 0.00329 [43] Young FN #2 0.00293
[12] Adam FN #2 0.00260 [44] Young FN #2 0.00286
[13] Adam FN #2 0.00287 [45] Young FN #2 0.00321
[14] Adam FT #1 0.00591 [46] Young FT #1 0.00633
[15] Adam FT #1 0.00700 [47] Young FT #1 0.00668
[16] Adam FT #1 0.00662 [48] Young FT #1 0.00657
[17] Adam FT #2 0.00686 [49] Young FT #2 0.00604
[18] Adam FT #2 0.00656 [50] Young FT #2 0.00581
[19] Adam FT #2 0.00645 [51] Young FT #2 0.00593
[20] Adam TN #1 0.00228 [52] Young TN #1 0.00342
[21] Adam TN #1 0.00213 [53] Young TN #1 0.00320
[22] Adam TN #2 0.00232 [54] Young TN #1 0.00344
[23] Adam TN #2 0.00249 [55] Young TN #2 0.00327
[24] Adam TT #1 0.00563 [56] Young TN #2 0.00339
[25] Adam TT #1 0.00598 [57] Young TN #2 0.00323
[26] Adam TT #2 0.00558 [58] Young TT #1 0.00730
[27] Adam TT #2 0.00567 [59] Young TT #1 0.00755
[28] Hinz FN #1 0.00285 [60] Young TT #1 0.00720
[29] Hinz FN #1 0.00293 [61] Young TT #2 0.00764
[30] Hinz FN #1 0.00261 [62] Young TT #2 0.00768
[31] Hinz FN #2 0.00282 [63] Young TT #1 0.00758
[32] Hinz FN #2 0.00277
TT=Test dose tumor; TN=Test dose normal tissue.
FT=Fraction #1 tumor; FN=Fraction #1 normal tissue.
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Table 7.2
B-10 concentrations of the tissue samples followed the HRQAR process
Sample 10B (ppm) Sample '0B (ppm)
[1] Adam FN #1 3.98 [28] Hinz FT #2 12.16
[2] Adam FN #1 4.46 [29] Hinz FT #2 11.71
[3] Adam FN #2 2.98 [30] Hinz FT #2 11.13
[4] Adam FN #2 3.54 [31] Young FN #1 4.19
[5] Adam FT #1 10.09 [32] Young FN #1 3.76
[6] Adam FT #1 12.44 [33] Young FN #1 3.96
[7] Adam FT #1 11.63 [34] Young FN #2 3.68
[8] Adam FT #2 12.14 [35] Young FN #2 3.58
[9] Adam FT #2 11.49 [36] Young FN #2 4.28
[10] Adam FT #2 11.26 [37] Young FT #1 10.99
[11] Adam TN #1 2.38 [38] Young FT #1 11.76
[12] Adam TN #1 1.96 [39] Young FT #1 11.51
[13] Adam TN #2 2.36 [40] Young FT #2 10.37
[14] Adam TN #2 2.74 [41] Young FT #2 9.89
[15] Adam TT #1 9.50 [42] Young FT #2 10.13
[16] Adam TT #1 10.26 [43] Young TN #1 4.74
[17] Adam TT #2 9.38 [44] Young TN #1 4.26
[18] Adam TT #2 9.57 [45] Young TN #1 4.77
[19] Hinz FN #1 3.52 [46] Young TN #2 4.41
[20] Hinz FN #1 3.69 [47] Young TN #2 4.68
[21] Hinz FN #1 2.99 [48] Young TN #2 4.32
[22] Hinz FN #2 3.45 [49] Young TT #1 13.09
[23] Hinz FN #2 3.33 [50] Young TT #1 13.63
[24] Hinz FN #2 3.70 [51] Young TT #1 12.86
[25] Hinz FT #1 13.58 [52] Young TT #2 13.81
[26] Hinz FT #1 11.90 [53] Young TT #2 13.91
[27] Hinz FT #1 11.96 [54] Young TT #1 13.69
TT=Test dose tumor; TN=Test dose normal tissue.
FT=Fraction #1 tumor; FN=Fraction #1 normal tissue.
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Table 7.3
quite different. Therefore, individual dose prescription for each patient is necessary, and,
at least, kinetic uptake test is necessary for each patient. Table 7.4 is a summary of the B-
10 concentrations in blood, normal tissue, and tumor. The uptake ratio between (i) tumor
to normal tissue, (ii) tumor to blood, and (iii) normal tissue to blood are presented in
Table 7.5.
7.5 Dosimetry for the Phase-I Trials
During the irradiation, the calculated dose was estimated to be 1,000 RBE c-Gy
because B-10 concentration for normal tissue was not available. Actual dose delivered to
blood, normal tissue, and tumor will be presented in this section. The total dose was
calculated using the following equation
Dose= [DF.*RBEF, + Dn*RBEh + Dr*RBEr + DBlo*RBEB]* P *t (7.1)5MW
where,
RBEs used were: 4.0 for fast neutron (Fn), slow neutron (Th), B-10 capture (B 10),
and 0.5 for Gamma (y).
P = reactor powder in MW
t = irradiation period in min.
Dose rates were measured using ionization chambers in a water head phantom. 3
The maximum dose rates at 2 cm depth were employed in these calculations. Detailed
dose-versus-depth profiles for fast neutron, thermal neutron, B-10, and gamma
components are described in Appendix A.
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Summary of B-10 concentrations in blood, normal tissue, and tumor
1 Blood data were obtained from PGNAA
2 Normal tissue (Norm.) and Tumor data were obtained from HRQAR
1,2,3Errors were calculated using error propagation.
*Blood sample was taken at 5 hr. (3.90±0.22) and it was scaled to 7 hr based on the
uptake curve for Mrs. Young.
Remark: Data for Mr. Hinz test dose are not available because those tissue samples were
destroyed due to some unexpected circumstances.
Chapter Seven 206
human Mr. Adam Mr. Adam Mr. Hinz Mrs. Young Mrs. Young
subject (Test dose) (Fraction#1) (Fraction#1) (Test dose) (Fraction #1)
(t = 3.0 hr.) (t = 7:20 hr.) (t = 4:50 hr.) (t = 5.0 hr.) (t = 7.0 hr.)
Experiment Test Dose Fraction #1 Fraction #1 Test Dose Fraction #1
Blood1 (ppm) 2.30-±0.19 3.20±0.20 3.00-0.21 4.20-0.23 4.49+0.22*
Norm2.(ppm) 2.36+0.77 3.74-0.97 3.45+0.76 4.53+0.87 3.91+0.81
Tumor 2 (ppm) 9.68±1.56 11.51±1.39 12.07±1.42 13.50-1.50 10.78±1.34
Tumor/Blood3  4.21+0.76 3.60-0.49 4.02+0.55 3.21+0.40 2.40-0.32
Tumor/Norm. 3 4.10±-1.49 3.08±0.88 3.50-0.87 2.98+0.66 2.76±+0.66
Norm./Blood 3 1.03-0.35 1.17-0.31 1.15±+0.27 1.08+0.22 0.87±-0.19
Table 7.4
Ratio N S2 _ 2  p value
Tumor/Blood 5 3.49 0.52 0.59 0.96
Tumor/Norm. 5 3.28 0.28 0.34 0.98
Norm./Blood 5 1.06 0.014 0.053 >0.99
N = Number of independent samples
N
S= mean 1
N
S2 = Sample variance -
_ 1
N-1 I
•1 2 2
X 2 = Chi-square = - ( xi -K) =X 1
(N- 1)S2
p value is a function of N-1 and X2 obtained from Chi-squared Distribution Table.
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ehi-sauared test for the uptake ratios
Table 
7.5
Dose rates for Mr. Adam:
At 5 MW, Oth = 1.744x10 8 n/cm2-sec, and
DFn = 3.50 RBE-cGy /min, Db = 1.26 RBE-cGy / min
DTh = 1.14 RBE - cGy / min, Dlo = 0.362 RBE - cGy / min - ppm(B10)
Dose rates for Mr. Hinz:
At 5 MW, Oth = 1.953x108 n/cm2-sec, and
Dn = 2.952 RBE -cGy / min, D6 = 1.254 RBE-cGy / min
Dn = 1.277 RBE-cGy /min, D6no = 0.406 RBE - cGy / min - ppm(B10)
Dose rates for Mrs. Young:
At 5 MW, Oth = 1.953x108 n/cm2-sec, and
DFn = 2.952 RBE-cGy / min, Dy = 1.254 RBE-cGy / min
D• = 1.277 RBE - cGy / min, Dmo = 0.406 RBE - cGy / min - ppm(B10)
The total doses delivered to blood, normal tissue, and tumor for each study subject
were calculated. Tables 7.6, 7.7, and 7.8 show the dosimetry records for subject Mr.
Adam, Mr. Hinz, and Mrs. Young, respectively.
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Fraction # Fraction #1 Fraction #2 Fraction #3 Fraction #4
Irradiation date 9/7/94 9/9/94 9/13/94 9/16/94
Human subject name Adam, Adam, Adam, Adam,
Venor Venor Venor Venor
Age 64 64 64 64
Weight 64 kg 64 kg 64 kg 64 kg
BPA dosage 400 400 /kmg/kg 400 mg/kg
BPA administered at 6:16 am 6:00 am 10:00 am 8:00 am
(0 min.) (0 min.) (0 min.) (0 min.)
Blood sample drawn at 1:35 pm 2:00 pm 3:30 pm 1:55 pm
(440 min.) (480 min.) (330 min.) (355 min.)
Irradiation started at 3:00 pm 3:33 pm 4:00 pm 2:48 pm
(525 min.) (570 min) (360 min) (408 min)
Irradiation period a 40.96 min. 23.81/18.28 min 46.77 min. 40.92 min.
Reactor power 4.5 MW 4.5 MW 4.0 MW 4.5 MW
Ave. blood 10B conc. b 2.4 ppm 2.5 ppm 2.0 ppm 2.2 ppm
Ave. tissue 10B conc. C 2.8 ppm 2.9 ppm 2.3 ppm 2.6 ppm
Ave tumor 10B conc.C 8.5 ppm 9.0 ppm 7.1 ppr 7.9 ppm
Max. blood dose d 249.0 257.8 247.4 246.5
Max. tissue dose d 254.3 263.7 251.9 251.4
Max. tumor dose d 330.9 346.9 316.8 322.3
Total max. blood dose 1000.7 RBE cGy (in 4 fractions)
Total max. tissue dose 1021.3 RBE cGy (in 4 fractions)
Total max. tumor dose 1316.9 RBE cGy (in 4 fractions)
[a] Calculated from the beam monitor epithermal counts
[b] Calculated by BNCTDOSE program
[c] Determined by HRQAR (Table 7.4)
[d] Calculated by equation (7.1):
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Table 7.7 Dosimetry record for Mr. Hinz (BNCT#94-2)
Fraction # Fraction #1 Fraction #2 Fraction #3 Fraction #4
Irradiation date 10/24/94 10/25/94 10/26/94 10/27/94
Human subject name Hinz, Hinz, Hinz, Hinz,
Gerald Gerald Gerald Gerald
Age 61 61 61 61
Weight 80.7 kg 80.7 kg 80.7 kg 80.7 kg
BPA dosage 400 mg/kg 400 mg/kg 400 mg/kg 400 mg/kg
BPA administered at 11:00 am 11:00 am 11:00 am 11:00 am
(0 min.) (0 min.) (0 min.) (0 min.)
Blood sample drawn at 3:50 pm 3:45 pm 3:50 pm 3:40 pm
(290 min.) (285 min.) (290 min.) (280 min.)
Irradiation started at 4:15 pm 4:48 pm 4:27 pm 4:32 pm
(315 min.) (348 min) (327 min) (332 min)
Irradiation period a 39.0 min. 39.5 min. 45.5 min. 45.3 min.
Reactor power 4.5 MW 4.5 MW 4.5 MW 4.5 MW
Ave. blood 10B conc. b 2.35 ppm 2.35 ppm 3.04 ppm 3.11 ppm
Ave. tissue 10B conc. c 2.70 ppm 2.70 ppm 3.50 ppm 3.58 ppm
Ave tumor 10B conc.c 9.45 ppm 9.45 ppm 12.22 ppm 12.50 ppm
Max. blood dose d 222.6 228.9 275.0 275.0
Max. tissue dose d 230.9 230.9 282.7 282.8
Max. tumor dose d 327.1 327.1 427.7 430.4
Total max. blood dose 1001 RBE cGy (in 4 fractions)
Total max. tissue dose 1027.3 RBE cGy (in 4 fractions)
Total max. tumor dose 1512.3 RBE cGy (in 4 fractions)
[a] Calculated from the beam monitor epithermal counts
[b] Calculated by BNCTDOSE program
[c] Determined by HRQAR (Table 7.4)
[d] Calculated by equation (7.1):
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Dosimetry record for Mrs. Young (BNCT#94-3)
[a] Calculated from the beam monitor epithermal counts
[b] Calculated by BNCTDOSE program
[c] Determined by HRQAR (Table 7.4)
[d] Calculated by equation (7.1):
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Fraction # Fraction #1 Fraction #2 Fraction #3 Fraction #4
Irradiation date 12/5/94 12/6/94 12/7/94 12/8/94
Human subject name Young, Young, Young, Young,
Jean Jean Jean Jean
Age 80 80 80 80
Weight 67 k 67 k  kg 67 kg
BPA dosage 400 mg/kg 400 mg/kg 400 mg/kg 400 mg/kg
BPA administered at 9:05 am 9:00 am 9:15 am 9:15 am
(0 min.) (0 min.) (0 min.) (0 min.)
Blood sample drawn at 2:00 pm 1:45 pm 2:55 pm 3:00 pm
(295 min.) (285 min.) (340 min.) (345 min.)
Irradiation started at 5:19 pm 4:43 pm 4:23 pm 4:48 pm
(494 min.) (463 min) (428 min) (453 min)
Irradiation period a 42.54 min. 35.92 min. 35.64 min. 32.48 min.
Reactor power 4.5 MW 4.5 MW 4.5 MW 4.5 MW
Ave. blood 10B conc. b 3.26 ppm 5.54 ppm 5.31 ppm 7.14 ppm
Ave. tissue 10B cone. C 2.84 ppm 4.82 ppm 4.62 ppm 6.21 ppm
Ave tumor 10B conc.c 7.82 ppm 13.30 ppm 12.74 ppm 17.14 ppm
Max. blood dose d 260.6 250.0 245.0 245.0
Max. tissue dose d 254.1 240.5 236.03 233.97
Max. tumor dose d 331.5 351.77 341.84 363.6
Total max. blood dose 1000.6 RBE cGy (in 4 fractions)
Total max. tissue dose 946.6 RBE cGy (in 4 fractions)
Total max. tumor dose 1388.7 RBE cGy (in 4 fractions)
Table 7.8
7.6 Conclusions
The B-10 concentrations for blood, normal tissue, and tumor were measured for
the subjects involved in the clinical trials. Marked difference in the shapes of the three
uptake curves for these subjects is observed. Results show that actual dose delivered to
these subjects is very close to the estimated dose of 1,000 RBE-cGy.
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Chapter 8 Evaluation of Capture Compound
Effectiveness
8.1 Introduction
The ideal boron compound for application in boron neutron capture therapy (BNCT)
should be selectively accumulated in tumor with concomitantly low concentrations in
neighboring normal tissues and blood. 1 As the presumed target of lethal radiation is the
nucleus, 2 an intracellular and, optimally, intranuclear localization of boron would be
preferred. 1,3,4 Boronated nucleosides, nucleotides, and DNA-intercalators have been
synthesized 5-7 in pursuit of this goal. This chapter describes an approach to predict the
RBE values for such boron compounds. The results of this study may prove useful for
future boron compound development for BNCT. Compound Efficacy for some potential
capture elements (U-235, Li-6, and He-3) were also evaluated.
8.2 Effectiveness of Boron Compounds
8.2.1 Figures-of-merit for B-10 Localization
Due to the short ranges of the high-LET a and Li-7 particles following the
IOB(n,a)Li7 reaction, the spatial distribution of boron compounds at the cellular level has
been a central factor in BNCT microdosimetry.3, 8-13 If a boron compound has a
preferential localization in the tumor nucleus a higher RBE would be expected. To
quantitate the effect of boron localization a figure of merit, the nuclear uptake factor (NUF)
is proposed:
Intranuclear boron concentration
Extranuclear boron concentration
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8.2.2 Monte Carlo Simulations
Energy distributions were calculated using Monte Carlo simulations in a 3D cell-
matrix model. The cell model assumed was based on the dimensions of the frequently
studied V79 cell line.9,13 A single cell consists of a cubical cell body, 13x13x13 p.m, and a
central spherical nucleus of radius 3.8 plm. A matrix of 27 such single cells was used to
include the "cross-fire" effect. 9 Energy depositions in the nucleus were scored by
integrating the LET values of the a and Li-7 ions along their paths, the LET values were
calculated using TRIM91.13,14 Standard microdosimetric parameters,15 such as energy
imparted and hit-size9 were calculated. Detailed descriptions of the cell model and Monte
Carlo simulations are described in chapter 5.
8.2.3 Single-Event Hit-Size Distributions
The energy imparted, e, defined as the amount of energy deposited in the nucleus
per 10B(n,a)Li 7 reaction, the hit-size probability density, z.f(z), with z, the hit-size,
defined as the energy imparted to the nucleus divided by its volume, and the weighted hit-
size distributions, z2.f(z), for single-event cases were calculated. Simulation results were
obtained after 10,000 trial runs were employed in each case. These results are presented in
figures 8.1, 8.2, and 8.3, respectively.
8.2.4 Multiple-Event Hit-Size Distributions
Multiple-event hit-size probability densities, f(z,D), at a given dose, D, were
calculated using Fast-Fourier-Transform (FFT) based on a convolution of the single-event
distribution.15 Detailed description of this FFT approach is described in chapter 4. The
number of 10B(n,a)Li 7 reactions incurred per cell is determined from the physical dose to
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Figure 8.1 Energy imparted calculated by Monte Carlo simulation as a function of
NUF.
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Hit size, z (keV/gm3)
Figure 8.2 Hit-size distributions calculated by Monte Carlo simulation as a function of
NUF. Hit-size is presented in z.f(z).
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Figure 8.3 Weighted Hit-size distributions calculated by Monte Carlo simulation as a
function of NUF. Hit-size is presented in z2.f(z).
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the cell. For the cell model used one B-10 reaction is equivalent to an absorbed dose of
0.325 Gy assuming the cell density to be 1.0 g/cm 3. Hit-size distributions were calculated
with physical dose ranging from 0.325 to 6.5 Gy (N= 1 to 20, where N is the number of B-
10 reactions per cell). For simplicity, only the results for NUF=1, i.e., a homogeneous
B-10 distribution, are presented in figure 8.4.
8.2.5 Relative Degree of Damage
The mean number of lesions, o(D), as proposed by Kellerer and Rossi 15,16 in the
theory of dual radiation action, was calculated with the results shown in figure 8.5. It is
assumed that the response of the cell can be characterized as a second-order reaction which
is interpreted as an interaction of two sublesions. Here, co(D) is named degree of damage ,
defined as: 16
co(D) = k. z2f(z,D) dz (8.2)
where, k is a proportionality constant which expresses the probability for the combination
of sublesions leading to the formation of lesions.
Another figure-of-merit proposed is the relative degree of damage (RDD), intended
to evaluate the relative efficacy of different boron compounds:
RDD = Dose for given degree of damage (reference boron compound) (8.3)Dose for the same given degree of damage (test boron compound)
where, the reference boron compound selected is BPA. The reasons for choosing BPA as
a standard are: 1) BPA have been well investigated, 2) the microdistribution of BPA is
believed to be homogeneous 3 (i.e., NUF=1), and 3) BPA is currently used in BNCT
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Figure 8.4 Multiple-event hit-size distributions calculated by FFT approach from
single-event distribution.
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Degree of damage for different B-10 compounds s a function of dose.
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clinical trials. 17,18 Figure 8.6 shows RDD values for different boron compounds. As an
example, the RDD values, at a degree of damage of 100, are calculated to be 1, 1.3, 2.0,
2.3 and 3.8 for boron compounds with NUF values of 1, 2, 5, 10, and oo, respectively.
8.2.6 Prediction of RBE
Although the relation between the mean number of lesions and survival is complex,
the evaluation of RBE from equations 2 and 3 can be accomplished if it is assumed that
equal numbers of lesions result in equal survival levels, 15,16 i.e., RBE can be expressed as
RBE(test compound) = RDD(test compound) x RBE(BPA). (8.4)
Based on this equation, the predicted RBE values for boron-compounds with NUF
values of 1, 2, 5, 10, and oo were calculated to be 1, 1.3, 2.0, 2.3, and 3.8 times greater
than the RBE values for BPA, respectively.
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Figure 8.6
8.3 Effectiveness of Other Potential Capture Elements
Nuclides with charged particles as decay daughters are selected for evaluations.
Physical properties of these potential capture elements for NCT are presented in table 8.1.
Due to the difference in capture cross-section, energy released per reaction, and ranges of
the decay daughters, the effectiveness in cell killing may be different. Similar efficacy
calcualtions were performed for He-3, Li-6, and U-235 as performed for B-10 in section
8.2. First, the LET functions and ranges of the decay daughters were calculated using
TRIM91.14 The results were used as input parameters in Monte Carlo simulation to
calculate absorbed energy distribtuions using the same cell model as used in section 8.2 for
B-10 compounds. Finally, relative degree of damage(RDD) were determined with the
method described previously.
8.3.1 Determination of LET functions and ranges
LET functions were calculated using TRIM91 for charged particles listed in table 8.1.
For U-235, the total number of fission products is 91 with different fission yield. 19 Figure
8.7 show the fission yield diagram per fission of U-235.2 0,21 The fission yield and kinetic
energy for each fission product are summarized in table 8.2. The kinetic energy of the
fission products were calculated by the mass ratio of the two daughters22 as shown in
figure 8.8. As seen from figure 8.8, the range of kinetic energy for all the fission products
paired is from about 150 to 175 MeV. Compare to 1.47 MeV in B-10 reaction, U-235 is
about 115 times higher in terms of energy release per capture reaction. For LET
calcualtions the 2 fission products with the highest yields were selected as representative
daughters, i.e., Zr-94 and Xe-134 fission product pair. The calculated LET functions and
ranges for the decay daughters from He-3, Li-6, B-10, and U-235 are shown in figures 8.9
to 8.14 .
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Physical Properties of Potential Nuclides for Neutron Capture Therapy
(with charged particles as reaction productions)
[a] Radioactive
[b] Data obtained from "Chart of the Nuclides" Ref. [15]
[c] Calculated by conservation of energy and linear momentum
[d] Calculated by TRIM-91 [14]
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Table 8.1
Nuclide Abundance 2200 m/s Neutron K.E. Range
(a/o) or Cross- reaction of C.P. of C.P.
half-lifeb section. (MeV)c (gnm)d
(barns)b
Helium 1.38E-4 5.33E3 3He(n,p) 3H p = 0.5725 p = 10.0
(3He2) 3H = 0.1913 3H = 3.03
Lithium 7.5 941 6Li(n,a) 3H a = 2.056 a = 10.5
(6Li3) 3H = 2.729 3H = 61.0
Boron 19.9 3838 loB(n,a)7Li a = 1.473 a = 7.3
(lOB 5) 7Li =0.840 7Li = 4.0
Uranium 0.72 585(f) 235U*(n,f) FPI=112.5 FP 1=27.2
(2 35U9 2)a 99(y) FP2=61.5 FP2= 11.6
Table 8.2. Physical data of fission products for U-235
Fission Z Half Life Decay Type, Yield K.E. Eq. K.E.[21
Product # (T 1/2) Total E[ll] (MeV) (%) (MeV) (MeV)[3]
Zn-72 30 46.5 h Beta -, 0.3 1.6e-05 129.39 2.07e-05
Ga-73 31 4.9 h Beta -, 1.006 le-04 129.24 1.29e-04
Ga-74 31 7.9 m Beta -, 4.010 0.00035 129.07 4.52e-04
Ge-75 32 82 m Beta -, 0.468 0.0008 128.87 1.03e-03
Ge-76 32 Stable 0.0025 128.64 3.22e-03
As-77 33 38.7 h Beta -, 0.240 0.0083 128.37 1.07e-02
As-78 33 91 m Beta -, 2.343 0.02 128.07 2.56e-02
As-79 33 9.0 m Beta -, 0.990 0.056 127.74 7.15e-02
Se-80 34 Stable 0.104 127.37 1.32e-01
Se-81 34 18.6 m Beta-, 0.552 0.148 126.96 1.88e-01
Se-82 34 Stable 0.32 126.52 4.05e-01
Br-83 35 2.41 h Beta -, 0.394 0.544 126.04 6.86e-01
Kr-84 36 Stable 0.97 125.52 1.22e+00
Rb-85 37 Stable 1.3 124.96 1.62e+00
Kr-86 36 Stable 1.89 124.37 2.35e+00
Rb-87 37 Stable 2.53 123.73 3.13e+00
Sr-88 38 Stable 3.58 123.05 4.41e+00
Sr-89 38 52 d Beta -, 0.607 4.76 122.34 5.82e+00
Sr-90 38 28.1 y Beta -, 0.221 5.83 121.59 7.09e+00
Zr-91 40 Stable 5.9 120.79 7.13e+00
Zr-92 40 Stable 5.98 119.96 7.17e+00
Zr-93 40 1.5e+6 y Beta -, 0.4 6.39 119.09 7.61e+00
Zr-94 40 Stable 6.44 118.18 7.61e+00
Zr-95 40 65 d Beta -, 0.883 6.41 117.24 7.51e+00
Zr-96 40 Stable 6.29 116.26 7.31e+00
Zr-97 40 17 h Beta -, 1.571 6.21 115.24 7.16e+00
Mo-98 42 Stable 5.86 114.18 6.69e+00
Mo-99 42 67 h Beta -, 0.687 6.16 113.10 6.97e+00
Mo-100 42 Stable 6.44 111.98 7.21e+00
Ru-101 44 Stable 5.02 110.82 5.56e+00
Ru-102 44 Stable 4.17 109.64 4.57e+00
Ru-103 44 39.6 d Beta -, 0.556 3 108.42 3.25e+00
Ru-104 44 Stable 1.81 107.18 1.94e+00
Ru-105 44 4.44 h Beta -, 1.074 0.9 105.91 9.53e-01
Ru-106 44 367 d Beta -, 0.010 0.399 104.61 4.17e-01
Rh-107 45 22 m Beta -, 0.79 0.19 103.29 1.96e-01
Rh-108 45 17 s Beta-, 2.505 0.075 101.95 7.65e-02
Pd-109 46 13.47 h Beta -, 0.413 0.03 100.58 3.02e-02
Pd-110 46 Stable 0.02 99.19 1.98e-02
Ag-111 47 7.5 d Beta -, 0.428 0.019 97.79 1.86e-02
Pd-112 46 21 h Beta-, 0.11 0.01 96.36 9.64e-03
Ag-113 47 5.3 h Beta -, 0.942 0.012 94.93 1.14e-02
Cd-114 48 Stable 0.011 93.47 1.03e-02
Cd-115 48 53.5 h Beta -, 0.564 0.0104 92.01 9.57e-03
Cd-116 48 Stable 0.0104 90.53 9.42e-03
Cd- 117 48 2.4 h Beta -, 1.367 0.011 89.04 9.79e-03
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Table 2 (Contiune)
In-118 49 5 s Beta-, 1.920 0.0105 87.55 9.19e-03
In-119 49 2.1 m Beta -, 1.487 0.0107 86.07 9.21e-03
In-120 49 46 s Beta -, 4.854 0.0113 84.59 9.56e-03
Sn-121 50 27 h Beta -, 0.112 0.014 83.11 1.16e-02
Sn-122 50 Stable 0.013 81.62 1.06e-02
Sn-123 50 125 d Beta -, 0.597 0.015 80.12 1.20e-02
Sn-124 50 Stable 0.017 78.62 1.34e-02
Sb-125 51 2.7 y Beta -, 0.561 0.0291 77.11 2.24e-02
Sb-126 51 11 s Beta-, 1.140 0.064 75.60 4.84e-02
Sb-127 51 93 h Beta-, 1.064 0.137 74.09 1.02e-01
Sn-128 50 59 m Beta -, 0.744 0.46 72.58 3.34e-01
1-129 53 1.7e+7 y Beta -, 0.111 1 71.07 7.11le-01
Sb-130 51 33 m Beta -, 3.347 2 69.55 1.39e+00
1-131 53 8.05 d Beta -, 0.589 2.93 68.04 1.99e+00
Te-132 52 78 h Beta -, 0.383 4.33 66.53 2.88e+00
Xe-133 54 5.27 d Beta -, 0.264 6.69 65.03 4.35e+00
Xe-134 54 Stable 7.92 63.53 5.03e+00
Xe-135 54 15.6 m Beta -, 0.567 6.43 62.03 3.99e+00
Xe-136 54 Stable 6.46 60.54 3.91e+00
Cs-137 55 30.0 y Beta-, 0.276 6.18 59.06 3.65e+00
Ba-138 56 Stable 6.71 57.58 3.86e+00
Ba-139 56 82.9 m Beta-, 0.935 6.48 56.12 3.64e+00
Ba-140 56 12.8 d Beta -, 0.563 6.34 54.66 3.47e+00
Ce-141 58 33 d Beta-, 0.332 6.1 53.22 3.25e+00
Ce-142 58 Stable 5.9 51.79 3.06e+00
Ce- 143 58 33 h Beta -, 0.840 5.91 50.37 2.98e+00
Ce-144 58 284d Beta -, 0.138 5.4 48.97 2.64e+00
Nd-145 60 Stable 3.88 47.58 1.85e+00
Nd-146 60 Stable 2.95 46.20 1.36e+00
Nd- 147 60 11.1 d Beta -, 0.548 2.19 44.84 9.82e-01
Nd-148 60 Stable 1.67 43.50 7.27e-01
Pm-149 61 53.1 h Beta -, 0.424 1.04 42.18 4.39e-01
Nd-150 60 Stable 0.65 40.88 2.66e-01
Sm-151 62 87 y Beta -, 0.030 0.41 39.60 1.62e-01
Sm-152 62 Stable 0.24 38.33 9.20e-02
Sm-153 62 47 h Beta -, 0.375 0.158 37.09 5.86e-02
Sm-154 62 Stable 0.064 35.87 2.30e-02
Eu-155 63 1.81 y Beta-, 0.142 0.031 34.67 1.07e-02
Eu-156 63 15 d Beta -, 1.678 0.0134 33.50 4.49e-03
Eu-157 63 15.2 h Beta -, 0.648 0.0066 32.34 2.13e-03
Eu-158 63 46 m Beta-, 2.678 0.0037 31.21 1.15e-03
Gd-159 64 18.0 h Beta -, 0.430 0.00105 30.11 3.16e-04
Gd-160 64 Stable 0.00039 29.02 1.13e-04
Tb-161 65 6.9 d Beta -, 0.274 0.00018 27.97 5.03e-05
Dy-162 66 Stable 6e-05 26.93 1.62e-05
[1] Total E = Total energy, in all forms, emitted per decay.
[2] Eq. K.E. = Fractional yield per fission * K.E. of the fission product
[3] Total K.E. per fission = I (Eq. K.E.)i = 173.99 MeV
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Figure 8.10 LET function of 3H in 3He(n,p) 3H reaction.
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Figure 8.11 LET function of a in 6Li(n,a)3H reaction.
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Figure 8.12 LET function of 3H in 6Li(n,a) 3H reaction.
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Figure 8.13 LET function of Zr-94 in 235U*(n,f) fission.
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Figure 8.14 LET function of Xe-134 in 235U*(n,f) fission.
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8.3.2 Monte Carlo simulation
Absorbed energy fraction, hit-length 15 (the distance traveled inside the nucleus by
high LET particles), and hit-size were calculated using Monte Carlo simulation using a
3x3x3 V79 cell-matrix model. However, an lxllxl 1 cell matrix was used for the
6Li(n,0u) 3H reaction because the long range of 3H ion (61.0 jim, see table 1). The number
of trial runs employed in each case is at least 10,000. The absorbed energy fractions,
average hit-lengths, and hit-size distributions for these 4 reactions are presented in figures
8.15 to 8.23. All results are referred to single-event reaction, i.e., effect per 1 reaction.
Results show that the absorbed energy fraction and hit-length converge when number of
trial runs employed is > 10,000. This number is consistent to our previous results running
fro the B-10 reaction (chapter 5).
8.3.3 Findings
A summary of the calcualted microdosimetric parameters is presented in table 8.3.
There are several findings obtained from this study:
(i) absorbed energy
The absorbed energy calculated for all 4 cases are the same, about 10.5 %, even the
ranges of the charged particles are different. This can be explained by the nature of random
sampling. Since the simulations were performed in homogeneous condition, therefore, the
change of depositing energy to the nucleus is proportional to the nuclear fraction. For the
cell model employed, 13 jim cubical cell and 3.8 jm radius nucleus, nuclear fraction is
4
vol. of nucleus 4i(3 .8)f vol.of nucleus 3 = 10.46%.
vol.of cell body 13x131x13
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Figure 8.15 Absorbed energy fraction for the 3He(n,p) 3H in V79 cell model.
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Figure 8.16 Absorbed energy fraction for the 6Li(n,a) 3H in V79 cell model.
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Figure 8.17 Absorbed energy fraction for the 235U*(n,f) in V79 cell model.
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Figure 8.18 Average hit-length for the 3He(n,p)3H in V79 cell model.
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Figure 8.19 Average hit-length for the 6Li(n,a) 3H in V79 cell model.
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Figure 8.20 Average hit-length for the 235U*(n,f) in V79 cell model.
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Figure 8.21 Hit-size distribution fraction for the 3He(n,p)3H in V79 cell model.
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Figure 8.22 Hit-size distribution fraction for the 6Li(n,ac) 3H in V79 cell model.
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Figure 8.23 Hit-size distribution fraction for the 235U*(n,f) in V79 cell model.
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500
Microdosimetric parameters for different capture element
Isotope Total K.E., Total Range, Abs. Energy, Abs. Energy, Hit-length in
MeV A rm % keV nucleus, gm
He-3 0.736 13.0 10.6 78 1.50
Li-6 4.785 71.5 10.5 502 7.82
B-10 2.313 11.3 10.6 261 1.26
U-235 176.3 38.9 10.5 18512 4.09
Total K.E.=initial K.E. per reaction
Total range=combined range from the two daughters
Hit-length=distance traveled by ion inside the nucleus
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Table 8.3
(ii) Absorbed energy
Although the absorbed energy fractions for all cases are the same, the size of energy
deposited to the nucleus is different. The absorbed energy shown in table 8.3 indicates that
the cellular energy density (hit-size) is very different from case to case. For example, the
absorbed energy per reaction for U-235 is 115 times larger than B-10. Basically, the
amount of energy deposited depends on the original kinetic energy of the two ions, i.e.,
energy=absorbed energy fraction x Total K.E. However, due to the saturation effect of
high LET radiation, 15 the cell killing effectiveness may not be directly proportional to the
absolute amount of energy deposited.
(iii) Hit-length
Hit-length, however, is proportional to the combined range of the two ions. As seen
from table 8.3, the calculated hit-lengths for He-3, Li-6, B-10, and U-235 are 1.50, 7.82,
1.26, and 4.09 gim, respectively. The ratios of these hit-lengths are exactly equivalent to
the ratios of their combined ranges, i.e., 13.0, 71.5, 11.3, and 38.9 gtm.
8.3.4 Prediction of RBE
RBE values of He-3, Li-6, and U-235 were calculated using the proposed "RDD"
method described in section 8.2. The calculations were similar to that for "B-10 compound
effectiveness" also performed in section 8.2. First, single-event hit-size distributions for
these capture elements, as shown in figures 8.21 to 8.23, were converted to multiple-event
distributions using FFT approach. Then, degree of damages ,o(D), were calculated by
integrating the weighted hit-size distributions, z2.f(z), for dose levels ranged from 0 to 60
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Gy. Finally, the RDD values were calcualted using Eq. (8.3) with the test boron
compound is replaced by test capture element, i.e.,
Dose for given degree of damage (reference boron compound)
Dose for the same given degree of damage (test capture element)
The RDD values for He-3, Li-6, and U-235 were determined to be 0.8, 2.2, and 11.5,
respectively. Using eq. (8.4),
RBE(test compound) = RDD(test compound) x RBE(BPA). (8.4)
the RBEs for He-3, Li-6, and U-235 are predicted to be 0.8, 2.2, and 11.5 times greater
than the RBE values for BPA, respectively.
8.4 Conclusions
An approach based on microdosimetry and the theory of dual radiation action is
proposed for the evaluation of boron compound efficacy. RBE values for boron
compounds with different NUF values are predicted. These results may be useful for the
assessment of future boron compounds. This model also allows predictions of RBE values
for other potential capture elements.
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* Chapter 9 Conclusions and Recommendations for
Future Works
9.1 Conclusions
Realistic Microdosimetry
A novel approach to measuring subcellular distributions of B-10 using high
resolution alpha-autoradiography and imaging processing has been studied. The
measured B-10 locations and cellular morphology are employed in a 2D Monte Carlo
code to study BNCT microdosimetry. This microdosimetry approach does not require
assumed B-10 distribution or hypothetical cell model.
Cell Volume
A novel approach to measuring cell and nuclear volumes has been developed.
This approach does not require any assumptions on the cell shape. With the knowledge
of cell and nuclear volumes, the number of 10B(n,a)7Li reactions can be converted from
the absorbed dose. Also, it was found that the size of the nucleus (nuclear fraction) may
be an important factor in determining the underlying radiobiology.
Multiple-event Energy Distribution - FFT approach
An approach based on fast-fourier transform (convolution) to determining
multiple-event energy distributions from the single-event distribution has been proposed.
The advantage of this approach is the reduction of heavy computer time that Monte Carlo
simulation always requires.
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Prediction of RBE Values for B-10 compounds and Potnetial Nuclides
Several figures-of-merit have been proposed to evaluate the radiobiological
efficacy for different B-10 compounds which have diifferent uptake affinity to the cell
nucleus. This information can guide researchers in choosing an appropriate compound
for boron neutron capture. The RBEs for some selected nuclides - 3He, 6Li, and 235U,
were also evaluated.
B-10 Concentrations Analysis in Clinical Trials
High resolution alpha-autoradiography was employed to determine the B-10
concentrations in human tissues for the MIT Phase I Clinical Trials. Three human
subjects were participated in this trial.
9.2 Recommendations for Future Works
The next step is to perform animal survival experiments. Using those "tools"
described in this thesis along with the animal survival data, a better understanding for the
radiobiology of BNCT should be gained.
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Appendix A
Characteristics of the MIT M67 Epithermal Neutron Beam
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Central Axis NCTPLAN/Experimental Comparison
M67 Beam, 5 MW, NF = 0.87
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4.0000 1.1600 1.0500
5.0000 0.96000 0.86300
6.0000 0.74000 0.64000
8.0000 0.40800 0.36500
10.000 0.19200 0.19000
12.000 0.080000 0.074800
2/23/95
RBE=4.0
2
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z
Central Axis Depth (cm)
Figure B. 1 Thermal neutron dose distributions along central axis
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Central Axis NCTPLAN/Experimental Comparison
M67 Beam, 5 MW, NF = 0.87
C.A. Depth (cm) NCTPLAN Experimental
0.0000 5.4100 4.931
1.0000 9.2400 9.7800
2.0000 12.020 12.240
2.8000 12.650
3.0000 12.320 12.330
4.0000 11.090 10.010
5.0000 9.1400 8.2300
6.0000 7.0700 6.1000
8.0000 3.8800 3.4800
10.000 1.8200 1.8060
12.000 0.75900 0.71100
- MCNP B-10 RBE Dose Rate (RBE-cGy/min)
SExp B-10 RBE Dose Rate (RBE-cGy/min)
2/23/94
RBE=4.0
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B-10 dose distributions along central axis
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Central Axis NCTPLAN/Experimental Comparison
M67 Beam, 5 MW, NF = 0.75
Central Axis Depth (cm) NCTPLAN Experimental
0.0000 5.2295 5.1990
1.0000 3.9205
2.0000 2.8432 2.9530
3.0000 2.0727
4.0000 1.5068 2.0740
5.0000 1.0295
6.0000 0.78409 1.1900
8.0000 0.44045 0.85300
10.000 0.25159 0.61900
I
Central Axis Depth (cm)
Fast neutron dose distributions along central axis
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,
Axis NCTPLAN/Experimental Comparison
Beam, 5 MW, NF = 1.8*Struc +Ind Comp
C.A. Depth (cm) NCTPLAN Experimental
0.0000 1.1400 1.11
1.0000 1.1700 1.2700
2.0000 1.2200 1.2800
3.0000 1.2300 1.2500
4.0000 1.2000 1.1800
5.0000 1.1000 1.0800
6.0000 1.0100 0.99000
8.0000 0.81900 0.80000
10.000 0.63000 0.65000
11.800 0.49400
Central Axis Depth (cm)
Photon dose distributions along central axis
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Appendix B
Microdosimetric Parameters - Definitions
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I. Definitions
Among the definitions set out in ICRU Report 33, the principle quantities used for
microdosimetric purposes are energy imparted and other stochastic quantities related to
energy imparted, as well as their distributions and expectation values. Some fundamental
quantities used in this thesis, as defined in ICRU Report 33 and 36, will be introduced in
the following.
I. Energy deposit, Ei
The energy deposit, ei, is the energy deposited in a single interaction, i:
e,= T,, -To, + Q, (B.1)
where
Tin = the energy of the incident ionizing particle (exclusive of the rest mass).
Tout = the sum of the energies of all ionizing particles leaving the interaction volume
(exclusive of the rest mass).
QAm = the changes of the rest mass energy of the atom and all particles involved in the
interaction ( QAm > 0: decrease of rest mass; QAm < 0: increase of rest mass).
The unit of Ei is the joule (J); Ei may also be expressed in the unit eV, or keV.
Notes:
(a) Ei is a stochastic quantity.
(b) Ei is considered as the energy deposited in the nucleus for the interaction.
(c) For BNCT, ei is the energy released per unit track length inside the nucleus from
high LET ionizing radiation.
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II. Energy imparted, e
The energy imparted, e, to the matter in a volume is
e = E (B.2)
where the summation is performed over all energy deposits, ei, in that volume. The unit
of e is the joule (J), e may be expressed in eV or keV.
Notes:
(a) E is a stochastic quantity.
(b) The energy deposits over which the summation is performed may be due to one or
more energy deposition event, i.e., due to one or more statistically independent particle
tracks.
III. Specific energy, z
The specific energy, z, is the quotient of E by m, where E is the energy imparted by
ionizing radiation to the matter of mass m.
Z (B.3)
The unit of z is the joule per kilogram (J kg-1). This has the same unit absorbed dose, Gy
1 Gy = 1 J kg-l
Note:
(a) z is a stochastic quantity. It is useful to consider the probability distribution of z.
The value of the distribution function, F(z), is the probability that the specific energy is
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equal to or less than z. The probability density, f(z), is the derivative of F(z) with respect
to z:
dF(z)f(z) = , (B.4)dz
the probability density, f(z), includes a discrete component at z=0 for the probability of
no energy deposition, i.e., no hits are arrived to the nucleus. The expectation value,
Z= fzf(z)dz, (B.5)
is called mean specific energy, Z, is a non-stochastic quantity.
(b) Specific energy may be due to one or more energy event. The distribution
function of the specifci energy deposited in a single event, FI(z), is the conditional
probability that a specific energy less than or equal to z is deposited if one event has
occurred in the interaction volume, e.g., a cell. The probability density of the single
event specific energy, fl(z), is the derivative of Fl(z) with respect to z:
dF (z)() = dz ' (B.6)
It is also called the single event distribution or spectrum of z. The expectation value,
Z = f*Zf (z)dz, (B.7)
is called frequancy-mean specific energy per event. zF is a non-stochastic quantity.
(c) The umber,n, of energy deposition events which have contributed to a particular
specific energy, z, is, in general, distributed at random and may be described by a Poisson
distribution for the case of homogeneous distribution The mean event number, ii, is the
quotient of mean specific energy, Z, by the frequency-mean specifci enrgy per event, z,
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n= (B.8)
ZF
(d) It is useful to consider also the dose distribution of z per enrgy deposition event.
Let DI(z) be the fraction of absorbed dose per event delivered by energy deposition
events of specific energy less than or equal to z. The dose probability density, dl(z), is
the derivative of D1(z) with respective to z:
d, (z) = dD(z (B.9)dz
The expectation value,
ZD = Id(z)dz, (B.10)
is called the dose-mean specific energy per event. ZD is a non-stichastic quantity. The
relation between dl(z) and fl(z) and between ZDand ZFis:
d (z)= -fl(z), (B.11)
ZF
and
1 - 2f, = z f1 (z)dz, (B.12)
ZF
The dose-mean specific energy per event, Z, is basically a measure of the effective
"size" of the "self-weighted" specific energy that deposited to the target per event. One
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would expect that it is a LET dependent quantity which can be used to determine the
degree of damage a the cellular level.
The quantities defined in this section are adapted from the ICRU Report 36 which
was suggested to be a standard guidance in microdosimetry.
II. Microdosimetry and RBE
All ionizing radiations produce the same initial products, namely ionizations and
excitations, and, furthurmore, about the same number of suchproducts per unit energy
imparted to a particular irradiation medium, irrespective of the radiation types.
Therefore, differences in radiation effectiveness must be due to differences in the spatial
distributions of energy deposits in charged particle tracks. The action of radiation by
intra-track effects was considered by Neary and by Kellerer and Rossi. In the model of
Neary, it is assumed "that an aberration results from an exchange between two damaged
regions" and the same concepts is applied to "cell killing". In the theory of dual radiation
action proposed by Kellerer and Rossi, it is assumed trhat the response of the cell can be
characterized as a second order reaction which is interpreted as an interaction of two
sublesions. If the number of sublesions in a particular sensitive volume is proposional to
specific energy, z, in the target volume, the expectation value for the number of lesions,
co, is proportional to the square of z:
co(z) = Kz2 . (B.13)
The proportionality constant, K, incorporates the probability of combination of sublesions
and formation of lesions. In the first approximation of the dual radiation action theory,
i.e., the "site" formulation, the mean number of lesions, as a function of absorbed dose,
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w(D), is obtained by averaging over o(z) for all sensitive volumes. Utilizing the
distribution of specific energy, f(z,D), at a given dose value, D, one obtains:
ao(D)= k. z2f(z,D)dz. (B. 14)
The relation between the mean number of lesions and survival is complex. It depends on
biological response of the cells being irradiated, characteristics of the radiation, radiation
modifliers involved, e.g., oxygen levels, fractionation, dose rate, etc. However, the
evaluation of RBE from equation (B.14) can be accomplished if it is assumed that equal
numbers of lesions results in equal survival levels.
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Appendix C
Macro Language for the 2D Monte Carlo Code
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macro 'Monte Carlo [Fl]';
var
image,results, dump,roiLeft,roiTop,roiWidth,roiHeight:integer;
h,v,value,MaxWidth,MaxHeight,width,height,width 1,height 1,TotArea: integer;
nPixels,nn,m,i,j,B 10Num,DeltaX,NuclPixel:integer;
nLength,nPaths,vv,hh,mm,pp,hl ,v 1,PixelValue,kk:integer;
NuclFrac,theta,mpp,TotEnergy,NuclEnergy,PerEnergy,NuclOrigin,NuclPos:real;
AlphaEn,LithiumEn,MeanLET,MeanTrack,TotalLET,LL,PreEn,AveEn:real;
En 1,En2,x 1 l,x2:integer;
InputFileName,InputPrompt: String;
begin
AlphaEn:=2516.09;
rUserl [1]:=228.98;
rUser1 [2]:=232.62;
rUser 1[3]:=233.66;
rUser 1[4]:=232.09;
rUser 1[5]:=227.92;
rUserl [6]:=221..15;
rUserl[7]:=211.77;
rUser 1[8]:= 199.79;
rUser 1 [9]:= 185.20;
rUser [10]:=168.01;
rUserl [11]:=148.22;
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rUserl [12]:=125.82;
rUserl[13]:=100.82;
rUserl[14]:=75.12;
LithiumEn:= 1408.2;
rUser2[1]:=271.44;
rUser2[2]:=253.31;
rUser2[3]:=230.61;
rUser2[4]:=203.35;
rUser2[5]:=171.52;
rUser2[6]:=135.13;
rUser2[7]:=94.17;
rUser2[8]:=48.64;
SetOptions('Area,Mean,Major');
for i:=1 to 256 do begin
rArea[i]:=i;
rMean[i]:=i*i;
rMajor[i]:= 100*sin(3.14116*i/2.0);
end;
SetCounter(256);
PutMessage('Select the nucleus profile file');
Open(");
image:=PicNumber;
MoveWindow(130,40);
GetPicSize(widthl,heightl);
TotArea:=widthl *heightl;
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NuclPos:=O;
NuclOrigin:=0.O;
NuclPixel:=0;
Measure;
NuclPixel:=histogram[O0];
width:=120;
height:=130;
SetNewSize(width,height);
MakeNewWindow('E %');
MoveWindow(5,345);
SetForegroundColor(2);
SetBackgroundColor(0);
results:=PicNumber;
MoveTo(O, 110);
LineTo(120,110);
MoveTo(10,0);
LineTo(10,120);
for m:=0 to 11. do begin
MoveTo(8,m* 10);
LineTo(12,m* 10);
MoveTo(m* 10,108);
LineTo(m* 10,112);
end;
SetForegroundColor(255);
MoveTo(35,125);
DrawText('No. of Trials');
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MoveTo(9,125);
DrawText('O');
MoveTo( 107,125);
DrawText(' 10k');
SetForegroundColor(255);
SetBackgroundColor(O);
width:=120;
height:=280;
SetNewSize(width,height);
MakeNewWindow('Monte');
dump:=PicNumber;
MoveWindow(5,40);
SetFont('Times');
SetFontSize(9);
SetText('With background; Left Justified');
MoveTo(10,10);
DrawText('Picture Width =');
MoveTo(90,10);
DrawNumber(width 1);
MoveTo(10,25);
DrawText('Picture Height =');
MoveTo(90,25);
DrawNumber(height 1l);
B 10Num:= 1000;
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mpp:=GetNumber('gnm/pixel[300dpi=0.576] =',0.576);
SelectPic(image);
DeltaX:=Round(TotArea/B 10Num);
SelectPic(dump);
MoveTo( 10,40);
DrawText('Alpha: 7.7 gm,');
m:=AlphaEn*mpp;
MoveTo(70,40);
DrawNumber(m);
MoveTo(95,40);
DrawText('keV');
MoveTo(10,55);
DrawText('Li-.7: 4.8 gm,');
m:=LithiumEn*mpp;
MoveTo(70,55);
DrawNumber(m);
MoveTo(95,55);
DrawText('keV');
MoveTo(10,140);
DrawText('Mean Abs. E % =');
MoveTo(10,160);
DrawText('B-10 Origin % =');
MoveTo(10,180);
DrawText('Mean LET
MoveTo(10,200);
DrawText('Mean Track (gm) =');
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nPixels:=0;
{ Random distribution I
SetForeground(1); { Red)
mm:=O;
MoveTo(10,70);
DrawText('Random B 10 Simulation');
MoveTo(10,410);
DrawText('-Click MOUSE to Stop-');
NuclEnergy:=NuclPixel* 1.0/TotArea;
MoveTo(10,120);
DrawText('Nuclear Fraction: ');
MoveTo(90,120);
DrawNumber(NuclEnergy);
nPaths:=(4.81.+7.7)/mpp;
TotEnergy:=0;
NuclEnergy:=--0;
NuclOrigin:=0;
NuclPos:=0;
SetForeground(255); {Black
mm:=0;
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kk:=O; {kk*mpp= Total Track Length in gmm}
pp:=O;
repeat
mm:=mm+ 1;
PerEnergy:= 100.0*NuclEnergy/(AlphaEn+LithiumEn)/mm;
if(mm=99) then begin
AveEn:=PerEnergy;
PreEn:=AveEn;
ChoosePic(results);
MoveTo(0,4);
DrawNumber(AveEn+5);
MoveTo(O, 110);
DrawNumber(AveEn-5);
end;
LL:=mm MOD 100.0;
if (LL=O) then begin
ChoosePic(results);
pp:=pp+1;
En 1:=60-(PreEn-AveEn)* 10;
En2:=60-(PerEnergy-AveEn)* 10;
xl:=pp;
x2:=pp+1;
MoveTo(xl+10,Enl);
LineTo(x2+10,En2);
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PreEn:=PerEnergy;
end;}
NuclOrigin:= 100.0*NuclPos/mm;
MeanTrack: =kk*mpp/mm;
ChoosePic(dump);
MoveTo(85,140);
DrawNumber(PerEnergy);
MoveTo(85,160);
DrawNumber(NuclOrigin);
MoveTo(85,180);
DrawNumber(MeanLET);
MoveTo(85,200);
DrawNumber(MeanTrack);
v:=height 1 *random;
h: =width 1 *random;
vl:=round(v);
hl:=round(h);
ChoosePic(image);
v:=GetPixel(vl,hl);
if((v=0) or (v=2)) then begin
PutPixel(vl,hl,2);
NuclPos:=NuclPos+1.0;
end;
if((v=1) or (v=255)) then
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PutPixel(v1,hl,255);
ChoosePic(dump);
MoveTo(10,85);
DrawText('Now ->');
MoveTo(50,85);
DrawNumber(mm);
MoveTo(10,100);
DrawText('[X,Y]= ');
MoveTo(55, 100);
Drawnumber(v 1);
MoveTo(85,100);
Drawnumber(hl);
ChoosePic(image);
MoveTo(vl ,hl);
theta:=360.0*random;
nLength:=0;
for m:= 1 to 14 do begin
nLength:=nLength+1.0;
hh:=hl+nLength*sin(theta);
vv:=v 1 +nLength*cos(theta);
hh:=round(hh);
vv:=round(vv);
if((hh>0) and (hh<widthl))
then
if((vv>0) and (vv<heightl))
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then begin
PixelValue:=GetPixel(vv,hh);
{ LineTo(vv,hh); }
if((PixelValue=0) or (PixelValue=2)) then begin
PutPixel(vv,hh,2);
NuclEnergy:=NuclEnergy+rUserl [m];
kk:=kk+1;
TotalLET:=TotalLET+rUser l [m];
MeanLET:=TotalLET/kk;
end;
if((PixelValue=1) or(PixelValue=255)) then
PutPixel(vv,hh,255);
end;
end;
nLength:=0;
for m:= 1 to 8 do begin
nLength:=nLength+1.0;
hh:=hl-nLength*sin(theta);
vv:=v 1-nLength*cos(theta);
hh:=round(hh);
vv:=round(vv);
if((hh>0) and (hh<widthl))
then
if((vv>0) and (vv<heightl))
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then begin
PixelValue:=GetPixel(vv,hh);
{ LineTo(vv,hh); }
if((PixelValue=0) or (PixelValue=2)) then begin
PutPixel(vv,hh,2);
NuclEnergy:=NuclEnergy+rUser2[m];
kk:=kk+1;
TotalLET:=TotalLET+rUser2[m];
MeanLET:=TotalLET/kk;
end;
if((PixelValue=1) or(PixelValue=255)) then
PutPixel(vv,hh,255);
end;
end;
until Button;
ShowResults;
end;
macro 'Show Read text file [F2]';
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begin
SetOptions('Userl ');
SetPrecision(3);
SetCounter(9);
SetUserlLabel ('Read Text');
ShowResults;
end;
macro 'Homo Tracks';
var
i,j,k,L,m:integer;
LL,dum:real;
begin
k:=0;
for i:=0 to 511 do
for j:=0 to 511 do begin
k:=k+1;
LL:=k MOD 323.0;
if(LL=0) then PutPixel(i,j,250);
end;
end;
macro 'Pixel exchange-Gray';
var
i,j,k,value,width 1,height 1l:integer;
begin
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PutMessage('Enter the Image file to change pixel value.');
Open(");
GetPicSize(widthl,heightl);
for i:=0 to heightl-1 do
for j:=0 to widthl-1 do begin
value:=GetPixel(i,j);
if(value=0) then k:=O;
if(value>0) then k:= 1;
if(k=0) then begin
value:=59;
PutPixel(i,j,value);
end;
if(k=1) then begin
value:=0;
PutPixel(i,j,value);
end;
end;
end;
macro 'Red-Gray';
var
i,j,k,value,widthl ,heightl:integer;
begin
PutMessage('Enter the Image file to change pixel value.');
Open(");
GetPicSize(widthl,height 1);
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for i:=0 to heightl-1 do
for j:=0 to widthl-1 do begin
value:=GetPixel(i,j);
if(value=0) then k:=O;
if(value= 1) then k:=1;
if(k=0) then begin
value:=59;
PutPixel(ij,value);
end;
if(k= 1) then begin
value:=0;
PutPixel(i,j,value);
end;
end;
end;
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